Cell Line Name,Disease Site,Sex,Age,Derived From Site,"European, South",Native American,African,"East Asian, North","European, North","East Asian, South",South Asian
1321N1,Astrocytoma,Male,47Y,Brain,0.81,0.0,1.06,1.62,96.5,0.0,0.0
143B,Osteosarcoma,Female,13Y,"Bone, right femur",58.98,0.0,0.0,0.0,0.0,4.02,37.0
201T,Lung adenocarcinoma,Male,68Y,Lung,5.55,0.0,88.81,2.58,3.06,0.0,0.0
22Rv1,Prostate carcinoma,Male,Adult,Prostate,30.62,0.23,0.89,0.52,67.46,0.0,0.27
23132/87,Gastric adenocarcinoma,Male,72Y,Stomach,39.98,0.35,3.42,1.75,54.5,0.0,0.0
42-MG-BA,Glioblastoma,Male,63Y,"Brain, temporal lobe",31.9,0.0,0.01,4.88,63.22,0.0,0.0
451Lu,Cutaneous melanoma,Male,22Y,"Arm, skin",29.61,1.32,0.0,0.06,67.32,0.98,0.7
5637,Bladder carcinoma,Male,68Y,Urinary bladder,11.89,0.45,30.56,11.48,4.97,40.31,0.35
59M,High grade ovarian serous adenocarcinoma,Female,65Y,Ascites,33.91,0.0,3.2,4.18,58.71,0.0,0.0
639V,Ureter urothelial carcinoma,Male,69Y,Ureter,24.62,0.0,0.0,0.0,74.77,0.6,0.0
647V,Bladder carcinoma,Male,59Y,Urinary bladder,32.52,0.0,1.52,1.95,64.01,0.0,0.0
697,Childhood B acute lymphoblastic leukemia,Male,12Y,Bone marrow,33.02,0.55,0.56,0.0,65.87,0.0,0.0
769-P,Renal cell carcinoma,Female,63Y,Kidney,27.0,0.0,1.32,3.45,68.23,0.0,0.0
786-O,Renal cell carcinoma,Male,58Y,Kidney,29.12,0.0,0.77,4.36,65.75,0.0,0.0
8-MG-BA,Glioblastoma,Female,54Y,"Brain, frontal lobe",33.19,0.1,0.0,2.53,61.9,0.0,2.29
8305C,Thyroid gland anaplastic carcinoma,Female,67Y,Thyroid gland,0.09,1.04,0.0,74.78,0.0,24.09,0.0
8505C,Thyroid gland anaplastic carcinoma,Female,78Y,Thyroid gland,2.8,0.0,0.58,84.79,0.0,11.83,0.0
A-1207,Glioblastoma,Sex unspecified,Age unspecified,Unknown,32.81,0.0,0.38,3.29,63.52,0.0,0.0
A-172,Glioblastoma,Male,53Y,Brain,27.77,0.0,0.0,2.05,68.98,0.0,1.21
A-204,Embryonal rhabdomyosarcoma,Female,1Y,Muscle,27.82,0.2,0.0,0.35,70.8,0.0,0.83
A-253,Submandibular gland squamous cell carcinoma,Male,54Y,"Salivary gland, submandibular gland",35.39,0.0,0.97,1.81,61.82,0.0,0.0
A-375,Amelanotic melanoma,Female,54Y,"Leg, skin",29.75,0.49,0.84,1.69,67.22,0.0,0.0
A-388,Skin squamous cell carcinoma,Male,86Y,Lymph node,41.03,0.32,4.06,3.84,50.76,0.0,0.0
A-427,Lung adenocarcinoma,Male,52Y,Lung,24.43,0.4,0.0,1.31,71.98,0.28,1.59
A-431,Skin squamous cell carcinoma,Female,85Y,"Skin, epidermis",65.16,0.0,3.82,7.84,17.15,0.0,6.03
A-498,Renal cell carcinoma,Male,52Y,Kidney,34.06,0.0,0.37,2.1,63.47,0.0,0.0
A-549,Lung adenocarcinoma,Male,58Y,Lung,33.16,0.0,0.0,0.72,66.12,0.0,0.0
A-673,Ewing sarcoma,Female,15Y,Muscle,28.57,0.0,0.54,1.77,69.11,0.0,0.0
A-704,Renal cell carcinoma,Male,78Y,Kidney,20.13,0.0,71.07,6.26,2.53,0.0,0.0
A101D,Melanoma,Male,56Y,Lymph node,27.21,0.0,0.0,0.99,71.28,0.0,0.52
A2058,Amelanotic melanoma,Male,43Y,Lymph node,26.84,0.45,0.0,0.51,71.7,0.0,0.49
A2780,Ovarian endometrioid adenocarcinoma,Female,Age unspecified,Ovary,4.17,0.0,93.08,2.76,0.0,0.0,0.0
A3/Kawakami,Diffuse large B-cell lymphoma,Female,68Y,Ascites,0.0,0.0,0.0,79.02,0.43,20.54,0.0
A4/Fukuda,Adult B acute lymphoblastic leukemia,Female,52Y,Ascites,0.0,0.0,0.0,75.76,0.0,24.23,0.0
ABC-1,Lung adenocarcinoma,Male,47Y,Pleural effusion,1.09,0.92,0.72,78.6,0.0,18.68,0.0
ACC-MESO-1,Pleural epithelioid mesothelioma,Female,61Y,"Lung, pleura",0.85,0.64,1.98,84.83,0.0,11.7,0.0
ACHN,Papillary renal cell carcinoma,Male,22Y,Pleural effusion,25.34,0.0,0.0,0.83,70.53,1.52,1.78
ACN,Melanoma,Sex unspecified,Age unspecified,Unknown,27.16,0.69,0.3,0.0,70.67,0.16,1.02
AGS,Gastric adenocarcinoma,Female,54Y,Stomach,31.12,32.25,3.44,5.38,27.58,0.0,0.23
ALL-PO,Childhood B acute lymphoblastic leukemia,Female,4M,Bone marrow,41.49,0.07,0.0,2.2,52.99,1.8,1.45
ALL-SIL,Childhood T acute lymphoblastic leukemia,Male,17Y,Peripheral blood,51.09,0.0,1.38,1.27,39.53,1.49,5.24
AM-38,Glioblastoma,Male,36Y,"Brain, left occipital lobe",2.85,0.0,1.14,90.78,0.0,5.24,0.0
AML-193,Childhood acute myeloid leukemia,Female,13Y,Peripheral blood,16.74,0.0,65.28,3.56,14.42,0.0,0.0
AMO1,Plasma cell myeloma,Female,64Y,Ascites,1.66,0.0,1.35,79.12,0.0,17.86,0.0
AN3-CA,Acanthosis nigricans,Female,55Y,Lymph node,31.54,0.0,0.36,0.85,62.96,1.08,3.21
ARH-77,Unknown,Female,33Y,Peripheral blood,61.25,0.38,2.24,0.0,25.32,2.18,8.63
ASH-3,Thyroid gland anaplastic carcinoma,Female,68Y,Thyroid gland,0.0,0.08,0.0,79.16,0.0,20.41,0.34
AsPC-1,Pancreatic ductal adenocarcinoma,Female,62Y,Ascites,37.57,0.0,0.97,3.23,58.23,0.0,0.0
ATN-1,Adult T acute lymphoblastic leukemia,Male,47Y,Peripheral blood,1.95,0.05,0.0,78.58,0.0,17.98,1.43
AU565,Breast adenocarcinoma,Female,43Y,Pleural effusion,34.08,0.0,0.17,1.67,64.07,0.0,0.01
AZ-521,Duodenal adenocarcinoma,Male,53Y,"Small intestine, duodenum",9.12,0.0,78.39,1.7,10.56,0.0,0.23
B-CPAP,Poorly differentiated thyroid gland carcinoma,Female,76Y,Thyroid gland,50.97,1.26,0.56,0.45,43.75,1.09,1.92
BALL-1,Adult B acute lymphoblastic leukemia,Male,75Y,Peripheral blood,0.0,0.0,0.0,81.09,0.0,18.9,0.0
BB30-HNC,Head and neck squamous cell carcinoma,Female,Age unspecified,Unknown,27.6,0.0,0.71,0.53,70.27,0.0,0.89
BB49-HNC,Floor of mouth squamous cell carcinoma,Female,70Y,Unknown,38.06,0.55,0.66,0.98,57.6,0.0,2.14
BB65-RCC,Renal cell carcinoma,Male,Age unspecified,Kidney,35.82,1.94,0.53,1.65,59.69,0.0,0.38
BC-1,Primary effusion lymphoma,Male,46Y,Ascites,30.53,0.64,0.0,0.52,67.92,0.0,0.4
BC-3,Primary effusion lymphoma,Male,85Y,Pleural effusion,53.67,1.02,7.13,6.58,25.3,0.0,6.31
BC-3C,Bladder carcinoma,Female,82Y,Urinary bladder,52.49,0.28,1.78,4.58,37.13,0.0,3.73
BCP-1,Primary effusion lymphoma,Male,94Y,Peripheral blood,62.51,0.07,1.81,2.0,24.92,0.6,8.1
BDCM,Acute myeloid leukemia,Male,Age unspecified,Peripheral blood,26.97,0.0,0.02,0.0,70.49,0.0,2.51
BE-13,Childhood T acute lymphoblastic leukemia,Female,4Y,Peripheral blood,69.88,1.38,3.02,0.0,13.65,1.18,10.89
Becker,Astrocytoma,Male,57Y,Brain,65.17,0.96,0.35,1.31,21.76,0.09,10.35
BEN,Lung non-small cell carcinoma,Male,71Y,Supraclavicular lymph node,33.78,0.0,2.03,4.23,59.95,0.0,0.0
BFTC-905,Bladder carcinoma,Female,51Y,Urinary bladder,3.98,0.0,0.82,33.39,0.0,61.81,0.0
BFTC-909,Renal pelvis urothelial carcinoma,Male,64Y,"Kidney, renal pelvis",1.02,0.0,0.0,27.83,0.0,71.15,0.0
BGC-823,Human papillomavirus-related cervical adenocarcinoma,Female,30Y6M,"Uterus, cervix",13.96,0.77,65.99,2.9,16.38,0.0,0.0
BHT-101,Thyroid gland anaplastic carcinoma,Female,63Y,Lymph node,37.97,0.75,0.56,2.42,57.43,0.0,0.87
BHY,Alveolar ridge squamous cell carcinoma,Male,52Y,"Oral cavity, alveolar ridge",1.09,1.12,0.0,81.47,0.0,16.1,0.22
BICR 10,Buccal mucosa squamous cell carcinoma,Female,Age unspecified,"Oral cavity, buccal mucosa",27.87,0.0,0.05,0.01,71.25,0.0,0.82
BICR 16,Tongue squamous cell carcinoma,Male,Age unspecified,"Oral cavity, tongue",35.88,0.0,0.43,3.56,60.13,0.0,0.0
BICR 18,Laryngeal squamous cell carcinoma,Male,Age unspecified,Lymph node,38.08,0.0,6.55,7.21,48.15,0.0,0.0
BICR 22,Tongue squamous cell carcinoma,Male,88Y,Lymph node,43.71,0.0,9.32,10.18,36.79,0.0,0.0
BICR 31,Tongue squamous cell carcinoma,Male,Age unspecified,"Oral cavity, tongue",34.81,0.0,1.67,1.96,61.56,0.0,0.0
BICR 56,Tongue squamous cell carcinoma,Female,Age unspecified,"Oral cavity, tongue",28.56,1.04,0.75,1.39,67.74,0.0,0.51
BICR 6,Hypopharyngeal squamous cell carcinoma,Male,Age unspecified,"Pharynx, hypopharynx",36.88,0.0,4.56,5.39,53.16,0.0,0.0
BICR 78,Alveolar ridge squamous cell carcinoma,Male,Age unspecified,"Oral cavity, alveolar ridge",28.89,1.14,3.26,2.29,63.51,0.0,0.91
BJ1-hTERT,Unknown,Male,<1M,"Foreskin, skin",24.72,0.6,0.29,1.01,73.33,0.0,0.05
BL-41,Burkitt lymphoma,Male,8Y,Unknown,40.71,0.06,0.05,0.0,57.31,0.52,1.34
BL-70,Burkitt lymphoma,Male,16Y,Unknown,42.5,1.03,2.11,0.85,52.49,0.0,1.04
BONNA-12,Hairy cell leukemia,Male,46Y,Spleen,26.91,0.0,0.35,1.04,71.7,0.0,0.0
BPH-1,Benign prostatic hyperplasia,Male,68Y,Prostate,29.17,0.0,0.0,1.5,66.48,0.02,2.82
BT-20,Invasive breast carcinoma of no special type,Female,74Y,Breast,41.56,0.0,5.3,9.54,43.6,0.0,0.0
BT-474,Invasive breast carcinoma of no special type,Female,60Y,Breast,26.74,0.0,0.6,2.47,70.19,0.0,0.0
BT-483,Invasive breast carcinoma of no special type,Female,23Y,Breast,41.87,0.0,3.96,5.8,48.37,0.0,0.0
BT-549,Invasive breast carcinoma of no special type,Female,72Y,Breast,62.87,0.0,0.21,3.6,26.05,0.0,7.26
BV-173,"Chronic myelogenous leukemia, BCR-ABL1 positive",Male,45Y,Peripheral blood,41.77,0.0,1.38,2.14,52.2,0.0,2.51
BxPC-3,Pancreatic ductal adenocarcinoma,Female,61Y,Pancreas,27.79,0.0,1.55,1.41,69.25,0.0,0.0
C-33 A,Human papillomavirus-independent cervical squamous cell carcinoma,Female,66Y,"Uterus, cervix",31.19,0.33,0.41,0.48,66.58,0.19,0.82
C-4-I,Human papillomavirus-related cervical squamous cell carcinoma,Female,41Y,"Uterus, cervix",25.76,0.73,0.0,0.0,72.49,0.0,1.02
C2BBe1,Colon adenocarcinoma,Male,72Y,Colon,40.62,0.0,0.0,1.84,57.43,0.11,0.0
C32 [Human melanoma],Amelanotic melanoma,Male,53Y,Skin,33.45,1.03,0.0,2.04,63.48,0.0,0.0
C8166,Unknown,Male,<1D,Umbilical cord blood,33.5,0.05,0.3,1.72,64.43,0.0,0.0
Ca Ski,Human papillomavirus-related cervical squamous cell carcinoma,Female,40Y,Small intestine,28.76,0.0,1.02,1.86,68.36,0.0,0.0
CA46,Burkitt lymphoma,Male,Age unspecified,Ascites,13.32,0.85,33.18,7.55,9.41,35.68,0.0
Ca9-22,Gingival squamous cell carcinoma,Male,43Y,"Oral cavity, gingiva",0.49,0.0,0.96,79.73,0.0,18.82,0.0
Caco-2,Colon adenocarcinoma,Male,72Y,Colon,44.73,0.0,3.33,4.59,47.35,0.0,0.0
CADO-ES1,Ewing sarcoma,Female,19Y,Pleural effusion,0.48,0.72,1.63,75.38,0.0,21.78,0.0
Caki-1,Clear cell renal cell carcinoma,Male,49Y,Skin,58.26,0.91,1.09,2.59,28.81,0.47,7.88
Caki-2,Papillary renal cell carcinoma,Male,69Y,Kidney,33.76,0.61,0.0,1.28,64.34,0.0,0.0
CAL-120,Breast carcinoma,Female,43Y,Pleural effusion,42.29,0.0,1.62,3.74,51.79,0.0,0.57
CAL-12T,Lung non-small cell carcinoma,Male,Age unspecified,Lung,40.37,0.91,0.12,2.34,56.03,0.23,0.0
CAL-148,Breast carcinoma,Female,58Y,Pleural effusion,48.96,0.26,3.17,2.18,44.85,0.0,0.58
CAL-27,Tongue adenosquamous carcinoma,Male,56Y,"Oral cavity, tongue",40.51,0.0,2.22,2.6,54.66,0.0,0.0
CAL-29,Bladder carcinoma,Female,80Y,Urinary bladder,45.18,0.1,0.0,2.83,51.89,0.0,0.0
CAL-33,Tongue squamous cell carcinoma,Male,69Y,"Oral cavity, tongue",49.56,0.0,0.92,2.32,46.86,0.33,0.0
CAL-39,Vulvar squamous cell carcinoma,Female,76Y,Vulva,59.19,0.78,2.88,0.0,26.43,1.64,9.08
CAL-51,Breast carcinoma,Female,45Y,Pleural effusion,40.31,0.75,0.0,0.86,55.8,0.0,2.28
CAL-54,Renal cell carcinoma,Male,75Y,Pleural effusion,45.35,0.0,0.26,0.0,51.11,0.56,2.72
CAL-62,Thyroid gland anaplastic carcinoma,Female,70Y,Thyroid gland,50.02,0.27,0.55,1.91,46.22,0.0,1.04
CAL-72,Osteosarcoma,Male,10Y,"Bone, patella",5.91,0.09,67.94,1.27,0.0,0.0,24.79
CAL-78,Dedifferentiated chondrosarcoma,Male,76Y,"Thigh, skeletal muscle",67.96,0.0,7.03,6.11,15.05,0.0,3.86
CAL-85-1,Breast carcinoma,Female,35Y,Breast,7.0,0.0,0.83,4.79,0.0,0.0,87.38
Calu-1,Lung squamous cell carcinoma,Male,47Y,Pleural effusion,57.8,0.74,0.0,0.11,31.4,0.0,9.94
Calu-3,Lung adenocarcinoma,Male,25Y,Pleural effusion,29.51,0.0,0.63,2.09,67.76,0.0,0.0
Calu-6,Lung adenocarcinoma,Female,61Y,Pleural effusion,32.08,0.95,0.17,0.74,66.06,0.0,0.0
CAMA-1,Breast adenocarcinoma,Female,51Y,Pleural effusion,31.74,0.0,0.37,1.38,66.52,0.0,0.0
Caov-3,High grade ovarian serous adenocarcinoma,Female,54Y,Ovary,68.85,0.12,2.29,2.22,11.3,0.0,15.22
Caov-4,High grade ovarian serous adenocarcinoma,Female,45Y,"Fallopian tube, subserosa",27.94,0.0,0.23,4.8,67.03,0.0,0.0
Capan-1,Pancreatic ductal adenocarcinoma,Male,40Y,Liver,66.44,0.56,1.95,4.79,19.06,0.11,7.09
Capan-2,Pancreatic ductal adenocarcinoma,Male,56Y,Pancreas,35.95,0.63,0.28,0.28,62.52,0.0,0.34
CaR-1,Rectal adenocarcinoma,Male,70Y,Left inguinal lymph node,0.0,0.0,0.0,77.73,0.0,21.34,0.92
CAS-1,Glioblastoma,Male,63Y,Brain,49.46,0.58,0.0,0.0,46.51,0.08,3.36
CCF-STTG1,Astrocytoma,Female,68Y,Brain,36.87,0.0,0.55,1.13,60.84,0.0,0.6
CCK-81,Colon adenocarcinoma,Female,62Y,Lymph node,0.0,1.38,0.0,77.93,0.0,20.68,0.0
CCRF-CEM,Childhood T acute lymphoblastic leukemia,Female,3Y11M,Peripheral blood,28.85,0.21,0.2,0.43,69.4,0.09,0.81
CESS,Adult acute myeloid leukemia,Male,Adult,Peripheral blood,59.54,0.8,6.92,5.8,21.66,0.0,5.27
CFPAC-1,Cystic fibrosis,Male,26Y,Liver,45.18,0.0,3.95,5.48,45.39,0.0,0.0
CGTH-W-1,Thyroid gland squamous cell carcinoma,Male,59Y,Thyroid gland,32.03,2.04,0.0,0.24,64.53,0.0,1.16
CH-157MN,Meningioma,Female,41Y,"Brain, meninges",38.99,0.0,0.5,2.54,57.82,0.0,0.15
ChaGo-K-1,Bronchogenic carcinoma,Male,45Y,Hypodermis,34.97,0.0,1.18,3.52,59.93,0.0,0.39
CHL-1,Melanoma,Female,36Y,Pleural effusion,31.21,0.0,0.0,0.39,68.4,0.0,0.0
CHP-126,Neuroblastoma,Female,1Y2M,Retroperitoneal space,31.9,0.41,0.0,1.27,65.66,0.0,0.75
CHP-134,Adrenal gland neuroblastoma,Male,1Y1M,Adrenal gland,28.62,0.0,0.04,0.15,70.26,0.0,0.93
CHP-212,Neuroblastoma,Male,1Y8M,Brain,25.19,0.0,2.16,1.09,70.26,0.43,0.86
CHSA0011,Chondrosarcoma,Male,Unknown,Unknown,29.42,0.01,1.37,3.14,66.06,0.0,0.0
CHSA0108,Chondrosarcoma,Male,Unknown,Unknown,32.32,0.79,2.14,1.29,63.46,0.0,0.0
CHSA8926,Chondrosarcoma,Male,Unknown,Unknown,26.02,0.93,0.0,0.0,68.86,0.11,4.08
Ci-1,B-cell non-Hodgkin lymphoma,Female,38Y,Ascites,54.11,0.0,0.56,0.29,34.89,1.5,8.65
CJM [Human melanoma],Melanoma,Unknown,Unknown,Unknown,0.4,0.61,0.43,76.74,0.0,21.81,0.0
CL-11,Colon adenocarcinoma,Male,Age unspecified,Colon,34.59,0.0,0.97,2.17,62.27,0.0,0.0
CL-14,Colon adenocarcinoma,Male,Age unspecified,"Colon, sigmoid",39.58,0.0,3.68,5.8,50.95,0.0,0.0
CL-34,Colon adenocarcinoma,Female,Age unspecified,Colon,21.37,0.86,0.8,2.45,74.0,0.0,0.51
CL-40,Colon adenocarcinoma,Female,Age unspecified,Colon,27.8,0.13,0.0,0.0,71.2,0.86,0.0
CMK,Down syndrome,Male,10M,Peripheral blood,2.33,0.0,0.58,93.95,0.0,3.14,0.0
CMK-11-5,Down syndrome,Male,10M,Peripheral blood,3.94,0.0,0.58,95.47,0.0,0.0,0.0
CMK-86,Down syndrome,Male,10M,Peripheral blood,0.0,0.34,0.0,91.48,0.0,8.18,0.0
CML-T1,"Chronic myelogenous leukemia, BCR-ABL1 positive",Female,36Y,Peripheral blood,0.92,0.0,0.0,71.95,0.0,26.83,0.3
COLO 201,Colon adenocarcinoma,Male,70Y,Ascites,47.3,0.0,13.18,12.19,27.33,0.0,0.0
COLO 205,Colon adenocarcinoma,Male,70Y,Ascites,36.53,0.0,0.0,2.08,61.39,0.0,0.0
COLO 320,Colon adenocarcinoma,Female,55Y,"Colon, sigmoid",80.72,2.1,0.51,3.77,3.59,0.13,9.18
COLO 320HSR,Colon adenocarcinoma,Female,55Y,"Colon, sigmoid",78.44,2.14,0.0,0.47,6.29,2.14,10.52
COLO 668,Lung small cell carcinoma,Female,47Y,Brain,45.77,16.55,2.4,3.63,28.55,0.0,3.09
COLO 678,Colon carcinoma,Male,69Y,Lymph node,35.83,0.29,2.56,3.34,57.97,0.0,0.0
COLO 679,Cutaneous melanoma,Female,47Y,Soft tissue,32.79,0.0,0.0,0.47,65.46,0.33,0.94
COLO 680N,Esophageal squamous cell carcinoma,Female,57Y,Esophagus,12.54,0.0,83.09,4.36,0.0,0.0,0.0
COLO 684,Endometrial adenocarcinoma,Female,63Y,Endometrium,30.43,0.0,0.0,2.07,67.5,0.0,0.0
COLO 704,High grade ovarian serous adenocarcinoma,Female,46Y,Ascites,30.15,0.08,0.0,1.33,68.17,0.27,0.0
COLO 741,Melanoma,Female,69Y,Pelvic wall,31.59,0.14,0.0,1.84,63.98,0.0,2.44
COLO 775,Plasma cell myeloma,Male,61Y,Peripheral blood,16.33,0.0,73.36,2.48,7.83,0.0,0.0
COLO 783,Melanoma,Female,48Y,Right axillary lymph node,30.81,0.51,0.0,1.36,67.32,0.0,0.0
COLO 792,Melanoma,Male,62Y,Brain,62.45,0.0,3.5,5.22,22.34,0.0,6.48
COLO 800,Cutaneous melanoma,Male,14Y,Hypodermis,56.06,0.0,0.0,0.05,40.03,0.97,2.89
COLO 818,Cutaneous melanoma,Male,14Y,Hypodermis,55.71,0.0,0.0,0.0,39.88,1.07,3.33
COLO 824,Breast carcinoma,Female,52Y,Pleural effusion,7.67,0.04,85.4,1.28,5.62,0.0,0.0
COLO 829,Cutaneous melanoma,Male,45Y,Skin,26.07,0.0,0.12,2.63,71.18,0.0,0.0
COLO 849,Cutaneous melanoma,Male,43Y,Right axillary lymph node,24.82,0.07,0.0,2.02,73.1,0.0,0.0
COR-L105,Lung adenocarcinoma,Male,Age unspecified,Pleural effusion,27.79,1.16,0.7,2.98,66.49,0.0,0.88
COR-L23,Lung large cell carcinoma,Male,62Y,Pleural effusion,28.32,0.14,0.0,1.45,69.11,0.0,0.98
COR-L24,Lung small cell carcinoma,Male,71Y,Lymph node,35.31,0.0,3.16,4.31,57.22,0.0,0.0
COR-L279,Lung small cell carcinoma,Male,63Y,Lymph node,34.17,0.3,2.83,2.65,60.06,0.0,0.0
COR-L303,Lung small cell carcinoma,Female,Age unspecified,Lung,28.16,0.33,1.07,2.4,68.04,0.0,0.0
COR-L311,Lung small cell carcinoma,Male,63Y,Lung,34.37,0.0,1.93,2.41,61.29,0.0,0.0
COR-L32,Lung squamous cell carcinoma,Sex unspecified,Age unspecified,Bone marrow,27.58,0.0,0.0,1.46,70.96,0.0,0.0
COR-L321,Lung carcinoma,Female,58Y,Unknown,32.26,0.0,0.0,0.7,67.03,0.0,0.0
COR-L47,Lung small cell carcinoma,Male,67Y,Bone marrow,34.99,0.43,1.67,2.28,59.47,0.0,1.16
COR-L51,Lung small cell carcinoma,Male,71Y,Pleural effusion,37.79,0.0,3.99,3.95,54.28,0.0,0.0
COR-L88,Lung small cell carcinoma,Male,55Y,Pleural effusion,36.74,0.0,2.68,2.39,58.19,0.0,0.0
COR-L95,Lung small cell carcinoma,Male,64Y,Lung,31.09,0.0,0.63,1.84,66.43,0.0,0.0
COV318,High grade ovarian serous adenocarcinoma,Female,Age unspecified,Ascites,27.85,0.0,0.0,1.46,70.13,0.0,0.55
COV362,High grade ovarian serous adenocarcinoma,Female,Age unspecified,Pleural effusion,33.05,0.2,1.85,3.12,61.78,0.0,0.0
COV434,"Ovarian small cell carcinoma, hypercalcemic type",Female,26Y,"Ovary, ovarian follicle, granulosa cell layer",36.51,0.68,1.5,0.76,60.55,0.0,0.0
COV504,Ovarian carcinoma,Female,Age unspecified,Pleural effusion,27.23,0.33,0.0,1.96,68.77,0.0,1.71
COV644,Ovarian mucinous adenocarcinoma,Female,Age unspecified,Ovary,57.17,0.0,1.23,3.96,16.37,0.0,21.27
CP50-MEL-B,Melanoma,Male,Age unspecified,Unknown,35.11,0.34,0.0,0.0,59.29,2.1,3.16
CP66-MEL,Melanoma,Male,Age unspecified,Unknown,29.58,0.27,0.0,0.56,67.46,0.0,2.13
CP67-MEL,Melanoma,Sex unspecified,Age unspecified,Unknown,35.28,0.46,0.09,0.0,64.17,0.0,0.0
CPC-N,Lung small cell carcinoma,Male,Age unspecified,Pleural effusion,42.0,0.0,0.41,0.58,55.27,0.17,1.56
CRO-AP2,Primary effusion lymphoma,Male,49Y,Pleural effusion,48.9,0.15,0.25,0.73,44.53,0.29,5.13
CRO-AP3,Primary effusion lymphoma,Male,42Y,Ascites,51.05,0.0,2.63,0.61,42.74,1.52,1.46
CS-1 [Human chondrosarcoma],Chondrosarcoma,Male,62Y,"Bone, humerus",29.41,0.36,0.0,1.25,68.97,0.0,0.0
CTB-1,Diffuse large B-cell lymphoma,Male,70Y,Pericardial effusion,0.0,0.23,0.0,25.3,0.0,74.47,0.0
CTV-1,Adult T acute lymphoblastic leukemia,Male,Age unspecified,Peripheral blood,46.55,1.28,1.02,0.0,45.18,0.34,5.64
CW-2,Colon adenocarcinoma,Female,55Y,Colon,0.0,0.0,0.0,75.46,0.0,24.54,0.0
D-245MG,Glioblastoma,Male,70Y,Brain,28.76,1.42,1.72,0.26,65.72,0.81,1.32
D-247MG,Gliosarcoma,Female,80Y,Brain,30.2,0.5,0.0,0.0,67.83,0.0,1.46
D-263MG,Glioblastoma,Female,71Y,Brain,31.01,1.08,0.41,0.75,63.92,0.0,2.84
D-336MG,Gliosarcoma,Male,68Y,Brain,28.79,0.37,0.62,0.73,68.29,0.0,1.2
D-392MG,Glioblastoma,Unknown,Adult,Brain,31.73,0.0,1.22,2.63,64.41,0.0,0.0
D-423MG,Glioblastoma,Male,Adult,Brain,28.1,0.32,0.0,1.3,68.67,1.42,0.18
D-502MG,Glioblastoma,Unknown,Adult,Brain,29.07,0.0,0.57,0.87,69.07,0.42,0.0
D-542MG,Glioblastoma,Female,Adult,Brain,3.16,2.46,0.45,53.35,1.0,39.58,0.0
D-566MG,Glioblastoma,Male,Adult,Brain,30.44,0.49,0.2,0.0,67.4,1.47,0.0
D283 Med,"Medulloblastoma, non-WNT/non-SHH, group 3",Male,6Y,Ascites,33.18,0.0,1.87,1.34,63.61,0.0,0.0
D341 Med,"Medulloblastoma, non-WNT/non-SHH, group 3",Male,3Y5M,"Brain, cerebellum",30.09,0.0,0.0,1.21,68.21,0.0,0.49
DAN-G,Pancreatic adenocarcinoma,Female,68Y,Pancreas,44.28,1.77,0.9,3.79,49.25,0.0,0.0
Daoy,"Medulloblastoma, SHH-activated, TP53-mutant",Male,4Y,"Brain, posterior fossa",32.54,0.0,0.45,1.54,64.36,0.0,1.1
Daudi,EBV-related Burkitt lymphoma,Male,16Y,Peripheral blood,4.74,0.12,91.6,2.24,0.0,0.0,1.3
DB,Diffuse large B-cell lymphoma germinal center B-cell type,Male,45Y,Ascites,29.16,0.0,0.0,0.4,67.72,0.73,1.98
DBTRG-05MG,Anaplastic astrocytoma,Female,59Y,Brain,63.44,0.0,0.0,0.59,16.56,0.0,19.4
DEL,"Anaplastic large cell lymphoma, ALK-positive",Male,12Y,Pleural effusion,40.18,0.0,0.65,1.56,56.65,0.0,0.96
Detroit 562,Pharyngeal squamous cell carcinoma,Female,Age unspecified,Pleural effusion,34.86,0.0,0.82,1.93,61.34,0.0,1.05
DG-75,Burkitt lymphoma,Male,10Y,Pleural effusion,62.01,1.16,1.72,0.0,25.56,1.7,7.84
DiFi,Colorectal carcinoma,Female,46Y,Ascites,40.55,0.44,2.91,1.85,54.25,0.0,0.0
DJM-1,Skin squamous cell carcinoma,Female,87Y,Skin,0.0,0.0,0.0,79.62,0.0,19.44,0.93
DK-MG,Glioblastoma,Female,67Y,"Brain, right parietal lobe",34.69,0.0,0.82,4.28,60.17,0.0,0.04
DLD-1,Colon adenocarcinoma,Male,67Y,Colon,32.2,0.31,0.0,0.0,64.92,0.3,2.26
DM-3,Pleural sarcomatoid mesothelioma,Male,62Y,"Lung, pleura",37.94,0.0,0.0,0.58,58.64,0.68,2.16
DMS 114,Thoracic SMARCA4-deficient undifferentiated tumor,Male,68Y,Lung,41.14,0.11,0.44,2.38,55.93,0.0,0.0
DMS 153,Lung small cell carcinoma,Male,44Y,Liver,43.66,0.56,0.64,3.7,51.44,0.0,0.0
DMS 273,Lung small cell carcinoma,Female,50Y,Pleural effusion,29.94,0.88,0.51,1.83,66.84,0.0,0.0
DMS 454,Lung small cell carcinoma,Male,Age unspecified,Lung,36.39,0.07,2.12,2.95,58.47,0.0,0.0
DMS 53,Lung small cell carcinoma,Male,54Y,Lung,37.36,0.0,2.98,4.32,55.34,0.0,0.0
DMS 79,Lung small cell carcinoma,Male,65Y,Pleural effusion,30.24,0.0,0.52,0.95,66.84,0.0,1.45
DND-41,Childhood T acute lymphoblastic leukemia,Male,13Y,Peripheral blood,45.76,0.0,1.28,1.0,46.97,0.0,4.99
DoHH2,Diffuse large B-cell lymphoma germinal center B-cell type,Male,60Y,Pleural effusion,27.92,1.29,0.28,0.0,69.22,0.0,1.29
DOK,Oral epithelial dysplasia,Male,57Y,"Oral cavity, tongue",29.51,0.7,0.41,2.72,66.66,0.0,0.0
DoTc2 4510,Cervical carcinoma,Female,Age unspecified,"Uterus, cervix",25.17,0.72,1.27,2.19,68.76,0.0,1.9
DOV13,Ovarian adenocarcinoma,Female,Age unspecified,Ovary,7.75,0.11,86.88,5.26,0.0,0.0,0.0
DSH1,Bladder carcinoma,Male,48Y,Urinary bladder,0.61,0.0,0.74,71.8,0.0,26.84,0.0
DU145,Prostate carcinoma,Male,69Y,Brain,32.8,0.0,0.75,2.66,63.74,0.0,0.04
DU4475,Breast carcinoma,Female,70Y,Skin,34.04,0.0,0.87,3.81,61.27,0.0,0.0
DV-90,Lung adenocarcinoma,Male,50Y,Pleural effusion,52.26,0.0,0.68,2.16,41.86,0.0,3.04
EB1,EBV-related Burkitt lymphoma,Female,9Y,"Bone, jaw, maxilla",3.27,0.0,94.08,1.53,0.0,0.0,1.12
EB2,EBV-related Burkitt lymphoma,Female,7Y,Ovary,4.8,0.0,92.74,2.43,0.0,0.0,0.02
EB3 [Human Burkitt lymphoma],EBV-related Burkitt lymphoma,Male,3Y,"Bone, jaw, maxilla",9.53,0.51,83.99,5.96,0.0,0.0,0.0
EBC-1,Lung squamous cell carcinoma,Male,69Y,Skin,2.73,0.0,1.01,85.35,0.0,10.91,0.0
EC-GI-10,Esophageal squamous cell carcinoma,Male,65Y,Lymph node,1.02,0.0,2.68,89.75,0.0,5.81,0.73
ECC10,Gastric small cell carcinoma,Male,73Y,Stomach,0.51,0.44,1.3,81.45,0.0,16.3,0.0
ECC12,Gastric small cell carcinoma,Male,63Y,Stomach,0.75,0.33,2.31,84.02,0.0,12.58,0.0
EFE-184,Endometrial carcinoma,Female,69Y,Ascites,38.76,0.31,0.39,1.81,58.73,0.0,0.0
EFM-19,Breast ductal carcinoma,Female,50Y,Pleural effusion,35.58,0.0,1.96,3.54,58.92,0.0,0.0
EFM-192A,Breast carcinoma,Female,46Y,Pleural effusion,29.07,0.0,0.34,2.91,67.61,0.0,0.06
EFO-21,Ovarian serous cystadenocarcinoma,Female,56Y,Ascites,31.61,0.0,1.88,4.99,61.52,0.0,0.0
EFO-27,Ovarian mucinous adenocarcinoma,Female,36Y,Omentum,27.58,0.0,0.18,1.36,70.88,0.0,0.0
EGI-1,Cholangiocarcinoma,Male,52Y,Bile duct,21.59,0.79,0.0,0.0,77.61,0.0,0.0
EHEB,Unknown,Female,69Y,Peripheral blood,27.82,1.03,0.0,0.0,69.25,0.0,1.9
EJM,Plasma cell myeloma,Female,58Y,Ascites,32.01,0.97,0.0,3.05,63.97,0.0,0.0
EKVX,Lung adenocarcinoma,Male,Age unspecified,Unknown,28.8,0.92,0.21,1.76,67.1,0.01,1.21
EM-2,"Childhood chronic myelogenous leukemia, BCR-ABL1 positive",Female,5Y,Bone marrow,28.35,0.0,0.62,2.74,68.28,0.0,0.0
EMC-BAC-1,Lung adenocarcinoma,Male,Age unspecified,Unknown,6.52,0.0,74.47,2.69,3.5,12.82,0.0
EMC-BAC-2,Lung adenocarcinoma,Sex unspecified,Age unspecified,Unknown,26.55,0.0,0.13,1.05,72.26,0.0,0.0
EN,Endometrial carcinoma,Female,50Y,Endometrium,1.18,0.0,0.78,80.75,0.4,16.89,0.0
EoL-1,"Chronic eosinophilic leukemia, not otherwise specified",Male,33Y,Peripheral blood,43.75,0.0,1.14,2.93,52.17,0.0,0.0
EPLC-272H,Lung mucoepidermoid carcinoma,Male,57Y,Unknown,48.24,0.0,7.58,9.18,35.01,0.0,0.0
ES-2,Ovarian clear cell adenocarcinoma,Female,47Y,Ovary,58.83,0.0,2.57,3.68,27.14,0.75,7.03
ES1,Ewing sarcoma,Female,Unknown,Unknown,27.13,0.47,0.83,0.13,70.63,0.0,0.81
ES3,Ewing sarcoma,Male,Unknown,Unknown,32.49,0.0,0.0,0.0,64.94,1.17,1.4
ES4,Ewing sarcoma,Male,Unknown,Unknown,26.22,7.84,1.29,0.0,61.75,1.09,1.81
ES5,Ewing sarcoma,Male,Unknown,Unknown,32.03,0.0,1.1,1.85,64.55,0.0,0.47
ES6,Ewing sarcoma,Male,Unknown,Unknown,29.16,0.0,0.0,0.57,67.61,0.0,2.66
ES7,Ewing sarcoma,Male,Unknown,Unknown,33.1,0.0,1.94,1.71,63.25,0.0,0.0
ES8,Ewing sarcoma,Male,10Y,Unknown,61.04,0.07,1.48,0.25,26.16,1.89,9.11
ESO-26,Gastroesophageal junction adenocarcinoma,Male,56Y,"Esophagus, distal",43.52,0.0,3.22,0.0,50.67,2.45,0.14
ESO-51,Esophageal adenocarcinoma,Male,74Y,"Esophagus, distal",43.9,0.59,3.22,0.0,50.02,1.07,1.19
ESS-1,Endometrioid stromal sarcoma,Female,76Y,Endometrium,31.95,0.0,0.37,1.73,65.49,0.0,0.47
ETK-1,Intrahepatic cholangiocarcinoma,Female,61Y,Ascites,4.05,0.0,3.1,74.88,0.67,17.31,0.0
Evsa-T,Breast carcinoma,Female,58Y,Ascites,67.19,1.1,0.86,2.9,19.45,0.0,8.5
EW-1,Ewing sarcoma,Male,19Y,Pleural effusion,44.3,1.76,0.04,0.0,53.73,0.0,0.17
EW-11,Ewing sarcoma,Female,11Y,Mediastinal lymph node,55.92,0.67,20.84,0.0,15.83,2.32,4.42
EW-12,Ewing sarcoma,Female,Age unspecified,Unknown,53.94,0.0,21.92,2.41,15.31,0.17,6.25
EW-13,Ewing sarcoma,Male,Age unspecified,Unknown,60.76,0.0,18.44,0.58,15.79,2.48,1.96
EW-16,Ewing sarcoma,Male,Age unspecified,Unknown,41.99,1.1,0.19,0.0,55.49,0.45,0.79
EW-18,Ewing sarcoma,Sex unspecified,Age unspecified,Unknown,30.15,0.97,0.0,0.41,68.25,0.0,0.22
EW-22,Ewing sarcoma,Sex unspecified,Age unspecified,Unknown,37.61,0.0,0.31,0.0,60.63,0.0,1.44
EW-24,Ewing sarcoma,Sex unspecified,Age unspecified,Unknown,38.28,0.0,0.0,0.0,60.48,1.24,0.0
EW-3,Ewing sarcoma,Male,14Y,Pleural effusion,45.2,0.33,0.0,0.83,47.05,0.4,6.18
EW-7,Ewing sarcoma,Female,20Y,Pleural effusion,38.66,0.0,0.24,0.0,57.71,0.0,3.39
EW-8,Ewing sarcoma,Male,Age unspecified,Bone marrow,32.38,0.0,0.0,1.08,66.53,0.0,0.0
EWS-502,Ewing sarcoma,Sex unspecified,Age unspecified,Unknown,51.14,0.0,5.9,4.68,38.28,0.0,0.0
F-36P,Myelodysplastic syndrome,Male,68Y,Pleural effusion,1.5,0.0,1.61,78.68,0.0,18.21,0.0
F5,Meningioma,Sex unspecified,Age unspecified,Unknown,33.25,0.0,2.76,3.58,60.4,0.0,0.0
FaDu,Hypopharyngeal squamous cell carcinoma,Male,56Y,"Pharynx, hypopharynx",7.42,0.0,2.06,11.01,0.0,0.0,79.51
Farage,Diffuse large B-cell lymphoma germinal center B-cell type,Female,70Y,Lymph node,60.11,0.0,2.2,0.0,23.94,1.9,11.86
FLO-1,Barrett adenocarcinoma,Male,68Y,Esophagus,27.15,0.21,0.63,0.0,71.2,0.68,0.12
FTC-133,Thyroid gland follicular carcinoma,Male,42Y,Thyroid gland,36.26,1.18,1.29,4.32,56.94,0.0,0.0
FTC-238,Thyroid gland follicular carcinoma,Male,42Y,Lung,33.42,2.05,1.72,2.0,60.8,0.0,0.0
FU-OV-1,High grade ovarian serous adenocarcinoma,Female,65Y,Ovary,2.06,0.66,0.0,78.56,0.0,18.72,0.0
Fu97,Gastric adenocarcinoma,Female,66Y,Stomach,0.0,0.0,0.0,80.85,0.0,19.14,0.0
G-292 clone A141B1,Osteosarcoma,Female,9Y,Bone,42.1,0.0,1.61,5.38,50.9,0.0,0.0
G-361,Melanoma,Male,31Y,Skin,28.21,0.03,0.0,1.43,70.33,0.0,0.0
G-401,Rhabdoid tumor of the kidney,Male,3M,Kidney,56.23,0.75,2.48,2.12,29.24,0.55,8.63
G-402,Kidney neoplasm,Female,9M,Kidney,18.54,0.17,32.1,0.64,46.83,0.0,1.72
G-mel,Cutaneous melanoma,Male,Unknown,Unknown,29.66,0.58,0.75,2.61,66.24,0.16,0.0
GA-10,Adult Burkitt leukemia,Male,41Y,Peripheral blood,28.14,0.0,1.05,0.0,68.9,0.44,1.46
GAK,Vulvar melanoma,Female,86Y,Inguinal lymph node,0.0,0.0,0.0,77.89,0.0,22.1,0.0
GaMG,Glioblastoma,Female,42Y,Brain,27.05,0.0,0.0,1.47,71.47,0.0,0.0
GB-1,Glioblastoma,Male,35Y,Brain,1.34,1.07,0.0,80.28,0.0,17.3,0.0
GCIY,Gastric adenocarcinoma,Female,39Y,Ascites,0.0,0.43,0.08,86.12,0.0,13.37,0.0
GCT,Undifferentiated pleomorphic sarcoma,Male,29Y,Pleural effusion,32.51,0.0,0.07,2.31,63.83,0.0,1.28
GDM-1,Adult acute myeloid leukemia,Female,66Y,Peripheral blood,58.5,1.16,1.71,0.0,27.3,2.32,9.02
GEO,Colon carcinoma,Sex unspecified,Age unspecified,Colon,14.94,2.66,61.65,1.33,19.42,0.0,0.0
GI-1,Gliosarcoma,Male,61Y,"Brain, left fronto-parietal lobe",0.24,0.0,0.0,78.75,0.0,20.38,0.63
GI-ME-N,Neuroblastoma,Female,3Y6M,Bone marrow,55.82,0.42,1.35,0.23,34.54,0.0,7.63
GLC-82,Human papillomavirus-related cervical adenocarcinoma,Female,30Y6M,"Uterus, cervix",14.1,1.23,66.32,2.62,15.73,0.0,0.0
GMS-10,Glioblastoma,Male,49Y,Brain,25.49,0.0,0.11,3.91,70.41,0.0,0.08
GOS-3,Glioblastoma,Male,54Y,"Brain, temporal lobe",20.9,0.0,1.06,2.96,75.07,0.0,0.0
GOTO,Adrenal gland neuroblastoma,Male,1Y1M,Adrenal gland,0.0,0.0,0.0,74.22,0.0,25.78,0.0
GP2d,Colon adenocarcinoma,Female,71Y,Colon,24.97,0.0,0.0,0.09,74.93,0.0,0.0
GP5d,Colon adenocarcinoma,Female,71Y,Colon,24.54,0.0,0.0,0.21,75.24,0.0,0.0
GR-M,Pancreatic adenocarcinoma,Male,Age unspecified,Pancreas,0.0,0.0,0.0,83.55,0.0,15.04,1.41
GR-ST,Childhood B acute lymphoblastic leukemia,Male,11Y,Peripheral blood,0.0,0.0,0.0,74.6,0.0,25.39,0.0
Granta-519,Mantle cell lymphoma,Female,58Y,Peripheral blood,30.67,0.0,1.28,1.9,66.14,0.0,0.0
GSS,Gastric carcinoma,Male,75Y,Liver,4.73,0.0,6.73,81.61,0.0,6.93,0.0
GSU,Gastric carcinoma,Male,37Y,Ascites,0.0,0.03,0.31,77.2,0.34,22.13,0.0
GT3TKB,Lung squamous cell carcinoma,Male,Age unspecified,Pleural effusion,0.0,0.0,0.0,89.7,0.87,9.37,0.05
H-EMC-SS,Extraskeletal myxoid chondrosarcoma,Female,77Y,Muscle,1.42,0.67,0.61,77.11,0.01,20.07,0.1
H4,Astrocytoma,Male,37Y,Brain,29.66,1.32,0.0,0.97,68.05,0.0,0.0
H9,Sezary syndrome,Male,53Y,Peripheral blood,26.72,1.41,4.91,5.59,61.37,0.0,0.0
HA7-RCC,Renal cell carcinoma,Male,Age unspecified,Unknown,22.26,0.85,0.05,0.0,74.38,0.47,1.99
HAL-01,B acute lymphoblastic leukemia with TCF3-HLF rearrangement,Female,17Y,Peripheral blood,1.33,0.89,0.0,78.59,0.0,19.2,0.0
HARA [Human squamous cell lung carcinoma],Lung squamous cell carcinoma,Male,57Y,Pleural effusion,0.21,0.0,0.26,78.38,0.0,20.35,0.8
HC-1,Hairy cell leukemia,Male,56Y,Peripheral blood,28.43,0.0,0.0,0.03,70.39,0.0,1.15
HCC-56,Gastric tubular adenocarcinoma,Male,76Y,Ascites,4.49,0.0,3.92,80.09,0.0,11.5,0.0
HCC1143,Breast ductal carcinoma,Female,52Y,Breast,35.48,0.04,1.22,3.69,59.57,0.0,0.0
HCC1171,Lung adenocarcinoma,Male,58Y,Lung,32.21,0.0,1.8,0.4,65.59,0.0,0.0
HCC1187,Breast ductal carcinoma,Female,41Y,Breast,32.34,0.0,1.83,3.32,62.5,0.0,0.0
HCC1195,Lung adenosquamous carcinoma,Male,47Y,Lung,18.66,0.0,70.13,4.8,6.41,0.0,0.0
HCC1359,Lung giant cell carcinoma,Female,55Y,Lung,9.72,0.0,86.21,3.0,1.07,0.0,0.0
HCC1395,Breast ductal carcinoma,Female,43Y,Breast,32.96,0.0,2.0,1.43,62.97,0.0,0.64
HCC1419,Breast ductal carcinoma,Female,42Y,Breast,32.48,36.71,5.31,7.6,17.9,0.0,0.0
HCC1428,Breast adenocarcinoma,Female,49Y,Pleural effusion,40.96,0.0,3.84,5.45,49.75,0.0,0.0
HCC15,Lung squamous cell carcinoma,Male,47Y,Lung,15.71,0.0,76.99,7.3,0.0,0.0,0.0
HCC1500,Breast ductal carcinoma,Female,32Y,Breast,16.94,1.42,75.35,6.28,0.0,0.0,0.0
HCC1569,Breast ductal carcinoma,Female,70Y,Breast,12.74,0.0,80.08,2.86,4.32,0.0,0.0
HCC1599,Breast ductal carcinoma,Female,44Y,Breast,41.85,0.18,4.77,6.87,46.32,0.0,0.0
HCC1806,"Breast squamous cell carcinoma, acantholytic variant",Female,60Y,Breast,8.72,0.0,80.71,3.77,6.8,0.0,0.0
HCC1897,Lung squamous cell carcinoma,Male,47Y,Unknown,15.76,1.11,77.47,4.48,1.19,0.0,0.0
HCC1937,Breast ductal carcinoma,Female,24Y,Breast,34.11,0.0,2.19,5.95,57.75,0.0,0.0
HCC1954,Breast ductal carcinoma,Female,61Y,Breast,12.74,0.0,0.47,5.83,2.65,0.0,78.3
HCC202,Breast ductal carcinoma,Female,82Y,Breast,35.61,0.0,2.66,3.54,58.19,0.0,0.0
HCC2157,Breast ductal carcinoma,Female,48Y,Breast,7.78,0.0,87.84,4.38,0.0,0.0,0.0
HCC2218,Breast ductal carcinoma,Female,38Y,Breast,39.75,0.0,1.2,1.97,55.07,0.0,2.0
HCC2279,Lung adenosquamous carcinoma,Female,52Y,Lung,9.04,0.0,4.25,46.33,0.0,40.38,0.0
HCC2814,Lung squamous cell carcinoma,Male,55Y,Unknown,38.17,0.0,1.59,5.79,54.45,0.0,0.0
HCC2935,Lung adenocarcinoma,Male,39Y,Unknown,37.21,0.03,3.09,3.93,54.96,0.0,0.78
HCC2998,Colon adenocarcinoma,Sex unspecified,Age unspecified,Unknown,53.15,0.0,1.41,0.0,35.72,1.46,8.24
HCC33,Lung small cell carcinoma,Male,52Y,Pleural effusion,33.69,0.0,2.5,2.1,61.5,0.0,0.21
HCC364,Lung adenocarcinoma,Male,76Y,Unknown,64.04,0.31,2.01,6.71,21.75,0.0,5.19
HCC366,Lung adenosquamous carcinoma,Female,80Y,Lung,32.8,0.77,1.18,2.6,62.65,0.0,0.0
HCC38,Breast ductal carcinoma,Female,50Y,Breast,34.34,0.0,1.51,2.67,60.89,0.0,0.58
HCC4006,Lung adenocarcinoma,Male,>50Y,Pleural effusion,38.54,0.0,1.52,5.13,54.8,0.0,0.0
HCC44,Lung adenocarcinoma,Female,54Y,Lung,35.99,0.0,0.0,2.25,61.76,0.0,0.0
HCC70,Breast ductal carcinoma,Female,49Y,Breast,20.07,0.0,70.85,5.47,3.61,0.0,0.0
HCC78,Lung adenocarcinoma,Male,65Y,Pleural effusion,30.25,0.1,0.0,0.0,67.1,0.13,2.41
HCC827,Lung adenocarcinoma,Female,39Y,Lung,67.96,0.39,1.62,3.47,19.48,0.0,7.09
HCC95,Lung squamous cell carcinoma,Male,65Y,Pleural effusion,33.13,0.36,0.18,1.64,62.63,0.0,2.05
HCE-4,Esophageal squamous cell carcinoma,Female,50Y,Esophagus,4.77,0.0,93.38,0.25,1.6,0.0,0.0
HCT 116,Colon carcinoma,Male,48Y,Colon,32.93,0.08,0.0,1.16,64.85,0.0,0.97
HCT 15,Colon adenocarcinoma,Male,67Y,Colon,42.32,0.0,2.68,5.84,49.17,0.0,0.0
HD-MY-Z,Adult acute myeloid leukemia,Male,29Y,Pleural effusion,28.77,0.0,0.65,4.15,66.43,0.0,0.0
HDLM-2,Hodgkin lymphoma,Male,74Y,Pleural effusion,35.08,0.0,1.09,1.64,62.14,0.0,0.05
HDQ-P1,Breast ductal carcinoma,Female,50Y,Breast,41.35,0.0,1.07,3.35,51.89,0.0,2.35
HEC-1,Endometrial adenocarcinoma,Female,71Y,Endometrium,0.0,0.0,0.0,89.14,0.0,10.41,0.45
HEC-1-A,Endometrial adenocarcinoma,Female,71Y,Endometrium,0.0,1.14,0.0,91.32,0.49,6.71,0.34
HEC-1-B,Endometrial adenocarcinoma,Female,71Y,Endometrium,0.0,0.76,0.0,92.48,0.0,6.76,0.0
HEC-108,Endometrial adenocarcinoma,Female,Age unspecified,Endometrium,0.0,0.0,0.0,78.21,0.0,21.79,0.0
HEC-151,Endometrial adenocarcinoma,Female,Age unspecified,Endometrium,0.0,0.66,0.0,76.07,0.0,23.27,0.0
HEC-251,Endometrial carcinoma,Female,53Y,Endometrium,0.0,0.73,0.0,78.55,0.0,20.72,0.0
HEC-265,Endometrial adenocarcinoma,Female,59Y,Endometrium,0.0,0.0,0.0,72.25,0.0,27.75,0.0
HEC-50B,Endometrial adenocarcinoma,Female,Age unspecified,Ascites,1.9,0.0,0.78,83.13,0.0,14.2,0.0
HEC-59,Endometrial adenocarcinoma,Female,Age unspecified,Endometrium,1.25,0.09,1.33,79.33,0.0,17.72,0.28
HEC-6,"Endometrial endometrioid adenocarcinoma, variant with squamous differentiation",Female,48Y,Endometrium,0.94,0.0,0.0,75.17,0.0,23.89,0.0
HEL,Erythroleukemia,Male,30Y,Peripheral blood,73.45,1.79,2.4,3.9,13.33,0.0,5.12
HEL 92.1.7,Erythroleukemia,Male,30Y,Peripheral blood,72.21,2.04,0.0,1.78,17.09,0.21,6.68
HeLa,Human papillomavirus-related cervical adenocarcinoma,Female,30Y6M,"Uterus, cervix",12.78,0.77,64.74,2.26,19.45,0.0,0.0
Hep 3B2.1-7,Childhood hepatocellular carcinoma,Male,8Y,Liver,15.69,0.52,71.82,3.16,8.8,0.0,0.0
Hep-G2,Hepatoblastoma,Male,15Y,Liver,48.99,20.88,2.83,4.48,22.82,0.0,0.0
Hep-G2/C3A,Hepatoblastoma,Male,15Y,Liver,47.02,22.36,1.61,0.85,26.42,1.57,0.18
HEY,High grade ovarian serous adenocarcinoma,Female,Age unspecified,Ovary,30.59,0.22,0.88,0.66,67.37,0.27,0.0
HEY A8,High grade ovarian serous adenocarcinoma,Female,Age unspecified,Ovary,33.46,0.0,1.54,2.65,62.34,0.0,0.0
HGC-27,Gastric carcinoma,Sex unspecified,Age unspecified,Lymph node,0.7,0.0,0.0,77.61,0.0,21.46,0.22
HH [Human lymphoma],Primary cutaneous T-cell non-Hodgkin lymphoma,Male,61Y,Peripheral blood,32.82,0.0,2.42,3.69,61.06,0.0,0.0
HK-2 [Human kidney],Unknown,Male,Adult,"Kidney, proximal tubule",29.92,0.0,3.63,3.68,62.77,0.0,0.0
HL-60,Adult acute myeloid leukemia,Female,36Y,Peripheral blood,26.32,0.42,1.15,0.4,71.71,0.0,0.0
HLC-1,Lung adenocarcinoma,Sex unspecified,Age unspecified,Pleural effusion,2.02,0.0,4.37,90.08,0.0,3.53,0.0
HLE,Adult hepatocellular carcinoma,Male,68Y,Liver,3.89,0.0,1.86,85.81,0.0,8.43,0.0
HLF,Adult hepatocellular carcinoma,Male,68Y,Liver,0.0,0.0,0.0,85.67,0.0,14.33,0.0
HLF-a,Unknown,Female,54Y,Lung,5.07,0.0,90.86,2.07,1.99,0.0,0.0
HMC-1-8,Breast carcinoma,Female,35Y,Pleural effusion,0.0,0.0,0.0,83.08,0.0,16.92,0.0
HMCB,Melanoma,Female,Unknown,Unknown,33.99,0.0,0.21,1.87,63.92,0.0,0.0
HMEL,Unknown,Female,Unknown,Breast,10.33,1.37,74.68,1.09,12.54,0.0,0.0
HMV-II,Vaginal melanoma,Female,65Y,Vagina,0.36,0.0,0.4,76.31,0.78,21.9,0.25
HN,Oral cavity squamous cell carcinoma,Male,60Y,Cervical lymph node,1.57,0.0,0.89,79.15,0.0,18.39,0.0
HNT-34,Adult acute myeloid leukemia,Female,47Y,Peripheral blood,3.91,0.0,1.86,80.82,0.0,13.41,0.0
HO-1-N-1,Buccal mucosa squamous cell carcinoma,Male,Age unspecified,Unknown,0.0,0.0,0.0,77.94,1.04,20.55,0.47
HO-1-u-1,Floor of mouth squamous cell carcinoma,Male,72Y,"Salivary gland, sublingual gland",0.0,0.0,1.54,76.45,1.61,19.98,0.41
HOP-62,Lung adenocarcinoma,Female,60Y,Lung,33.3,0.13,0.83,2.13,63.51,0.0,0.11
HOP-92,Lung non-small cell carcinoma,Male,62Y,Lung,24.16,0.0,0.37,1.34,74.13,0.0,0.0
HOS,Osteosarcoma,Female,13Y,"Bone, right femur",59.79,0.0,0.0,1.17,0.0,3.52,35.51
HPAC,Pancreatic adenocarcinoma,Female,64Y,Pancreas,34.47,0.7,0.23,2.44,62.15,0.0,0.0
HPAF-II,Pancreatic ductal adenocarcinoma,Male,44Y,Ascites,33.49,0.23,0.96,0.7,64.61,0.0,0.0
HPB-ALL,Childhood T acute lymphoblastic leukemia,Male,14Y,Peripheral blood,0.0,0.0,0.0,78.04,0.0,20.81,1.14
HRT-18,Colon adenocarcinoma,Male,67Y,Colon,32.91,0.15,0.0,0.34,63.7,1.05,1.84
Hs 172.T,Unknown,Male,50Y,Urinary bladder,29.31,0.85,0.56,1.69,67.59,0.0,0.0
Hs 229.T,Unknown,Male,65Y,Lung,29.18,0.3,0.0,0.0,68.77,1.25,0.49
Hs 274.T,Unknown,Female,66Y,Breast,29.67,0.0,0.6,1.24,67.67,0.53,0.28
Hs 281.T,Unknown,Female,37Y,Breast,58.64,0.98,1.57,2.05,31.57,0.0,5.19
Hs 294T,Melanoma,Male,56Y,Lymph node,27.07,0.39,0.0,0.0,72.19,0.0,0.34
Hs 343.T,Unknown,Female,47Y,Breast,56.3,0.0,1.49,0.52,33.67,1.3,6.72
Hs 445,Unknown,Female,56Y,Lymph node,34.78,0.0,0.48,1.04,63.69,0.01,0.0
Hs 571.T,Ovarian carcinoma,Female,Age unspecified,Ovary,39.76,0.08,0.0,0.95,57.56,0.0,1.65
Hs 578T,Invasive breast carcinoma of no special type,Female,74Y,Breast,34.01,0.0,0.53,1.71,63.73,0.0,0.0
Hs 600.T,Unknown,Male,Age unspecified,Skin,31.02,1.98,0.0,1.7,65.3,0.0,0.0
Hs 604.T,Unknown,Male,21Y,Lymph node,9.79,0.15,0.0,0.0,84.03,4.01,2.02
Hs 606.T,Unknown,Female,44Y,Unknown,59.5,1.87,1.63,0.0,28.96,0.76,7.27
Hs 611.T,Hodgkin lymphoma,Female,48Y,Lymph node,26.44,0.0,0.0,0.5,71.76,0.05,1.24
Hs 616.T,Unknown,Male,16Y,Unknown,27.55,0.47,0.0,0.0,68.82,0.96,2.19
Hs 618.T,Unknown,Female,60Y,Lung,33.72,21.61,2.37,1.07,38.2,1.4,1.63
Hs 675.T,Unknown,Male,Age unspecified,Colon,25.15,0.02,0.0,0.97,70.6,0.0,3.25
Hs 683,Oligodendroglioma,Male,76Y,"Brain, left temporal lobe",30.54,0.33,0.0,0.16,68.26,0.0,0.7
Hs 688(A).T,Unknown,Male,69Y,Skin,31.35,0.0,0.0,0.14,65.65,0.0,2.86
Hs 695T,Amelanotic melanoma,Male,26Y,Lymph node,25.59,0.62,0.0,0.95,71.17,0.69,0.98
Hs 698.T,Unknown,Male,70Y,Connective tissue,3.59,0.0,0.32,3.02,0.0,0.0,93.06
Hs 706.T,Malignancy in giant cell tumor of bone,Female,16Y,Bone,36.71,0.03,2.7,2.51,57.98,0.0,0.07
Hs 729.T,Embryonal rhabdomyosarcoma,Male,74Y,Muscle,37.75,0.0,1.21,2.49,57.58,0.0,0.96
Hs 737.T,Unknown,Female,10Y,Unknown,30.8,0.61,0.0,1.03,67.56,0.0,0.0
Hs 739.T,Unknown,Female,52Y,Breast,0.0,0.15,0.34,79.91,0.0,19.42,0.17
Hs 742.T,Unknown,Female,71Y,Breast,25.22,1.14,0.0,0.0,72.94,0.7,0.0
Hs 746.T,Gastric adenocarcinoma,Male,74Y,"Left leg, skeletal muscle",31.23,0.16,0.0,2.9,65.13,0.0,0.58
Hs 751.T,Unknown,Male,19Y,Lymph node,31.12,0.12,0.33,0.59,67.84,0.0,0.0
Hs 766T,Pancreatic adenocarcinoma,Male,64Y,Lymph node,32.62,0.92,0.11,1.96,62.85,0.0,1.54
Hs 819.T,Unknown,Male,60Y,Bone,29.93,0.0,0.0,1.16,67.05,0.22,1.63
Hs 821.T,Unknown,Female,31Y,Bone,21.62,46.51,1.92,5.29,22.78,0.0,1.88
Hs 822.T,Unknown,Female,9Y,Bone,30.33,21.59,0.59,1.66,43.77,0.0,2.06
Hs 839.T,Unknown,Female,42Y,Skin,31.06,0.18,0.72,0.79,67.25,0.0,0.0
Hs 840.T,Unknown,Male,7Y,Pharynx,21.8,0.34,0.0,0.0,76.29,1.56,0.0
Hs 852.T,Melanoma,Male,53Y,Skin,1.3,0.0,1.89,80.03,0.0,16.58,0.19
Hs 863.T,Unknown,Female,5Y,Bone,26.04,0.35,0.0,4.46,67.06,1.13,0.95
Hs 870.T,Unknown,Male,22Y,Bone,38.77,28.57,5.79,5.49,21.38,0.0,0.01
Hs 888.T,Unknown,Male,20Y,Lung,57.38,0.69,2.45,0.26,29.88,1.64,7.7
Hs 895.T,Unknown,Female,48Y,Skin,29.96,1.02,0.77,0.49,67.7,0.0,0.06
Hs 934.T,Unknown,Female,58Y,Connective tissue,28.98,0.08,0.0,0.36,69.72,0.85,0.0
Hs 936.T,Melanoma,Male,Age unspecified,Skin,34.35,0.0,1.32,3.21,60.44,0.0,0.68
Hs 939.T,Melanoma,Female,24Y,Unknown,27.95,0.0,0.37,2.9,68.28,0.0,0.5
Hs 940.T,Unknown,Male,57Y,Skin,26.75,0.31,0.79,1.11,71.04,0.0,0.0
Hs 944.T,Cutaneous melanoma,Male,51Y,Unknown,31.37,0.0,0.0,2.22,66.41,0.0,0.0
HSC-2,Oral cavity squamous cell carcinoma,Male,69Y,Cervical lymph node,0.07,0.0,0.05,83.8,0.0,14.71,1.36
HSC-3,Tongue squamous cell carcinoma,Male,64Y,Cervical lymph node,1.7,0.0,0.32,85.88,0.0,12.09,0.0
HSC-39,Gastric signet ring cell adenocarcinoma,Male,54Y,Ascites,0.47,0.0,0.43,78.69,1.03,18.67,0.72
HSC-4,Tongue squamous cell carcinoma,Male,64Y,Cervical lymph node,0.12,0.0,0.0,84.74,0.0,13.79,1.33
HT,Diffuse large B-cell lymphoma germinal center B-cell type,Male,70Y,Ascites,30.44,0.0,0.33,0.0,67.93,0.35,0.95
HT-1080,Fibrosarcoma,Male,35Y,"Bone, pelvis, acetabulum",28.94,0.35,0.86,1.36,68.21,0.29,0.0
HT-1197,Recurrent bladder carcinoma,Male,44Y,Urinary bladder,31.77,0.12,0.0,1.86,66.24,0.0,0.0
HT-1376,Bladder carcinoma,Female,58Y,Urinary bladder,58.6,1.4,1.48,1.78,26.62,1.08,9.04
HT-144,Melanoma,Male,29Y,Hypodermis,25.86,0.49,0.0,0.47,73.18,0.0,0.0
HT-29,Colon adenocarcinoma,Female,44Y,Colon,63.24,1.05,1.57,3.24,26.11,0.0,4.8
HT-3,Cervical carcinoma,Female,58Y,Lymph node,37.73,0.0,2.04,3.34,55.35,0.0,1.53
HT-55,Rectal adenocarcinoma,Female,54Y,Rectum,33.83,0.0,1.79,2.4,61.97,0.0,0.0
HT115,Colon carcinoma,Unknown,Unknown,Unknown,31.73,0.04,0.18,1.25,66.59,0.0,0.21
HTC-C3,Thyroid gland anaplastic carcinoma,Female,44Y,Pleural effusion,1.88,0.3,0.77,74.17,0.12,22.11,0.65
HTK-,Osteosarcoma,Female,13Y,"Bone, right femur",59.95,0.0,0.0,0.0,0.0,5.13,34.91
HuCC-T1,Intrahepatic cholangiocarcinoma,Male,56Y,Ascites,10.57,0.0,7.42,82.0,0.0,0.0,0.0
HuG1-N,Gastric tubular adenocarcinoma,Male,55Y,Ascites,1.43,0.2,1.71,75.56,0.0,21.1,0.0
HuH-1,Adult hepatocellular carcinoma,Male,53Y,Liver,0.92,0.87,0.02,80.09,0.0,18.1,0.0
HuH-28,Intrahepatic cholangiocarcinoma,Female,37Y,Liver,1.86,0.0,3.05,84.08,0.0,11.01,0.0
HuH-6,Hepatoblastoma,Male,1Y,Liver,0.0,0.3,0.79,80.92,0.0,17.99,0.0
HuH-6 Clone 5,Hepatoblastoma,Male,1Y,Liver,3.49,1.36,1.77,76.85,0.0,16.52,0.0
Huh-7,Adult hepatocellular carcinoma,Male,57Y,Liver,5.69,0.0,1.56,79.68,0.0,13.08,0.0
HuNS1,Unknown,Male,Age unspecified,Peripheral blood,35.24,1.22,0.0,0.0,56.19,1.71,5.64
HuO-3N1,Osteosarcoma,Female,15Y,Bone,0.24,0.0,1.58,72.02,1.15,23.28,1.73
HuO9,Osteosarcoma,Female,13Y,"Bone, right distal femur",3.83,0.0,2.89,77.77,1.78,13.74,0.0
HuP-T3,Pancreatic adenocarcinoma,Male,66Y,Ascites,0.95,0.0,0.94,78.19,0.0,19.92,0.0
HuP-T4,Pancreatic adenocarcinoma,Male,60Y,Ascites,0.13,0.39,0.0,74.65,0.0,24.82,0.0
HuT 102,Mycosis fungoides,Male,28Y,Lymph node,6.25,0.23,84.86,1.93,6.73,0.0,0.0
HuT 78,Sezary syndrome,Male,53Y,Peripheral blood,28.04,0.76,0.32,2.56,68.01,0.0,0.32
HuTu 80,Duodenal adenocarcinoma,Male,53Y,"Small intestine, duodenum",11.22,0.0,77.36,2.96,8.45,0.0,0.0
IA-LM,Lung large cell carcinoma,Male,68Y,Unknown,1.68,0.29,0.16,82.4,0.0,13.99,1.48
IGR-1,Cutaneous melanoma,Male,42Y,Inguinal lymph node,35.49,0.0,0.53,2.53,60.87,0.0,0.58
IGR-37,Melanoma,Male,26Y,Inguinal lymph node,34.77,0.29,1.28,1.79,61.87,0.0,0.0
IGR-39,Melanoma,Male,26Y,Skin,35.28,1.18,1.8,2.76,58.99,0.0,0.0
IGROV-1,Ovarian endometrioid adenocarcinoma,Female,47Y,Ovary,47.29,0.0,0.69,0.0,46.04,1.43,4.55
IHH-4,Thyroid gland papillary carcinoma,Male,75Y,Left cervical lymph node,2.88,0.0,1.71,73.08,0.89,21.44,0.0
IM-9,Unknown,Female,Age unspecified,Bone marrow,31.43,0.41,0.0,0.0,68.16,0.0,0.0
IM95,Gastric adenocarcinoma,Male,63Y,Stomach,0.0,0.0,0.0,71.45,0.0,28.36,0.19
IMR-32,Neuroblastoma,Male,1Y1M,Abdomen,20.72,0.56,0.0,1.01,73.7,0.0,3.99
IMR-5,Neuroblastoma,Male,1Y1M,Abdomen,19.24,0.86,0.0,0.0,75.37,0.06,4.46
INA-6,Plasma cell myeloma,Male,80Y,Pleural effusion,33.82,0.15,0.46,2.2,63.38,0.0,0.0
IPC-298,Cutaneous melanoma,Female,64Y,Unknown,44.9,0.2,0.17,1.84,52.05,0.0,0.84
Ishikawa (Heraklio) 02 ER-,Endometrial adenocarcinoma,Female,39Y,Endometrium,0.0,0.0,0.0,80.66,0.0,19.33,0.0
IST-MEL1,Melanoma,Male,Adult,Skin,59.56,1.88,1.49,0.0,29.45,1.65,5.96
IST-Mes1,Pleural epithelioid mesothelioma,Female,70Y,Pleural effusion,53.62,0.0,2.78,4.12,38.45,0.0,1.03
IST-Mes2,Pleural epithelioid mesothelioma,Male,71Y,Pleural effusion,51.54,0.1,0.0,2.01,43.48,0.0,2.87
IST-SL1,Lung small cell carcinoma,Male,60Y,Supraclavicular lymph node,63.08,0.0,0.24,0.16,34.83,1.69,0.0
IST-SL2,Lung small cell carcinoma,Male,Age unspecified,Pleural effusion,47.35,0.72,0.3,0.0,46.2,0.93,4.5
J82,Bladder carcinoma,Male,58Y,Urinary bladder,26.21,0.0,0.13,2.62,70.61,0.0,0.42
JAR,Gestational choriocarcinoma,Male,Fetus,Unknown,23.14,0.66,30.11,2.4,42.28,0.0,1.4
JEG-3,Gestational choriocarcinoma,Male,Fetus,Fetal brain,26.16,0.09,0.01,0.97,71.88,0.0,0.9
JeKo-1,Mantle cell lymphoma,Female,78Y,Peripheral blood,2.27,0.0,2.41,63.65,0.0,31.67,0.0
JH-EsoAd1,Barrett adenocarcinoma,Male,66Y,Esophagus,38.99,0.0,0.64,1.94,58.42,0.0,0.0
JHH-1,Hepatitis C infection,Sex unspecified,50Y,Unknown,0.0,0.0,0.0,81.93,0.0,18.06,0.0
JHH-2,Adult hepatocellular carcinoma,Male,56Y,Ascites,0.7,0.24,0.15,82.5,0.0,16.41,0.0
JHH-4,Hepatitis C infection,Male,51Y,Unknown,2.54,0.0,0.12,81.09,0.0,16.25,0.0
JHH-5,Adult hepatocellular carcinoma,Male,50Y,Liver,0.0,0.04,0.41,81.84,0.0,17.72,0.0
JHH-6,Hepatitis C infection,Female,57Y,Unknown,0.43,0.29,0.0,84.12,0.0,15.16,0.0
JHH-7,Adult hepatocellular carcinoma,Male,53Y,Unknown,0.0,0.0,0.0,86.04,0.0,12.59,1.36
JHOC-5,Ovarian clear cell adenocarcinoma,Female,47Y,Ovary,0.0,0.0,0.38,85.18,0.0,14.43,0.0
JHOM-1,Ovarian mucinous adenocarcinoma,Female,88Y,Ovary,0.0,0.0,1.03,82.29,0.0,16.67,0.0
JHOM-2B,Ovarian mucinous adenocarcinoma,Female,56Y,Ovary,0.04,0.7,0.86,79.5,0.0,18.16,0.74
JHOS-2,High grade ovarian serous adenocarcinoma,Female,45Y,Lymph node,0.68,0.18,0.0,83.51,0.0,14.94,0.69
JHOS-3,Ovarian serous adenocarcinoma,Female,48Y,Lymph node,0.0,0.0,0.0,83.55,0.0,16.2,0.24
JHOS-4,High grade ovarian serous adenocarcinoma,Female,44Y,Peritoneum,2.54,0.0,0.71,82.16,0.0,13.28,1.31
JHU-011,Laryngeal squamous cell carcinoma,Male,45Y,Larynx,29.59,0.0,2.03,2.06,66.03,0.0,0.29
JHU-022,Laryngeal squamous cell carcinoma,Male,53Y,Larynx,34.14,0.12,0.81,1.81,63.12,0.0,0.0
JHU-029,Laryngeal squamous cell carcinoma,Male,70Y,Larynx,4.45,0.0,92.58,2.96,0.0,0.0,0.0
JHUEM-1,Endometrial adenocarcinoma,Female,56Y,Endometrium,0.0,0.0,0.0,76.96,0.0,23.04,0.0
JHUEM-2,Endometrial adenocarcinoma,Female,62Y,Endometrium,0.0,0.0,0.0,81.43,0.0,17.67,0.89
JHUEM-3,Endometrial adenocarcinoma,Female,60Y,Endometrium,2.25,0.0,0.23,84.53,0.0,12.99,0.0
JHUEM-7,Endometrial adenocarcinoma,Female,58Y,Endometrium,0.0,0.0,0.0,77.1,0.0,22.67,0.22
JIMT-1,Breast ductal carcinoma,Female,62Y,Pleural effusion,16.59,0.79,3.6,7.75,71.27,0.0,0.0
Jiyoye,EBV-related Burkitt lymphoma,Male,7Y,Ascites,5.16,0.0,92.69,2.15,0.0,0.0,0.0
JJN-3,Plasma cell myeloma,Female,57Y,Bone marrow,32.53,0.0,0.8,2.53,64.14,0.0,0.0
JK-1,"Chronic myelogenous leukemia, BCR-ABL1 positive",Male,58Y,Unknown,0.0,0.0,0.0,74.72,0.0,25.28,0.0
JL-1,Pleural epithelioid mesothelioma,Male,54Y,"Lung, pleura",37.42,0.0,0.03,3.05,56.74,0.0,2.74
JM-1,B acute lymphoblastic leukemia,Male,Age unspecified,Peripheral blood,31.71,0.0,0.0,1.68,66.6,0.0,0.0
JMSU-1,Bladder carcinoma,Male,75Y,Ascites,1.75,0.3,1.12,80.58,0.0,16.26,0.0
JSC-1,Primary effusion lymphoma,Male,52Y,Ascites,31.24,0.09,0.79,0.94,65.05,0.0,1.9
Jurkat,Childhood T acute lymphoblastic leukemia,Male,14Y,Peripheral blood,26.45,0.0,0.4,0.13,70.73,1.21,1.08
JURL-MK1,"Chronic myelogenous leukemia, BCR-ABL1 positive",Male,73Y,Peripheral blood,57.22,0.0,3.4,1.62,29.18,0.0,8.59
JVM-2,Mantle cell lymphoma,Female,63Y,Peripheral blood,30.59,0.51,0.33,0.25,67.89,0.0,0.43
JVM-3,B-cell prolymphocytic leukemia,Male,73Y,Peripheral blood,27.94,0.22,0.28,1.54,70.02,0.0,0.0
K-562,"Blast phase chronic myelogenous leukemia, BCR-ABL1 positive",Female,53Y,Pleural effusion,42.97,0.0,5.19,8.4,43.44,0.0,0.0
K029AX,Cutaneous melanoma,Unknown,Unknown,Unknown,30.86,0.0,0.32,1.49,67.33,0.0,0.0
K2 [Human melanoma],Melanoma,Unknown,Unknown,Unknown,30.11,0.0,0.06,0.0,67.62,1.34,0.87
K5,Thyroid gland papillary carcinoma,Male,58Y,Thyroid gland,54.17,0.0,1.75,0.0,35.45,1.37,7.25
KALS-1,Glioblastoma,Female,74Y,Brain,1.68,0.0,1.68,78.93,0.0,16.7,1.01
Karpas-1106P,Primary mediastinal (thymic) large B-cell lymphoma,Female,23Y,Pleural effusion,65.12,0.48,1.68,0.25,19.43,1.18,11.86
Karpas-231,Diffuse large B-cell lymphoma,Female,71Y,Peripheral blood,30.33,0.0,0.0,1.09,68.07,0.0,0.51
Karpas-299,"Anaplastic large cell lymphoma, ALK-positive",Male,25Y,Peripheral blood,31.36,0.18,0.22,0.0,67.06,0.0,1.17
Karpas-422,Diffuse large B-cell lymphoma germinal center B-cell type,Female,73Y,Pleural effusion,27.64,0.49,0.0,0.0,71.53,0.0,0.34
Karpas-45,Childhood T acute lymphoblastic leukemia,Male,2Y,Bone marrow,28.16,0.47,0.06,0.03,68.54,0.0,2.75
Karpas-620,Plasma cell myeloma,Female,77Y,Peripheral blood,31.96,0.0,1.6,2.67,63.77,0.0,0.0
Kasumi-1,Childhood acute myeloid leukemia with maturation,Male,7Y,Peripheral blood,1.67,0.0,1.19,74.84,0.0,22.29,0.0
Kasumi-2,Childhood B acute lymphoblastic leukemia,Male,15Y,Bone marrow,0.78,0.35,0.0,80.22,1.01,17.64,0.0
Kasumi-6,Adult acute myeloid leukemia,Male,64Y,Peripheral blood,0.0,0.0,0.79,75.55,0.0,23.65,0.0
KATO III,Down syndrome,Male,57Y,Pleural effusion,0.0,0.0,0.78,78.55,0.06,19.58,1.02
KCI-MOH1,Pancreatic adenocarcinoma,Female,64Y,Pancreas,32.5,0.11,0.0,2.33,65.07,0.0,0.0
KCL-22,"Chronic myelogenous leukemia, BCR-ABL1 positive",Female,32Y,Pleural effusion,0.0,0.5,0.0,75.25,0.0,24.24,0.0
KE-37,Adult T acute lymphoblastic leukemia,Male,27Y,Unknown,30.66,0.41,0.86,0.97,66.92,0.0,0.18
KE-39,Gastric adenocarcinoma,Male,77Y,Lymph node,4.45,0.0,1.5,89.52,0.0,4.53,0.0
KE-97,Unknown,Unknown,Unknown,Unknown,0.0,0.0,0.0,80.49,0.0,19.51,0.0
Kelly,Neuroblastoma,Female,1Y,Brain,33.22,0.0,2.15,2.95,61.68,0.0,0.0
KG-1,Adult acute myeloid leukemia,Male,59Y,Bone marrow,7.34,0.0,84.82,3.33,3.95,0.0,0.57
KG-1-C,Oligodendroglioma,Male,13Y,Brain,6.98,0.0,8.0,84.74,0.0,0.27,0.0
KGN,Ovarian granulosa cell tumor,Female,63Y,"Ovary, ovarian follicle, granulosa cell layer",0.0,0.09,0.0,73.92,0.0,24.17,1.82
KHM-1B,Plasma cell myeloma,Male,53Y,Pleural effusion,4.66,0.0,0.34,77.81,0.0,17.18,0.0
Ki-JK,"Anaplastic large cell lymphoma, ALK-positive",Male,15Y,Pleural effusion,0.97,0.0,0.29,78.51,0.0,20.22,0.0
KINGS-1,Anaplastic astrocytoma,Male,67Y,Brain,0.0,0.0,0.0,73.94,0.0,26.06,0.0
KLE,Endometrial adenocarcinoma,Female,68Y,Endometrium,35.06,0.23,0.19,3.62,60.58,0.0,0.32
KLM-1,Pancreatic ductal adenocarcinoma,Male,Age unspecified,Liver,0.0,0.0,0.52,88.41,0.0,10.63,0.44
KM-H2,Hodgkin lymphoma,Male,37Y,Pleural effusion,1.75,0.0,1.68,78.89,0.0,17.68,0.0
KM12,Colon carcinoma,Male,Age unspecified,Colon,32.97,0.44,0.84,1.48,63.68,0.0,0.59
KMBC-2,Bladder carcinoma,Sex unspecified,Age unspecified,Unknown,0.81,0.61,0.09,77.27,0.0,21.21,0.0
KMH-2,Thyroid gland anaplastic carcinoma,Male,71Y,Thyroid gland,1.41,0.61,1.62,81.17,0.83,14.36,0.0
KMM-1,Plasma cell myeloma,Male,62Y,Unknown,0.0,0.0,0.0,81.62,0.0,17.61,0.77
KMOE-2,Erythroleukemia,Female,2Y,Peripheral blood,0.0,0.02,0.41,78.12,0.23,19.8,1.43
KMRC-1,Clear cell renal cell carcinoma,Male,Adult,Kidney,0.0,0.41,0.0,74.54,0.0,25.05,0.0
KMRC-2,Clear cell renal cell carcinoma,Male,Adult,Kidney,0.0,0.74,0.0,73.3,0.0,25.71,0.24
KMRC-20,Clear cell renal cell carcinoma,Sex unspecified,Age unspecified,Kidney,4.3,0.0,3.3,77.74,0.0,14.66,0.0
KMRC-3,Clear cell renal cell carcinoma,Male,Adult,Kidney,2.47,0.0,1.13,78.77,0.0,17.63,0.0
KMS-11,Plasma cell myeloma,Female,67Y,Pleural effusion,2.81,0.01,4.44,82.62,0.0,10.11,0.0
KMS-12-BM,Plasma cell myeloma,Female,64Y,Bone marrow,2.0,0.0,0.01,81.71,0.0,16.28,0.0
KMS-18,Plasma cell myeloma,Male,60Y,Peripheral blood,0.0,0.0,0.0,81.47,0.0,18.53,0.0
KMS-20,Plasma cell myeloma,Female,65Y,Bone marrow,0.81,0.24,0.0,84.32,0.0,14.3,0.32
KMS-21-BM,Unknown,Sex unspecified,Age unspecified,Unknown,0.0,0.0,0.0,78.63,0.0,21.2,0.16
KMS-26,Plasma cell myeloma,Male,50Y,Pleural effusion,5.08,0.0,1.51,82.18,0.0,11.23,0.0
KMS-27,Plasma cell myeloma,Male,52Y,Peripheral blood,0.0,0.28,0.0,76.27,0.0,23.45,0.0
KMS-28BM,Plasma cell myeloma,Female,77Y,Bone marrow,0.91,0.0,2.75,76.63,0.0,19.7,0.0
KMS-34,Plasma cell myeloma,Female,60Y,Pleural effusion,0.0,0.47,0.0,71.46,0.05,28.03,0.0
KNS-42,Glioblastoma,Male,16Y,"Brain, right fronto-parietal lobe",0.22,0.32,0.0,85.4,0.0,14.06,0.0
KNS-60,Glioblastoma,Male,55Y,Brain,0.73,0.0,0.0,80.41,0.0,18.86,0.0
KNS-62,Lung squamous cell carcinoma,Male,49Y,Brain,5.26,0.0,2.64,85.09,0.0,7.0,0.0
KNS-81,Glioblastoma,Male,65Y,Brain,2.06,1.05,0.61,78.9,0.0,17.38,0.0
KNS-81-FD,Glioblastoma,Male,65Y,Brain,0.0,1.58,0.0,77.83,0.0,20.58,0.0
KO52,Adult acute myeloid leukemia,Male,46Y,Bone marrow,0.49,0.74,0.61,70.18,0.0,27.99,0.0
KON,Floor of mouth squamous cell carcinoma,Male,76Y,Cervical lymph node,0.25,0.46,0.36,79.36,0.27,18.6,0.7
KOPN-8,Childhood B acute lymphoblastic leukemia,Female,3M,Peripheral blood,2.49,0.0,3.7,80.77,0.0,13.03,0.0
KOSC-2,Floor of mouth squamous cell carcinoma,Male,51Y,"Oral cavity, floor of mouth",3.2,0.0,1.44,72.8,0.0,22.55,0.0
KP-1N,Pancreatic ductal adenocarcinoma,Male,56Y,Pancreas,32.09,0.95,0.39,0.0,65.14,1.14,0.29
KP-2,Pancreatic carcinoma,Female,65Y,Pancreas,2.24,0.0,1.37,79.94,0.0,16.44,0.0
KP-3,Pancreatic adenosquamous carcinoma,Male,75Y,Liver,0.25,0.8,0.33,78.29,0.07,19.41,0.83
KP-4,Pancreatic carcinoma,Male,50Y,Ascites,0.0,0.0,0.0,78.42,1.23,20.35,0.0
KP-N-RT-BM-1,Adrenal gland neuroblastoma,Female,1Y2M,Bone marrow,2.27,0.27,0.43,72.99,0.0,24.04,0.0
KP-N-SI9s,Adrenal gland neuroblastoma,Male,5Y,Left axillary lymph node,0.0,0.0,0.0,75.78,0.0,24.21,0.0
KP-N-YN,Adrenal gland neuroblastoma,Male,2Y,Right pararenal lymph node,0.76,0.15,0.0,73.42,0.0,25.67,0.0
KP-N-YS,Adrenal gland neuroblastoma,Male,4Y,Bone marrow,0.0,1.29,0.0,74.96,0.0,23.74,0.0
KPL-1,Invasive breast carcinoma of no special type,Female,69Y,Pleural effusion,40.02,0.0,2.04,4.61,53.32,0.0,0.0
KS-1 [Human glioblastoma],Glioblastoma,Female,45Y,Brain,0.52,0.0,0.01,74.63,0.0,23.63,1.21
KTCTL-13,Clear cell renal cell carcinoma,Male,57Y,Kidney,20.46,0.52,0.27,1.51,76.23,0.0,1.01
KTCTL-140,Clear cell renal cell carcinoma,Female,65Y,Kidney,33.41,0.77,0.0,2.03,62.07,0.0,1.72
KTCTL-195,Clear cell renal cell carcinoma,Male,46Y,Kidney,33.4,1.71,0.0,0.0,62.95,0.0,1.93
KTCTL-1M,Clear cell renal cell carcinoma,Male,63Y,Kidney,34.35,0.0,0.0,0.0,63.61,0.82,1.22
KTCTL-21,Clear cell renal cell carcinoma,Male,49Y,Unknown,35.62,0.07,0.0,0.03,62.87,0.0,1.41
KTCTL-26A,Clear cell renal cell carcinoma,Male,77Y,Kidney,29.34,0.87,0.0,1.55,66.58,0.0,1.66
KU-19-19,Bladder carcinoma,Male,76Y,Urinary bladder,0.57,0.0,0.0,77.87,0.0,21.55,0.0
Ku812,"Chronic myelogenous leukemia, BCR-ABL1 positive",Male,38Y,Peripheral blood,0.42,0.62,0.0,85.34,0.88,12.57,0.16
Kuramochi,High grade ovarian serous adenocarcinoma,Female,Age unspecified,Ascites,2.48,0.0,0.0,85.58,0.0,11.82,0.12
KY821,Acute myelomonocytic leukemia,Male,28Y,"Brain, meninges",0.0,0.0,0.0,76.02,0.0,23.98,0.0
KYAE-1,Esophageal adenocarcinoma,Male,60Y,Pleural effusion,0.0,1.72,0.0,76.1,0.0,22.17,0.0
KYM-1,Embryonal rhabdomyosarcoma,Male,9M,Neck,0.0,0.0,0.0,74.54,0.0,24.94,0.51
KYO-1,"Chronic myelogenous leukemia, BCR-ABL1 positive",Male,22Y,Peripheral blood,5.83,0.0,3.73,78.04,0.0,12.39,0.0
KYSE-140,Esophageal squamous cell carcinoma,Male,54Y,Esophagus,6.23,0.0,3.5,83.8,0.0,6.46,0.0
KYSE-150,Esophageal squamous cell carcinoma,Female,49Y,Esophagus,1.08,0.0,0.41,79.69,0.0,18.82,0.0
KYSE-180,Esophageal squamous cell carcinoma,Male,53Y,Esophagus,0.04,0.0,0.0,75.43,0.0,22.18,2.35
KYSE-220,Esophageal squamous cell carcinoma,Male,78Y,Esophagus,1.15,0.0,0.96,75.9,1.79,20.19,0.0
KYSE-270,Esophageal squamous cell carcinoma,Male,79Y,Esophagus,0.78,0.0,0.0,78.68,0.0,20.54,0.0
KYSE-30,Esophageal squamous cell carcinoma,Male,64Y,Esophagus,0.0,0.0,0.0,75.07,0.0,24.93,0.0
KYSE-410,Esophageal squamous cell carcinoma,Male,51Y,Esophagus,0.0,0.0,0.02,79.58,0.0,19.99,0.41
KYSE-450,Esophageal squamous cell carcinoma,Male,59Y,Esophagus,0.21,0.0,0.35,79.0,0.0,19.85,0.58
KYSE-50,Esophageal squamous cell carcinoma,Male,58Y,Esophagus,0.0,0.0,0.31,73.2,0.0,24.47,2.01
KYSE-510,Esophageal squamous cell carcinoma,Female,67Y,Esophagus,2.16,0.0,0.71,82.59,0.0,14.53,0.0
KYSE-520,Esophageal squamous cell carcinoma,Female,58Y,Esophagus,2.7,1.16,1.52,82.25,0.0,12.37,0.0
KYSE-70,Esophageal squamous cell carcinoma,Male,77Y,Esophagus,0.0,0.0,0.22,75.55,0.0,23.91,0.33
L-1236,Hodgkin lymphoma,Male,34Y,Peripheral blood,27.1,0.0,0.0,1.96,70.78,0.0,0.15
L-363,Plasma cell myeloma,Female,36Y,Peripheral blood,26.89,0.14,0.73,1.89,70.35,0.0,0.0
L-428,Hodgkin lymphoma,Female,37Y,Pleural effusion,28.79,0.0,2.16,3.23,65.81,0.0,0.0
L-540,Hodgkin lymphoma,Female,20Y,Bone marrow,27.46,0.0,0.0,1.11,70.77,0.61,0.05
L3.3,Pancreatic adenosquamous carcinoma,Female,77Y,Celiac axis lymph node,5.87,2.01,82.98,6.2,2.94,0.0,0.0
LA-N-6,Neuroblastoma,Male,6Y,Bone marrow,28.2,23.6,2.47,3.12,42.61,0.0,0.0
LAMA-84,"Chronic myelogenous leukemia, BCR-ABL1 positive",Female,29Y,Peripheral blood,52.05,0.0,14.08,1.13,29.64,1.46,1.64
LB1047-RCC,Renal cell carcinoma,Female,Age unspecified,Lymph node,58.33,0.0,0.9,0.45,20.14,0.0,20.18
LB2241-RCC,Renal cell carcinoma,Male,Age unspecified,Kidney,27.17,1.3,0.0,0.0,69.13,0.65,1.75
LB2518-MEL,Melanoma,Female,Age unspecified,Unknown,34.71,0.0,0.84,0.0,61.82,0.68,1.95
LB373-MEL-D,Melanoma,Female,Age unspecified,Unknown,31.01,0.56,1.8,0.8,65.32,0.0,0.51
LB647-SCLC,Lung small cell carcinoma,Male,Age unspecified,Unknown,32.15,0.14,0.0,0.0,66.53,0.99,0.19
LB771-HNC,Head and neck squamous cell carcinoma,Male,Age unspecified,Unknown,37.83,0.55,0.73,0.07,59.61,0.71,0.51
LB831-BLC,Bladder carcinoma,Male,65Y,Urinary bladder,33.23,0.49,0.0,0.0,63.52,0.01,2.75
LB996-RCC,Renal cell carcinoma,Male,Age unspecified,Kidney,49.72,1.05,0.0,0.0,45.92,0.4,2.91
LC-1/sq,Lung squamous cell carcinoma,Male,69Y,Lung,0.0,0.0,0.33,91.84,0.0,7.55,0.28
LC-1/sq-SF,Lung squamous cell carcinoma,Male,69Y,Lung,0.0,0.0,1.68,96.94,0.0,1.38,0.0
LC-1F,Lung squamous cell carcinoma,Male,69Y,Lung,5.06,0.0,6.24,88.7,0.0,0.0,0.0
LC-2/ad,Lung adenocarcinoma,Female,51Y,Pleural effusion,4.65,0.63,3.51,76.2,0.91,13.98,0.14
LC4-1,Childhood B acute lymphoblastic leukemia,Female,13Y,Unknown,0.0,0.0,0.0,75.57,0.0,23.72,0.71
LCLC-103H,Lung large cell carcinoma,Male,61Y,Pleural effusion,33.55,0.0,1.78,3.13,61.54,0.0,0.0
LCLC-97TM1,Lung large cell carcinoma,Male,44Y,Lung,39.32,0.5,4.96,5.82,49.41,0.0,0.0
Li-7,Adult hepatocellular carcinoma,Male,45Y,Liver,0.0,0.93,0.0,80.68,0.44,17.95,0.0
LIM1215,Colon adenocarcinoma,Male,34Y,Omentum,57.24,0.0,5.72,3.18,26.95,0.0,6.91
LK-2,Lung squamous cell carcinoma,Male,74Y,Lung,1.08,0.0,0.42,82.35,0.0,16.15,0.0
LMSU,Gastric carcinoma,Female,27Y,Lymph node,0.71,0.32,0.29,85.74,0.0,12.36,0.58
LN-18,Glioblastoma,Male,61Y,"Brain, right temporal lobe",41.12,0.22,0.83,3.7,53.19,0.0,0.94
LN-229,Glioblastoma,Female,60Y,"Brain, right frontal parieto-occipital cortex",38.27,0.0,0.0,2.23,59.47,0.0,0.02
LN-235,Astrocytoma,Male,38Y,"Brain, right fronto-temporal lobe",65.09,0.31,3.32,4.46,23.54,0.0,3.28
LN-308,Astrocytoma,Male,60Y,"Brain, right parieto-occipital lobe",52.76,0.47,0.02,2.42,44.33,0.0,0.0
LN-319,Astrocytoma,Male,67Y,"Brain, right temporal lobe",29.81,0.71,1.07,1.65,65.6,0.0,1.15
LN-340,Glioblastoma,Male,57Y,"Brain, right parietal lobe",41.49,0.0,0.66,3.84,54.01,0.0,0.0
LN-382,Glioblastoma,Male,67Y,"Brain, right fronto-parietal lobe",38.35,0.0,0.37,1.0,59.11,0.55,0.62
LN-405,Glioblastoma,Female,61Y,"Brain, left fronto-temporal lobe",38.13,0.0,1.81,1.39,55.54,0.0,3.12
LN-443,Glioblastoma,Female,48Y,"Brain, left parietal lobe",60.91,0.0,3.39,4.23,27.1,0.0,4.37
LNCaP clone FGC,Prostate carcinoma,Male,50Y,Left supraclavicular lymph node,57.41,0.31,2.89,0.0,28.39,2.4,8.61
LNZTA3WT4,Astrocytoma,Male,60Y,"Brain, right parieto-occipital lobe",49.7,1.36,1.42,1.52,44.35,0.0,1.65
LOU-NH91,Lung squamous cell carcinoma,Female,64Y,"Lung, right lower lobe",37.36,0.0,0.6,3.36,58.24,0.0,0.43
Loucy,Adult T acute lymphoblastic leukemia,Female,38Y,Peripheral blood,58.12,0.51,0.63,1.01,26.95,2.78,9.99
LoVo,Colon adenocarcinoma,Male,56Y,Left supraclavicular lymph node,27.34,0.0,0.0,0.0,71.69,0.0,0.96
LOX-IMVI,Amelanotic melanoma,Male,58Y,Axillary lymph node,29.14,0.0,1.11,2.55,67.19,0.0,0.0
LP-1,Plasma cell myeloma,Female,56Y,Peripheral blood,51.44,0.0,0.21,3.2,42.82,0.0,2.32
LS1034,Cecum adenocarcinoma,Male,54Y,Cecum,34.98,1.06,0.0,0.24,62.34,1.27,0.11
LS123,Colon adenocarcinoma,Female,65Y,Colon,28.34,0.0,0.0,1.17,70.48,0.0,0.0
LS180,Colon adenocarcinoma,Female,58Y,Colon,55.48,0.0,1.1,0.33,35.25,0.79,7.05
LS411N,Cecum adenocarcinoma,Male,32Y,Cecum,59.95,0.0,1.71,2.86,27.91,0.0,7.57
LS513,Cecum adenocarcinoma,Male,63Y,"Intestine, ileocecal valve",43.0,0.0,0.3,4.01,52.68,0.0,0.0
Lu-134-A,Lung small cell carcinoma,Male,80Y,Lung,0.0,0.0,0.6,73.6,0.3,23.8,1.7
Lu-135,Lung small cell carcinoma,Male,69Y,Lung,3.52,0.34,1.7,77.4,0.0,17.05,0.0
Lu-139,Lung small cell carcinoma,Male,63Y,Lung,0.0,0.0,1.34,86.97,2.93,5.88,2.89
Lu-165,Lung small cell carcinoma,Male,50Y,Lymph node,0.0,0.53,0.0,28.73,0.0,70.74,0.0
Lu-65,Lung giant cell carcinoma,Male,64Y,Lung,1.17,0.0,0.0,79.97,0.3,18.08,0.48
Lu-99,Lung giant cell carcinoma,Male,63Y,Lung,1.62,0.0,0.25,84.63,0.0,13.5,0.0
Lu-99A,Lung giant cell carcinoma,Male,63Y,Lung,7.13,0.0,5.88,75.94,2.28,8.76,0.0
LUDLU-1,Lung squamous cell carcinoma,Male,72Y,Unknown,37.65,0.66,1.82,3.82,56.05,0.0,0.0
LXF 289,Lung adenocarcinoma,Male,62Y,Lung,30.93,0.0,0.0,2.04,66.88,0.0,0.14
M-07e,Childhood acute megakaryoblastic leukemia,Female,6M,Peripheral blood,41.63,0.0,8.96,0.92,45.47,0.0,3.01
M059J,Glioblastoma,Male,33Y,Brain,28.55,0.0,1.01,2.75,67.68,0.0,0.0
M059K,Glioblastoma,Male,33Y,Brain,28.16,0.0,0.16,2.3,69.38,0.0,0.0
M14,Amelanotic melanoma,Male,33Y,"Right buttock, hypodermis",30.39,0.0,0.64,0.0,67.89,1.08,0.0
Malme-3M,Melanoma,Male,43Y,Lung,31.17,0.0,0.63,1.38,66.47,0.0,0.35
MC-1010,Adult acute myeloid leukemia,Male,Unknown,Unknown,35.76,0.93,0.31,2.01,60.99,0.0,0.0
MC/CAR,Unknown,Male,81Y,Peripheral blood,32.76,0.0,0.32,0.0,66.92,0.0,0.0
MC116,B-cell non-Hodgkin lymphoma,Male,Age unspecified,Pleural effusion,30.78,0.0,0.0,1.22,64.91,0.0,3.09
MCAS,Ovarian mucinous cystadenocarcinoma,Female,60Y,Ovary,0.0,0.0,0.0,78.1,0.0,21.89,0.0
MCC13,Merkel cell carcinoma,Female,80Y,Cervical lymph node,31.08,0.0,0.0,0.0,64.74,1.16,3.02
MCC26,Merkel cell carcinoma,Female,82Y,Unknown,30.75,0.82,0.0,1.72,66.7,0.0,0.0
MCF-7,Invasive breast carcinoma of no special type,Female,69Y,Pleural effusion,38.15,0.0,0.74,4.2,56.91,0.0,0.0
MDA-MB-134-VI,Invasive breast lobular carcinoma,Female,47Y,Pleural effusion,29.06,0.0,2.96,3.67,64.3,0.0,0.0
MDA-MB-157,Breast carcinoma,Female,44Y,Pleural effusion,16.09,0.0,77.9,4.71,1.3,0.0,0.0
MDA-MB-175-VII,Invasive breast carcinoma of no special type,Female,56Y,Pleural effusion,10.73,0.0,83.61,5.65,0.0,0.0,0.0
MDA-MB-231,Breast adenocarcinoma,Female,51Y,Pleural effusion,60.03,0.0,1.95,2.44,28.16,0.0,7.42
MDA-MB-330,Invasive breast lobular carcinoma,Female,43Y,Pleural effusion,29.63,0.0,0.4,2.68,67.3,0.0,0.0
MDA-MB-361,Breast adenocarcinoma,Female,40Y,Brain,36.11,0.71,0.0,0.0,62.27,0.0,0.9
MDA-MB-415,Breast adenocarcinoma,Female,38Y,Pleural effusion,42.03,12.27,1.43,1.2,40.99,1.74,0.34
MDA-MB-435S,Amelanotic melanoma,Male,33Y,"Right buttock, hypodermis",32.63,0.0,0.01,2.13,65.23,0.0,0.0
MDA-MB-436,Invasive breast carcinoma of no special type,Female,43Y,Pleural effusion,32.49,0.0,1.41,2.21,63.9,0.0,0.0
MDA-MB-453,Breast adenocarcinoma,Female,48Y,Pericardial effusion,34.13,0.0,0.0,2.43,63.01,0.0,0.43
MDA-MB-468,Breast adenocarcinoma,Female,51Y,Pleural effusion,13.51,0.0,80.3,6.19,0.0,0.0,0.0
MDA-PCa-2b,Prostate carcinoma,Male,63Y,Bone,7.34,0.0,90.02,2.64,0.0,0.0,0.0
MDST8,Colon carcinoma,Unknown,Unknown,Colon,31.91,0.98,0.18,1.64,63.72,0.0,1.57
ME-1 [Human leukemia],Adult acute myeloid leukemia,Male,40Y,Peripheral blood,0.0,0.61,0.67,75.25,0.0,23.47,0.0
ME-180,Human papillomavirus-related cervical squamous cell carcinoma,Female,66Y,Omentum,32.53,0.16,1.51,1.49,64.3,0.0,0.0
MEC-1,Chronic lymphocytic leukemia,Male,61Y,Peripheral blood,64.15,0.0,1.9,2.04,26.14,0.0,5.76
MEC-2,Chronic lymphocytic leukemia,Male,61Y,Peripheral blood,65.6,0.0,1.35,2.58,25.37,0.0,5.1
MEG-01,"Blast phase chronic myelogenous leukemia, BCR-ABL1 positive",Male,55Y,Bone marrow,2.33,0.0,1.14,79.13,0.0,17.4,0.0
Mel Ho,Melanoma,Female,Unknown,Skin,34.59,0.0,0.0,1.05,64.35,0.0,0.0
Mel JuSo,Cutaneous melanoma,Female,58Y,Skin,35.59,0.0,0.0,0.0,63.28,1.12,0.0
MES-SA,Uterine corpus sarcoma,Female,56Y,Uterus,43.94,0.0,1.13,1.61,50.63,0.25,2.44
MeWo,Cutaneous melanoma,Male,78Y,Lymph node,61.86,1.31,2.39,0.6,25.84,0.77,7.24
MFE-280,Endometrial adenocarcinoma,Female,77Y,Endometrium,37.62,0.41,1.51,4.71,55.75,0.0,0.0
MFE-296,Endometrial adenocarcinoma,Female,68Y,Endometrium,27.84,0.0,0.0,0.0,71.44,0.0,0.72
MFE-319,Endometrial adenosquamous carcinoma,Female,81Y,Endometrium,31.06,0.0,0.0,0.0,66.31,0.0,2.63
MFH-ino,Undifferentiated pleomorphic sarcoma,Female,45Y,Unknown,0.0,0.0,0.0,75.44,0.0,24.26,0.29
MFM-223,Breast carcinoma,Female,>45Y,Pleural effusion,38.73,0.0,0.51,3.43,55.91,0.0,1.41
MG-63,Osteosarcoma,Male,14Y,"Bone, left femur",65.26,0.69,3.1,2.05,23.83,0.0,5.07
MHH-CALL-2,Childhood B acute lymphoblastic leukemia,Female,15Y,Peripheral blood,22.68,0.0,1.65,2.18,73.49,0.0,0.0
MHH-CALL-3,Childhood B acute lymphoblastic leukemia,Female,11Y,Bone marrow,31.45,1.07,0.15,0.95,66.38,0.0,0.0
MHH-CALL-4,Childhood B acute lymphoblastic leukemia,Male,10Y,Peripheral blood,30.81,0.0,0.24,0.15,65.48,1.34,1.97
MHH-ES-1,Ewing sarcoma,Male,12Y,Ascites,41.22,0.83,1.53,4.32,41.94,3.68,6.47
MHH-NB-11,Neuroblastoma,Male,4Y,Adrenal gland,26.69,0.0,0.35,1.33,69.36,0.0,2.27
MHH-PREB-1,B-cell non-Hodgkin lymphoma,Male,7Y,Lymph node,59.05,0.19,1.87,2.12,34.51,0.44,1.83
MIA PaCa-2,Pancreatic ductal adenocarcinoma,Male,65Y,Pancreas,63.79,0.0,1.15,3.82,22.54,0.0,8.7
Mino,Mantle cell lymphoma,Male,68Y,Peripheral blood,51.98,0.0,0.85,1.5,39.56,0.0,6.1
MJ,Primary cutaneous T-cell non-Hodgkin lymphoma,Male,50Y,Peripheral blood,28.85,0.0,0.0,0.0,70.84,0.31,0.0
MKN1,Gastric adenosquamous carcinoma,Male,72Y,Lymph node,2.44,0.0,0.31,81.4,0.44,15.4,0.0
MKN28,Gastric tubular adenocarcinoma,Male,37Y,Liver,0.0,0.0,0.0,83.28,0.0,16.71,0.0
MKN45,Gastric adenocarcinoma,Female,62Y,Liver,3.67,0.0,1.54,85.37,0.0,9.42,0.0
MKN7,Gastric tubular adenocarcinoma,Male,39Y,Lymph node,0.49,0.09,0.0,81.05,0.0,18.37,0.0
MKN74,Gastric tubular adenocarcinoma,Male,37Y,Liver,1.29,0.0,0.0,88.48,0.0,9.79,0.44
ML-1 [Human thyroid carcinoma],Thyroid gland follicular carcinoma,Female,50Y,Thyroid gland,38.3,0.68,0.17,3.84,57.01,0.0,0.0
ML-2,Adult acute myeloid leukemia,Male,26Y,Peripheral blood,29.2,0.0,0.0,0.0,70.54,0.0,0.26
MLMA,Hairy cell leukemia,Female,32Y,Peritoneal effusion,0.0,0.54,0.0,77.94,0.0,21.52,0.0
MM1.S,Plasma cell myeloma,Female,45Y,Peripheral blood,6.87,0.0,88.68,4.01,0.0,0.0,0.43
MMAc-SF,Melanoma,Female,39Y,Ascites,0.25,0.05,0.62,77.21,0.0,20.11,1.76
MN-60,Burkitt lymphoma,Male,20Y,Peripheral blood,16.53,0.16,0.18,2.87,78.96,0.48,0.82
Mo,Hairy cell leukemia,Male,33Y,Spleen,29.24,0.37,0.0,0.0,68.22,1.84,0.34
MOG-G-CCM,Anaplastic astrocytoma,Sex unspecified,Age unspecified,Brain,29.68,0.0,0.19,0.2,69.93,0.0,0.0
MOG-G-UVW,Anaplastic astrocytoma,Male,Age unspecified,Brain,37.14,0.0,1.89,2.75,58.22,0.0,0.0
MOLM-13,Adult acute myeloid leukemia,Male,20Y,Peripheral blood,0.0,1.24,0.0,76.64,0.0,22.12,0.0
MOLM-16,Adult acute myeloid leukemia,Female,77Y,Peripheral blood,3.54,0.0,2.33,81.24,0.0,12.89,0.0
MOLM-6,"Chronic myelogenous leukemia, BCR-ABL1 positive",Male,44Y,Peripheral blood,0.0,0.75,0.0,75.67,0.0,23.58,0.0
MOLP-2,Plasma cell myeloma,Male,55Y,Peripheral blood,5.11,1.1,3.42,76.4,0.0,13.96,0.0
MOLP-8,Plasma cell myeloma,Male,52Y,Peripheral blood,0.0,0.26,0.0,74.81,0.46,24.35,0.12
MOLT-13,Childhood T acute lymphoblastic leukemia,Female,2Y,Bone marrow,40.12,0.55,0.68,0.0,54.27,0.0,4.38
MOLT-16,Childhood T acute lymphoblastic leukemia,Female,5Y,Peripheral blood,8.47,0.82,79.1,2.03,7.73,0.0,1.85
MOLT-3,Adult T acute lymphoblastic leukemia,Male,19Y,Peripheral blood,30.32,0.0,0.91,2.31,66.02,0.0,0.44
MOLT-4,Adult T acute lymphoblastic leukemia,Male,19Y,Peripheral blood,28.87,0.0,0.38,1.74,68.08,0.0,0.94
Mono-Mac-1,Adult acute monocytic leukemia,Male,64Y,Peripheral blood,40.63,0.46,1.61,2.85,54.45,0.0,0.0
Mono-Mac-6,Adult acute monocytic leukemia,Male,64Y,Peripheral blood,39.32,1.11,2.82,2.05,54.71,0.0,0.0
MOR/CPR,Lung adenocarcinoma,Sex unspecified,Age unspecified,Lung,32.53,0.0,1.26,4.44,61.77,0.0,0.0
MOTN-1,T-cell large granular lymphocyte leukemia,Female,65Y,Peripheral blood,0.64,0.4,0.84,73.72,0.0,24.39,0.0
MPP 89,Pleural epithelioid mesothelioma,Male,67Y,Pleural effusion,54.38,0.0,5.06,6.98,33.57,0.0,0.0
MRK-nu-1,Breast carcinoma,Female,46Y,Pleural effusion,0.74,1.19,0.98,73.82,0.07,23.21,0.0
MS-1 [Human lung carcinoma],Lung small cell carcinoma,Male,54Y,Pleural effusion,7.23,0.17,9.93,64.82,5.2,12.65,0.0
MS751,Human papillomavirus-related cervical squamous cell carcinoma,Female,47Y,Lymph node,31.66,0.44,0.0,0.0,67.07,0.42,0.41
MSTO-211H,Pleural biphasic mesothelioma,Male,62Y,Pleural effusion,33.49,0.17,0.0,1.28,62.92,0.0,2.13
MUTZ-5,B acute lymphoblastic leukemia,Male,26Y,Peripheral blood,55.18,0.51,16.18,0.0,13.74,2.27,12.13
MV4-11,Childhood acute monocytic leukemia,Male,10Y,Peripheral blood,28.91,0.0,0.59,0.34,67.58,0.0,2.57
MY-M12,Acute biphenotypic leukemia,Female,52Y,Bone marrow,0.0,0.38,0.94,81.47,0.0,16.04,1.17
MZ-MEL-2,Melanoma,Sex unspecified,Age unspecified,Abdomen,33.8,0.15,0.0,0.41,64.57,0.66,0.41
MZ-MEL-7,Melanoma,Female,25-26Y,Spleen,30.35,0.24,0.42,1.19,67.07,0.69,0.03
MZ-PC-1,Pancreatic ductal adenocarcinoma,Male,46Y,Pleural effusion,32.2,0.0,0.66,2.92,62.36,0.0,1.85
NALM-1,"Childhood chronic myelogenous leukemia, BCR-ABL1 positive",Female,3Y,Peripheral blood,9.12,6.08,77.03,2.94,4.83,0.0,0.0
NALM-19,B acute lymphoblastic leukemia,Male,26Y,Peripheral blood,3.83,0.1,1.76,79.97,0.0,14.34,0.01
NALM-6,Adult B acute lymphoblastic leukemia,Male,19Y,Peripheral blood,22.21,0.55,0.12,0.0,75.01,2.1,0.0
Namalwa,EBV-related Burkitt lymphoma,Female,Children,Unknown,3.91,0.0,94.65,1.43,0.0,0.0,0.0
NB(TU)1,Neuroblastoma,Female,1Y8M,Unknown,0.0,0.24,0.86,77.99,0.0,19.62,1.28
NB1,Neuroblastoma,Male,2Y3M,Cervical lymph node,3.8,0.21,2.29,80.53,0.0,13.17,0.0
NB4,Acute promyelocytic leukemia with PML-RARA,Female,23Y,Bone marrow,41.98,0.0,3.99,4.75,49.28,0.0,0.0
NB69,Neuroblastoma,Male,1Y4M,Unknown,34.0,0.26,0.0,0.67,64.54,0.0,0.54
NBsusSR,Neuroblastoma,Male,18Y,Unknown,0.68,0.0,1.34,75.7,0.87,20.79,0.62
NCC-IT,Testicular embryonal carcinoma,Male,24Y,Unknown,0.0,0.0,0.0,81.79,0.0,18.2,0.0
NCC-StC-K140,Gastric carcinoma,Female,36Y,Stomach,4.29,0.0,1.19,80.7,0.0,13.81,0.0
NCC010,Renal cell carcinoma,Male,Age unspecified,Unknown,0.0,0.0,0.0,22.3,0.0,77.7,0.0
NCC021,Renal cell carcinoma,Sex unspecified,Age unspecified,Unknown,0.12,0.02,0.31,27.12,0.0,71.39,1.05
NCI-H1048,Lung small cell carcinoma,Female,53Y,Pleural effusion,21.04,0.0,69.86,6.8,2.3,0.0,0.0
NCI-H1092,Lung small cell carcinoma,Male,67Y,Bone marrow,39.59,0.0,1.87,4.65,53.89,0.0,0.0
NCI-H1105,Lung small cell carcinoma,Male,73Y,Lymph node,34.95,0.0,1.28,1.06,62.71,0.0,0.0
NCI-H1155,Lung large cell carcinoma,Male,36Y,Lymph node,34.42,1.0,1.09,2.22,60.47,0.0,0.79
NCI-H1184,Lung small cell carcinoma,Male,42Y,Lymph node,31.77,0.52,0.45,0.92,65.61,0.0,0.72
NCI-H128,Lung small cell carcinoma,Male,60Y,Pleural effusion,10.46,0.0,69.81,2.05,17.44,0.0,0.25
NCI-H1299,Lung large cell carcinoma,Male,43Y,Lymph node,34.68,0.0,0.33,2.13,62.86,0.0,0.0
NCI-H1304,Lung small cell carcinoma,Female,Unknown,Unknown,24.05,0.31,1.09,1.44,72.97,0.13,0.0
NCI-H1339,Lung small cell carcinoma,Female,49Y,Pleural effusion,12.01,1.01,70.93,4.29,11.76,0.0,0.0
NCI-H1341,Cervical small cell neuroendocrine carcinoma,Female,26Y,"Uterus, cervix",25.77,0.96,0.0,2.27,70.16,0.0,0.84
NCI-H1355,Lung adenocarcinoma,Male,53Y,Pleural effusion,49.01,0.0,1.64,2.95,41.22,0.42,4.77
NCI-H1373,Lung adenocarcinoma,Male,56Y,Lung,11.46,1.21,71.79,4.32,11.21,0.0,0.0
NCI-H1385,Lung squamous cell carcinoma,Female,49Y,Lymph node,16.46,0.0,69.29,3.93,10.32,0.0,0.0
NCI-H1395,Lung adenocarcinoma,Female,55Y,Lung,37.38,0.0,3.03,6.76,52.83,0.0,0.0
NCI-H1417,Lung small cell carcinoma,Female,61Y,Lung,26.71,0.0,0.09,1.05,67.94,0.15,4.06
NCI-H1435,Lung adenocarcinoma,Female,35Y,Lung,31.67,15.63,2.26,9.39,41.04,0.0,0.0
NCI-H1436,Lung small cell carcinoma,Male,39Y,Lymph node,27.63,0.28,0.29,3.22,67.17,0.0,1.4
NCI-H1437,Lung adenocarcinoma,Male,60Y,Pleural effusion,28.43,1.16,0.0,1.67,68.74,0.0,0.0
NCI-H146,Lung small cell carcinoma,Male,59Y,Bone marrow,30.99,0.0,0.37,2.05,66.14,0.0,0.45
NCI-H1563,Lung adenocarcinoma,Male,Age unspecified,Lung,61.99,0.0,0.33,0.56,24.17,2.48,10.47
NCI-H1568,Lung adenocarcinoma,Female,48Y,Lymph node,38.41,0.0,0.1,2.23,56.39,0.0,2.88
NCI-H1573,Lung adenocarcinoma,Female,35Y,Lung,38.22,0.0,1.85,5.57,54.36,0.0,0.0
NCI-H1581,Lung large cell carcinoma,Male,44Y,Lung,37.76,0.0,0.94,1.51,59.07,0.0,0.71
NCI-H1618,Lung small cell carcinoma,Female,55Y,Bone marrow,34.4,0.54,0.23,0.24,61.08,0.0,3.51
NCI-H1623,Lung adenocarcinoma,Male,58Y,Lymph node,35.4,0.03,1.52,2.83,60.22,0.0,0.0
NCI-H1648,Lung adenocarcinoma,Male,39Y,Lymph node,11.82,0.0,69.05,4.46,14.67,0.0,0.0
NCI-H1650,Minimally invasive lung adenocarcinoma,Male,27Y,Pleural effusion,34.34,0.0,0.57,3.27,61.83,0.0,0.0
NCI-H1651,Lung adenocarcinoma,Male,71Y,Lung,29.37,0.0,1.5,2.72,66.41,0.0,0.0
NCI-H1666,Minimally invasive lung adenocarcinoma,Female,50Y,Pleural effusion,32.47,0.0,1.25,1.76,63.0,0.0,1.52
NCI-H1688,Lung small cell carcinoma,Male,50Y,Liver,35.0,0.0,0.98,2.19,61.82,0.0,0.0
NCI-H1693,Lung adenocarcinoma,Female,55Y,Lymph node,31.2,0.67,0.99,3.46,63.68,0.0,0.0
NCI-H1694,Lung small cell carcinoma,Male,61Y,Ascites,62.14,1.28,4.95,5.88,23.45,0.17,2.13
NCI-H1703,Lung squamous cell carcinoma,Male,54Y,Lung,43.93,0.0,3.29,5.58,47.2,0.0,0.0
NCI-H1734,Lung adenocarcinoma,Female,56Y,Lung,30.13,0.78,0.0,1.29,67.8,0.0,0.0
NCI-H1755,Lung adenocarcinoma,Female,65Y,Liver,34.66,0.15,0.64,2.9,61.65,0.0,0.0
NCI-H1770,Lung non-small cell carcinoma,Male,57Y,Lymph node,33.09,0.35,2.3,4.49,59.77,0.0,0.0
NCI-H1781,Minimally invasive lung adenocarcinoma,Female,66Y,Pleural effusion,32.22,0.0,0.0,1.69,65.63,0.0,0.46
NCI-H1792,Lung adenocarcinoma,Male,50Y,Pleural effusion,34.89,0.75,2.29,2.43,59.22,0.0,0.41
NCI-H1793,Lung adenocarcinoma,Female,52Y,Lung,53.57,0.91,0.24,1.4,36.54,0.39,6.96
NCI-H1836,Lung small cell carcinoma,Male,52Y,Lung,27.28,0.84,0.0,0.99,70.01,0.0,0.88
NCI-H1838,Lung adenocarcinoma,Female,Age unspecified,Lung,36.13,0.0,2.12,3.65,58.09,0.0,0.0
NCI-H1869,Lung squamous cell carcinoma,Male,58Y,Lung,33.45,0.0,0.87,2.87,62.8,0.0,0.0
NCI-H187,Lung small cell carcinoma,Male,47Y,Pleural effusion,33.62,0.51,0.56,0.71,64.51,0.08,0.0
NCI-H1876,Lung small cell carcinoma,Male,59Y,Lymph node,26.6,0.51,0.78,1.19,70.91,0.0,0.0
NCI-H1915,Lung non-small cell carcinoma,Female,61Y,Lung,62.34,0.18,3.05,4.07,23.9,0.0,6.45
NCI-H1930,Lung small cell carcinoma,Male,41Y,Lymph node,37.69,0.0,2.23,3.79,56.29,0.0,0.0
NCI-H1944,Lung adenocarcinoma,Female,62Y,Lung,33.73,0.24,0.85,2.96,61.33,0.0,0.89
NCI-H196,Lung sarcomatoid carcinoma,Male,68Y,Pleural effusion,43.59,0.1,0.0,0.0,50.92,1.64,3.75
NCI-H1963,Lung small cell carcinoma,Male,56Y,Lung,17.68,0.5,56.07,4.15,21.6,0.0,0.0
NCI-H1975,Lung adenocarcinoma,Female,Age unspecified,Lung,60.85,0.0,0.35,1.32,30.01,0.0,7.46
NCI-H1993,Lung adenocarcinoma,Female,47Y,Lymph node,29.05,0.66,1.07,0.47,67.35,1.32,0.09
NCI-H2009,Lung adenocarcinoma,Female,68Y,Lymph node,38.19,0.0,5.66,7.51,48.63,0.0,0.0
NCI-H2023,Lung adenocarcinoma,Male,26Y,Lung,32.18,0.48,0.0,0.88,66.45,0.0,0.0
NCI-H2029,Lung small cell carcinoma,Female,69Y,Lymph node,38.55,0.0,4.84,5.65,50.95,0.0,0.0
NCI-H2030,Lung adenocarcinoma,Male,Age unspecified,Lymph node,32.52,0.0,0.43,0.0,64.18,0.0,2.87
NCI-H2052,Pleural sarcomatoid mesothelioma,Male,65Y,Pleural effusion,32.79,0.0,0.17,2.33,64.49,0.0,0.22
NCI-H2066,Lung squamous cell carcinoma,Female,70Y,Lung,34.61,0.0,3.0,2.95,59.43,0.0,0.0
NCI-H2073,Lung adenocarcinoma,Female,47Y,Lung,32.48,0.0,1.14,2.07,64.31,0.0,0.0
NCI-H2081,Lung small cell carcinoma,Female,59Y,Pleural effusion,43.27,0.0,2.93,6.2,47.59,0.0,0.0
NCI-H2085,Lung adenocarcinoma,Male,45Y,Lung,34.93,0.0,0.71,2.54,61.81,0.0,0.0
NCI-H2087,Lung adenocarcinoma,Male,69Y,Lymph node,29.44,0.0,0.0,3.19,67.37,0.0,0.0
NCI-H209,Lung small cell carcinoma,Male,55Y,Bone marrow,31.02,0.0,1.88,1.08,65.94,0.0,0.08
NCI-H2106,Lung large cell carcinoma,Male,58Y,Lymph node,32.31,1.71,0.0,1.71,64.26,0.0,0.0
NCI-H211,Lung small cell carcinoma,Female,50Y,Bone marrow,39.33,0.0,3.08,5.72,51.87,0.0,0.0
NCI-H2110,Lung non-small cell carcinoma,Sex unspecified,Age unspecified,Pleural effusion,12.13,0.0,82.92,4.2,0.75,0.0,0.0
NCI-H2122,Lung adenocarcinoma,Female,46Y,Pleural effusion,31.01,0.26,0.0,1.42,65.92,0.0,1.39
NCI-H2126,Lung large cell carcinoma,Male,65Y,Pleural effusion,35.45,0.65,1.91,3.65,58.35,0.0,0.0
NCI-H2135,Lung non-small cell carcinoma,Sex unspecified,Age unspecified,Unknown,58.84,0.0,5.4,0.0,21.96,1.13,12.67
NCI-H2141,Lung small cell carcinoma,Male,58Y,Lymph node,30.38,0.27,1.17,1.08,65.94,0.0,1.16
NCI-H2170,Lung squamous cell carcinoma,Male,Age unspecified,Unknown,28.61,0.0,0.09,0.85,69.01,0.49,0.94
NCI-H2171,Lung small cell carcinoma,Male,50Y,Pleural effusion,35.63,0.0,3.06,4.89,56.36,0.05,0.0
NCI-H2172,Lung non-small cell carcinoma,Female,Age unspecified,Lung,9.75,0.46,81.79,2.23,5.77,0.0,0.0
NCI-H2196,Lung small cell carcinoma,Male,67Y,Bone marrow,28.81,0.0,2.17,2.28,66.73,0.0,0.0
NCI-H2227,Lung small cell carcinoma,Male,54Y,Lung,31.37,0.0,0.0,1.89,65.68,0.0,1.06
NCI-H2228,Lung adenocarcinoma,Female,Age unspecified,Lung,33.09,0.08,0.1,0.5,65.31,0.06,0.85
NCI-H226,Pleural epithelioid mesothelioma,Male,Age unspecified,Pleural effusion,31.86,0.0,0.0,0.16,65.62,0.88,1.48
NCI-H2286,Lung adenocarcinoma,Female,57Y,Lung,32.33,0.0,2.79,4.22,60.65,0.0,0.0
NCI-H2291,Lung adenocarcinoma,Male,Age unspecified,Lymph node,39.15,0.0,1.1,3.67,54.53,0.0,1.55
NCI-H23,Lung adenocarcinoma,Male,51Y,Lung,16.3,2.12,67.86,2.83,10.88,0.0,0.0
NCI-H2342,Lung adenocarcinoma,Male,55Y,Lung,36.81,0.0,0.24,4.52,58.43,0.0,0.0
NCI-H2347,Lung adenocarcinoma,Female,54Y,Lung,35.9,0.0,0.0,0.74,62.76,0.0,0.59
NCI-H2369,Pleural malignant mesothelioma,Male,Age unspecified,Unknown,30.22,0.0,0.75,0.77,67.35,0.91,0.0
NCI-H2373,Pleural sarcomatoid mesothelioma,Male,Adult,"Lung, pleura",29.5,0.0,0.63,0.0,66.33,0.91,2.63
NCI-H2405,Lung adenocarcinoma,Male,47Y,Lung,34.69,0.0,3.18,2.88,58.28,0.0,0.97
NCI-H2444,Lung non-small cell carcinoma,Male,Age unspecified,Lung,35.85,1.22,0.0,3.0,58.66,0.0,1.26
NCI-H2452,Pleural biphasic mesothelioma,Male,Adult,"Lung, pleura",34.76,0.0,0.27,1.66,63.32,0.0,0.0
NCI-H2461,Pleural epithelioid mesothelioma,Male,Adult,"Lung, pleura",33.37,0.07,0.92,1.1,63.28,1.25,0.0
NCI-H250,Lung small cell carcinoma,Male,34Y,Brain,7.7,0.09,91.03,1.17,0.0,0.0,0.0
NCI-H2591,Pleural epithelioid mesothelioma,Male,Adult,"Lung, pleura",29.11,0.0,0.0,0.0,68.64,0.61,1.63
NCI-H2595,Pleural epithelioid mesothelioma,Male,Adult,"Lung, pleura",31.93,0.21,0.03,0.0,64.92,0.22,2.69
NCI-H2722,Pleural malignant mesothelioma,Male,Unknown,Unknown,37.33,1.83,0.26,0.0,57.77,0.0,2.81
NCI-H2731,Pleural sarcomatoid mesothelioma,Male,Unknown,Unknown,30.53,0.84,0.0,1.33,65.41,0.0,1.88
NCI-H2795,Pleural epithelioid mesothelioma,Male,Unknown,Unknown,29.89,1.03,1.04,1.57,65.63,0.0,0.85
NCI-H28,Pleural malignant mesothelioma,Male,48Y,Pleural effusion,15.05,0.21,65.11,3.2,16.44,0.0,0.0
NCI-H2803,Pleural malignant mesothelioma,Unknown,Unknown,Unknown,15.28,0.46,59.04,1.75,22.93,0.0,0.55
NCI-H2804,Pleural malignant mesothelioma,Male,Age unspecified,Unknown,28.74,0.0,1.05,2.06,68.14,0.0,0.0
NCI-H2810,Pleural epithelioid mesothelioma,Male,Age unspecified,Unknown,60.38,0.47,2.41,2.44,28.37,0.76,5.17
NCI-H2818,Pleural epithelioid mesothelioma,Male,Age unspecified,Unknown,19.07,1.13,0.0,0.0,76.08,0.17,3.55
NCI-H2869,Pleural biphasic mesothelioma,Male,Age unspecified,Unknown,34.91,0.0,0.0,0.0,63.53,0.6,0.96
NCI-H290,Pleural malignant mesothelioma,Male,Age unspecified,Pleural effusion,29.45,0.64,0.1,0.0,66.44,0.75,2.62
NCI-H292,Lung mucoepidermoid carcinoma,Female,32Y,Lymph node,10.06,0.17,81.43,2.03,6.04,0.0,0.28
NCI-H3118,Parotid gland mucoepidermoid carcinoma,Female,Unknown,Unknown,34.08,0.01,0.85,2.51,59.54,0.0,3.02
NCI-H3122,Lung adenocarcinoma,Male,54Y,Pleural effusion,31.26,0.0,0.0,1.36,65.9,0.0,1.48
NCI-H322,Minimally invasive lung adenocarcinoma,Male,52Y,Lung,27.95,0.0,1.01,2.38,68.65,0.0,0.0
NCI-H322M,Minimally invasive lung adenocarcinoma,Male,52Y,Lung,25.2,0.0,0.44,0.73,72.75,0.88,0.0
NCI-H3255,Lung adenocarcinoma,Female,47Y,Pleural effusion,34.46,0.0,3.63,2.06,59.85,0.0,0.0
NCI-H345,Lung small cell carcinoma,Male,64Y,Bone marrow,61.17,0.71,1.67,2.16,25.58,1.53,7.19
NCI-H358,Minimally invasive lung adenocarcinoma,Male,Age unspecified,Lung,35.82,0.0,3.45,4.63,56.1,0.0,0.0
NCI-H378,Lung small cell carcinoma,Female,66Y,Pleural effusion,58.4,1.24,2.92,1.45,26.04,1.89,8.06
NCI-H441,Lung papillary adenocarcinoma,Male,33Y,Pericardial effusion,33.69,0.0,0.09,3.45,61.67,0.0,1.1
NCI-H446,Lung small cell carcinoma,Male,61Y,Pleural effusion,27.05,0.0,2.76,6.47,63.72,0.0,0.0
NCI-H460,Lung large cell carcinoma,Male,Age unspecified,Pleural effusion,32.24,0.0,0.0,1.96,65.65,0.0,0.15
NCI-H508,Cecum adenocarcinoma,Male,55Y,Abdominal wall,38.18,0.0,0.01,3.05,58.76,0.0,0.0
NCI-H510A,Lung small cell carcinoma,Male,53Y,Adrenal gland,33.11,0.3,0.05,2.01,64.53,0.0,0.0
NCI-H513,Lung adenosquamous carcinoma,Male,61Y,Hypodermis,5.9,0.0,83.85,2.18,5.9,0.0,2.16
NCI-H520,Lung squamous cell carcinoma,Male,Age unspecified,Lung,35.5,0.0,0.0,0.92,63.58,0.0,0.0
NCI-H522,Lung adenocarcinoma,Male,58Y,Lung,23.13,0.0,1.94,1.91,69.74,0.0,3.27
NCI-H524,Lung small cell carcinoma,Male,63Y,Lymph node,32.01,0.0,0.55,1.32,66.11,0.0,0.0
NCI-H526,Lung small cell carcinoma,Male,55Y,Bone marrow,33.49,0.0,0.0,1.13,63.44,0.0,1.94
NCI-H596,Lung adenosquamous carcinoma,Male,73Y,Lung,35.26,0.0,0.07,2.55,62.11,0.0,0.0
NCI-H630,Unknown,Sex unspecified,Age unspecified,Unknown,29.61,0.04,0.0,0.0,67.59,1.38,1.38
NCI-H64,Lung small cell carcinoma,Female,48Y,Lymph node,11.33,0.62,67.82,1.03,19.2,0.0,0.0
NCI-H647,Lung adenosquamous carcinoma,Male,56Y,Pleural effusion,27.13,0.88,0.0,0.0,70.95,0.0,1.04
NCI-H650,Lung adenocarcinoma,Male,Age unspecified,Lung,33.15,0.0,0.0,1.27,65.1,0.48,0.0
NCI-H660,Prostate small cell carcinoma,Male,63Y,Cervical lymph node,37.0,0.0,2.18,2.77,58.05,0.0,0.0
NCI-H661,Lung large cell carcinoma,Male,43Y,Lymph node,34.14,0.51,0.22,0.62,63.58,0.0,0.92
NCI-H69,Lung small cell carcinoma,Male,55Y,Pleural effusion,35.34,0.0,0.79,1.48,61.96,0.0,0.42
NCI-H716,Cecum adenocarcinoma,Male,33Y,Ascites,44.03,14.7,3.04,4.64,30.38,0.0,3.2
NCI-H720,Lung carcinoid tumor,Male,Age unspecified,Lung,60.36,1.07,2.64,3.8,25.94,0.0,6.19
NCI-H727,Lung carcinoid tumor,Female,65Y,Unknown,32.88,0.23,0.37,3.94,62.32,0.0,0.26
NCI-H740,Lung small cell carcinoma,Male,63Y,Lymph node,31.56,0.0,1.71,1.31,64.24,0.0,1.18
NCI-H747,Cecum adenocarcinoma,Male,69Y,Lymph node,60.13,0.23,2.58,4.27,24.28,0.0,8.5
NCI-H748,Lung small cell carcinoma,Male,62Y,Lymph node,6.8,0.85,86.3,1.88,3.72,0.4,0.04
NCI-H810,Lung large cell carcinoma,Male,51Y,Lung,7.26,0.47,81.52,4.23,6.51,0.0,0.0
NCI-H82,Lung small cell carcinoma,Male,41Y,Pleural effusion,19.9,0.0,0.24,1.21,78.65,0.0,0.0
NCI-H820,Lung papillary adenocarcinoma,Male,53Y,Lymph node,32.19,0.0,0.6,0.97,65.84,0.0,0.4
NCI-H835,Lung carcinoid tumor,Female,48Y,Lung,7.28,0.0,80.01,2.97,9.74,0.0,0.0
NCI-H838,Lung adenocarcinoma,Male,59Y,Lymph node,43.22,0.84,0.05,0.79,50.18,1.88,3.04
NCI-H841,Thoracic SMARCA4-deficient undifferentiated tumor,Male,51Y,Lung,40.35,0.0,1.52,2.66,55.47,0.0,0.0
NCI-H847,Lung small cell carcinoma,Male,63Y,Pleural effusion,35.3,0.08,5.07,4.4,55.14,0.0,0.0
NCI-H854,Colon adenocarcinoma,Male,75Y,Colon,31.78,0.03,1.09,1.91,64.74,0.0,0.45
NCI-H889,Lung small cell carcinoma,Female,69Y,Lymph node,26.44,0.0,0.19,1.86,71.51,0.0,0.01
NCI-H929,Plasma cell myeloma,Female,62Y,Pleural effusion,28.21,0.61,0.0,2.52,68.5,0.0,0.16
NCI-N87,Gastric tubular adenocarcinoma,Male,Age unspecified,Liver,16.04,0.0,61.23,2.17,20.57,0.0,0.0
NCO2,"Chronic myelogenous leukemia, BCR-ABL1 positive",Female,35Y,Peripheral blood,1.73,0.0,0.0,82.46,0.0,15.81,0.0
NEC8,Testicular embryonal carcinoma,Male,24Y,Testis,4.15,0.61,2.09,79.76,0.0,13.39,0.0
NH-12,Adrenal gland neuroblastoma,Male,1Y3M,Adrenal gland,0.0,0.0,0.0,74.87,0.0,25.12,0.0
NH-6,Adrenal gland neuroblastoma,Female,9M,Adrenal gland,2.86,0.0,2.3,79.85,0.0,14.99,0.0
NK-92MI,Natural killer cell lymphoblastic leukemia/lymphoma,Male,50Y,Peripheral blood,32.85,0.5,1.91,2.04,62.71,0.0,0.0
NKM-1,Adult acute myeloid leukemia,Male,33Y,Peripheral blood,0.01,0.0,0.0,76.96,0.9,21.17,0.96
NMC-G1,Astrocytoma,Female,Unknown,Brain,0.0,0.0,0.0,81.52,0.0,18.48,0.0
NOMO-1,Adult acute monocytic leukemia,Female,31Y,Bone marrow,0.27,0.99,0.4,76.88,0.98,20.48,0.0
NOS-1 [Human osteosarcoma],Osteosarcoma,Male,16Y,"Bone, left proximal tibia",0.0,0.97,0.0,79.98,0.0,18.61,0.44
NT2-D1,Embryonal carcinoma,Male,22Y,Lung,39.23,0.0,1.78,0.45,53.03,1.42,4.09
NU-DHL-1,Diffuse large B-cell lymphoma,Male,73Y,Left inguinal lymph node,37.82,0.04,2.04,3.55,56.54,0.0,0.0
NU-DUL-1,Diffuse large B-cell lymphoma activated B-cell type,Male,43Y,Cerebrospinal fluid,32.78,0.0,0.0,1.39,63.99,0.48,1.36
NUGC-2,Gastric adenocarcinoma,Female,56Y,Paragastric lymph node,0.61,0.0,0.0,74.56,0.0,24.67,0.16
NUGC-3,Gastric adenocarcinoma,Male,72Y,Brachialis muscle,0.71,0.09,0.0,82.25,0.0,16.95,0.0
NUGC-4,Gastric signet ring cell adenocarcinoma,Female,35Y,Paragastric lymph node,1.27,0.72,0.0,65.95,0.0,32.05,0.0
NY,Osteosarcoma,Male,15Y,"Bone, right femur",0.55,0.2,0.02,78.63,0.59,19.14,0.88
OACM5.1 C,Esophageal adenocarcinoma,Female,47Y,Lymph node,26.29,0.02,0.0,0.0,72.08,0.0,1.6
OACP4 C,Esophageal adenocarcinoma,Male,55Y,Unknown,31.76,0.55,0.19,0.0,66.1,1.33,0.08
OAW28,High grade ovarian serous adenocarcinoma,Female,75Y,Ascites,31.91,0.0,0.74,2.29,63.18,0.0,1.87
OAW42,Ovarian serous cystadenocarcinoma,Female,46Y,Ascites,32.29,0.0,2.28,3.68,61.75,0.0,0.0
OC 314,Ovarian serous adenocarcinoma,Female,39Y,Ascites,21.79,1.66,0.0,1.17,75.37,0.0,0.0
OC 316,Ovarian serous adenocarcinoma,Female,39Y,Ascites,21.63,1.57,0.0,1.31,75.5,0.0,0.0
OCI-AML-2,Adult acute myeloid leukemia,Male,65Y,Peripheral blood,32.89,0.0,1.2,1.51,62.12,0.0,2.28
OCI-AML-3,Adult acute myeloid leukemia,Male,57Y,Peripheral blood,38.78,1.44,0.0,2.86,55.94,0.0,0.99
OCI-AML-5,Adult acute myeloid leukemia,Male,77Y,Peripheral blood,31.16,0.08,1.01,2.79,64.96,0.0,0.0
OCI-Ly10,Diffuse large B-cell lymphoma activated B-cell type,Female,66Y,Lymph node,28.0,0.93,0.25,0.48,70.29,0.0,0.05
OCI-Ly19,Diffuse large B-cell lymphoma germinal center B-cell type,Female,27Y,Bone marrow,39.33,0.0,2.55,4.58,53.54,0.0,0.0
OCI-Ly3,Diffuse large B-cell lymphoma activated B-cell type,Male,52Y,Bone marrow,30.48,0.0,0.02,4.08,65.42,0.0,0.0
OCI-Ly7,Diffuse large B-cell lymphoma germinal center B-cell type,Male,48Y,Peripheral blood,28.35,0.13,0.44,0.0,69.58,0.31,1.19
OCI-M1,Adult acute myeloid leukemia,Sex unspecified,62Y,Unknown,60.94,0.0,3.87,4.72,27.28,0.0,3.18
OCI-My5,Plasma cell myeloma,Sex unspecified,Age unspecified,Peripheral blood,36.05,0.0,3.85,4.08,54.74,0.0,1.28
OCI-My7,Plasma cell myeloma,Sex unspecified,Age unspecified,Unknown,64.1,0.0,2.65,2.7,21.26,1.34,7.94
OCUB-M,Breast carcinoma,Female,53Y,Pleural effusion,4.31,1.63,2.46,78.49,0.0,13.1,0.0
OCUM-1,Gastric signet ring cell adenocarcinoma,Female,38Y,Pleural effusion,0.0,0.6,0.0,77.58,0.0,21.82,0.0
OE19,Esophageal adenocarcinoma,Male,72Y,Esophagus,62.99,0.16,15.01,1.83,8.22,0.0,11.79
OE21,Esophageal squamous cell carcinoma,Male,74Y,Esophagus,33.81,0.0,0.0,1.35,64.63,0.2,0.0
OE33,Barrett adenocarcinoma,Female,73Y,Esophagus,31.03,0.0,0.01,1.2,67.21,0.55,0.0
OELE,Unknown,Female,Age unspecified,Ovary,48.72,0.23,3.73,0.0,40.72,1.63,4.96
OMC-1 [Human cervical carcinoma],"Cervical squamous cell carcinoma, not otherwise specified",Female,52Y,Left supraclavicular lymph node,0.16,0.0,0.0,76.41,0.62,22.8,0.0
ONCO-DG-1,High grade ovarian serous adenocarcinoma,Female,60Y,Ascites,34.52,0.0,0.0,4.26,61.21,0.0,0.0
Onda 10,Glioblastoma,Male,62Y,"Brain, left parietal lobe",0.0,0.27,0.63,79.08,0.4,19.61,0.0
Onda 11,Glioblastoma,Female,64Y,"Brain, right parietal lobe",2.21,1.06,1.72,76.42,1.56,17.02,0.0
ONS-76,"Medulloblastoma, SHH-activated, TP53-wildtype",Female,2Y,Brain,4.58,0.0,3.13,83.83,0.0,8.46,0.0
OPM-1,Plasma cell myeloma,Female,56Y,Peripheral blood,2.68,0.0,0.52,74.49,0.0,22.3,0.0
OPM-2,Plasma cell myeloma,Female,56Y,Peripheral blood,1.51,0.0,0.58,74.2,0.08,23.62,0.0
OS-RC-2,Clear cell renal cell carcinoma,Male,52Y,Kidney,1.66,0.0,0.1,77.03,0.95,20.25,0.0
OSC-19,Tongue squamous cell carcinoma,Male,61Y,Cervical lymph node,0.01,0.32,0.1,72.98,1.7,24.24,0.65
OSC-20,Tongue squamous cell carcinoma,Female,59Y,Cervical lymph node,4.24,0.23,3.14,75.72,0.0,16.66,0.0
OUMS-23,Colon carcinoma,Male,37Y,Pericardial effusion,1.41,0.0,0.0,82.03,0.0,16.25,0.32
OUMS-27,Primary central chondrosarcoma,Male,65Y,"Bone, left proximal humerus",2.39,0.0,0.16,79.69,0.0,17.75,0.0
OV-90,Ovarian adenocarcinoma,Female,64Y,Ascites,53.08,0.0,2.24,2.36,37.26,0.0,5.06
OV17R,Ovarian adenocarcinoma,Female,50Y,Ascites,35.44,0.0,2.39,1.99,60.17,0.0,0.0
OV56,Ovarian serous adenocarcinoma,Female,46Y,Ascites,27.28,0.0,0.0,0.0,69.8,0.52,2.39
OV7,Ovarian carcinoma,Female,78Y,Ovary,31.62,0.0,1.94,1.71,63.24,0.0,1.49
OVCA420,Ovarian serous adenocarcinoma,Female,Age unspecified,Ovary,8.81,0.0,82.47,2.6,3.32,0.0,2.8
OVCA433,Ovarian serous adenocarcinoma,Female,Age unspecified,Ovary,38.24,1.3,0.31,0.31,59.83,0.0,0.0
OVCAR-3,High grade ovarian serous adenocarcinoma,Female,60Y,Ascites,35.08,0.0,0.0,3.99,60.92,0.0,0.0
OVCAR-4,High grade ovarian serous adenocarcinoma,Female,42Y,Ascites,42.96,0.0,0.0,3.58,53.46,0.0,0.0
OVCAR-5,High grade ovarian serous adenocarcinoma,Female,67Y,Ascites,31.46,0.13,0.0,0.98,67.06,0.0,0.37
OVCAR-8,High grade ovarian serous adenocarcinoma,Female,64Y,Unknown,34.66,0.0,0.22,3.41,60.74,0.0,0.98
OVISE,Ovarian clear cell adenocarcinoma,Female,40Y,"Pelvis, innominate bone",2.13,0.0,0.05,80.54,0.0,17.28,0.0
OVK18,Ovarian endometrioid adenocarcinoma,Female,49Y,Ascites,0.0,0.0,0.0,78.65,0.0,21.35,0.0
OVKATE,High grade ovarian serous adenocarcinoma,Female,40Y,Ovary,0.72,0.0,2.37,79.04,0.0,17.87,0.0
OVMANA,Ovarian clear cell adenocarcinoma,Female,51Y,Ovary,0.0,0.0,0.0,79.88,0.36,19.76,0.0
OVMIU,High grade ovarian serous adenocarcinoma,Female,64Y,Ovary,0.0,0.2,0.26,75.07,0.0,23.44,1.02
OVSAHO,High grade ovarian serous adenocarcinoma,Female,56Y,Abdomen,2.15,0.0,0.0,83.52,0.0,14.27,0.06
OVTOKO,Ovarian clear cell adenocarcinoma,Female,78Y,Spleen,0.89,0.0,0.0,82.47,0.0,16.63,0.0
P12-Ichikawa,Childhood T acute lymphoblastic leukemia,Male,7Y,Peripheral blood,0.35,0.31,0.9,84.31,0.65,13.48,0.0
P30/OHK,Childhood B acute lymphoblastic leukemia,Female,11Y,Bone marrow,0.0,0.0,0.0,75.09,0.0,24.91,0.0
P31/FUJ,Childhood acute myeloid leukemia,Male,7Y,Peripheral blood,0.0,0.0,0.0,79.39,0.0,20.61,0.0
P32/ISH,EBV-related Burkitt lymphoma,Male,8Y,Unknown,0.0,0.0,0.0,72.36,0.0,27.64,0.0
P3HR-1,EBV-related Burkitt lymphoma,Male,7Y,Ascites,1.51,0.0,97.8,0.68,0.0,0.0,0.0
PA-1,Ovarian mixed germ cell tumor,Female,12Y,Ascites,32.58,17.69,21.08,1.54,26.01,0.7,0.4
Panc 02.03,Pancreatic adenocarcinoma,Female,70Y,Pancreas,35.18,0.75,1.78,2.77,59.53,0.0,0.0
Panc 02.13,Pancreatic adenocarcinoma,Female,64Y,Pancreas,32.69,0.98,2.03,0.28,63.98,0.0,0.04
Panc 03.27,Pancreatic adenocarcinoma,Female,65Y,Pancreas,39.18,0.0,1.16,2.19,56.57,0.0,0.9
Panc 04.03,Pancreatic ductal adenocarcinoma,Male,70Y,Pancreas,19.17,0.03,0.36,3.59,75.12,0.0,1.72
Panc 05.04,Pancreatic ductal adenocarcinoma,Female,77Y,Pancreas,30.05,0.0,0.0,0.48,67.06,0.0,2.41
Panc 08.13,Pancreatic ductal adenocarcinoma,Male,85Y,Pancreas,32.37,0.57,2.26,2.49,62.31,0.0,0.0
Panc 10.05,Pancreatic ductal adenocarcinoma,Male,81Y,Pancreas,31.0,1.14,0.61,0.96,66.18,0.0,0.11
PANC-1,Pancreatic ductal adenocarcinoma,Male,56Y,Pancreas,35.65,0.0,2.26,2.09,60.0,0.0,0.0
PaTu 8902,Pancreatic adenocarcinoma,Female,44Y,Pancreas,35.45,0.21,0.0,1.73,62.61,0.0,0.0
PaTu 8988s,Pancreatic adenocarcinoma,Female,64Y,Liver,38.45,0.0,1.16,1.35,59.03,0.0,0.0
PaTu 8988t,Pancreatic adenocarcinoma,Female,64Y,Liver,36.86,0.0,0.4,0.58,61.7,0.47,0.0
PC-14,Lung adenocarcinoma,Male,45Y,Lymph node,1.72,0.0,0.88,83.17,0.0,13.42,0.81
PC-3,Prostate carcinoma,Male,62Y,Bone,32.14,0.0,0.41,0.52,65.73,0.0,1.19
PC-3 [Human lung carcinoma],Lung adenocarcinoma,Female,48Y,Lymph node,1.63,0.0,0.27,77.82,0.0,20.28,0.0
PCI-04B,Laryngeal squamous cell carcinoma,Male,51Y,Lymph node,37.12,0.0,0.38,1.29,61.21,0.0,0.0
PCI-06A,Tonsillar squamous cell carcinoma,Male,81Y,"Oral cavity, tonsil",28.85,0.0,0.89,1.02,68.64,0.0,0.59
PCI-15A,Pyriform fossa squamous cell carcinoma,Male,69Y,"Pharynx, hypopharynx, pyriform sinus",34.95,0.21,0.36,2.01,62.27,0.0,0.21
PCI-30,Tongue squamous cell carcinoma,Male,54Y,Unknown,50.82,0.0,0.38,0.85,42.64,0.5,4.81
PCI-38,Tongue squamous cell carcinoma,Male,56Y,Unknown,55.42,0.0,3.33,3.92,30.5,0.0,6.82
PCM6,Plasma cell myeloma,Female,63Y,Peripheral blood,0.08,0.38,1.03,74.85,0.0,22.81,0.86
PE/CA-PJ15,Tongue squamous cell carcinoma,Male,45Y,"Oral cavity, tongue",35.0,0.0,1.75,3.5,59.74,0.0,0.0
PE/CA-PJ34 (clone C12),Head and neck basaloid carcinoma,Male,60Y,Oral cavity,39.01,0.0,3.76,3.52,53.71,0.0,0.0
PE/CA-PJ41 (clone D2),Oral cavity squamous cell carcinoma,Female,67Y,Unknown,31.58,0.0,2.91,3.3,62.2,0.0,0.0
PE/CA-PJ49,Tongue squamous cell carcinoma,Male,57Y,"Oral cavity, tongue",33.63,0.0,2.94,4.31,59.12,0.0,0.0
Peer,Childhood T acute lymphoblastic leukemia,Female,4Y,Peripheral blood,72.11,0.87,3.73,2.76,10.64,0.35,9.54
PEO1,BRCA2-associated hereditary breast and ovarian cancer syndrome,Female,Age unspecified,Ascites,28.85,0.14,0.0,0.57,70.43,0.0,0.0
PF-382,Childhood T acute lymphoblastic leukemia,Female,6Y,Pleural effusion,53.26,0.0,0.02,0.88,36.79,0.06,8.99
Pfeiffer,Diffuse large B-cell lymphoma germinal center B-cell type,Male,Adult,Pleural effusion,63.47,0.65,1.72,0.0,22.11,2.24,9.82
PFSK-1,Primitive neuroectodermal tumor,Male,1Y10M,"Brain, right frontal lobe",30.55,0.0,0.31,2.03,66.34,0.0,0.77
PK-1,Pancreatic ductal adenocarcinoma,Male,Age unspecified,Liver,1.25,0.0,0.26,88.21,0.7,8.65,0.93
PK-45H,Pancreatic carcinoma,Sex unspecified,Age unspecified,Unknown,0.8,0.12,1.31,85.33,0.0,10.26,2.18
PK-59,Pancreatic carcinoma,Female,66Y,Liver,1.44,0.12,0.0,83.8,0.0,14.64,0.0
PL-21,Adult acute myeloid leukemia,Male,24Y,Peripheral blood,1.05,1.5,0.0,78.62,0.0,18.83,0.0
PL4,Pancreatic ductal adenocarcinoma,Unknown,Unknown,Unknown,31.75,0.0,0.4,1.3,64.99,1.55,0.0
PL45,Pancreatic ductal adenocarcinoma,Male,81Y,Unknown,34.98,0.0,1.25,1.71,62.06,0.0,0.0
PLB-985,Adult acute myeloid leukemia,Female,36Y,Peripheral blood,28.11,0.0,0.99,1.35,69.55,0.0,0.0
PLC/PRF/5,Adult hepatocellular carcinoma,Male,24Y,Liver,2.59,0.0,95.79,1.61,0.0,0.0,0.0
PrEC LH,Unknown,Male,Unknown,"Prostate, epithelium",31.28,0.0,0.32,0.26,67.13,0.0,1.0
PSN1,Pancreatic adenocarcinoma,Male,Age unspecified,Pancreas,0.0,0.0,0.0,83.56,0.0,16.44,0.0
PWR-1E,Unknown,Male,67Y,"Prostate, epithelium",30.58,0.0,2.52,2.82,64.08,0.0,0.0
QGP-1,Pancreatic somatostatinoma,Male,61Y,"Pancreas, islets of Langerhans",0.0,0.0,0.0,82.5,0.0,17.02,0.48
QIMR-WIL,Adult acute myeloid leukemia,Female,69Y,Peripheral blood,28.92,0.0,0.0,0.0,70.81,0.0,0.26
Raji,EBV-related Burkitt lymphoma,Male,11Y,"Bone, jaw, maxilla",0.0,0.0,99.39,0.6,0.0,0.0,0.0
Ramos.2G6.4C10,Burkitt lymphoma,Male,3Y,Ascites,25.29,43.61,4.71,3.64,22.74,0.0,0.0
RC-K8,Diffuse large B-cell lymphoma germinal center B-cell type,Male,55Y,Peritoneal effusion,0.0,1.19,0.0,73.44,0.06,24.52,0.79
RCC10RGB,Renal cell carcinoma,Male,Unknown,Kidney,0.08,0.0,0.11,84.52,0.0,15.29,0.0
RCC4,Clear cell renal cell carcinoma,Sex unspecified,Age unspecified,Kidney,39.47,0.0,1.89,3.32,55.04,0.0,0.27
RCH-ACV,Childhood B acute lymphoblastic leukemia,Female,8Y,Bone marrow,30.22,0.59,0.05,1.16,65.94,0.0,2.04
RCM-1 [Human rectal adenocarcinoma],Rectal adenocarcinoma,Female,73Y,Rectum,0.77,0.0,0.97,75.44,0.0,22.81,0.01
RD,Embryonal rhabdomyosarcoma,Female,7Y,"Pelvis, muscle",37.61,0.0,3.96,4.77,53.65,0.0,0.0
RD-ES,Ewing sarcoma,Male,19Y,"Bone, humerus",33.89,0.02,1.21,3.1,61.77,0.0,0.0
REC-1,Mantle cell lymphoma,Male,61Y,Peripheral blood,46.91,0.0,1.88,2.34,48.87,0.0,0.0
Reh,Childhood B acute lymphoblastic leukemia,Female,15Y,Peripheral blood,58.04,0.09,21.18,1.57,15.6,2.0,1.52
RERF-GC-1B,Gastric adenocarcinoma,Male,41Y,Pyloric lymph node,1.57,0.65,0.94,82.0,0.0,14.34,0.5
RERF-LC-A1,Lung squamous cell carcinoma,Male,Age unspecified,Pleural effusion,0.0,0.0,0.35,91.19,1.14,6.87,0.45
RERF-LC-Ad1,Lung adenocarcinoma,Male,70Y,Lung,0.57,0.0,0.0,76.75,0.0,22.67,0.0
RERF-LC-Ad2,Lung adenocarcinoma,Male,Age unspecified,Lung,2.52,0.0,0.21,77.51,0.0,19.75,0.0
RERF-LC-FM,Lung small cell carcinoma,Male,Age unspecified,Pleural effusion,0.57,0.0,0.25,77.86,0.0,20.45,0.87
RERF-LC-KJ,Lung adenocarcinoma,Male,78Y,Unknown,5.26,0.0,3.56,81.6,0.0,9.57,0.0
RERF-LC-MS,Lung adenocarcinoma,Male,Age unspecified,Lung,4.39,0.17,1.74,85.02,0.0,8.67,0.0
RERF-LC-Sq1,Lung squamous cell carcinoma,Female,74Y,Lung,1.32,0.0,0.0,81.28,0.0,17.4,0.0
RF-48,Lymphoma,Male,62Y,Unknown,29.24,31.68,5.29,3.25,27.68,0.0,2.87
Rh18,Alveolar rhabdomyosarcoma,Female,2Y,"Perineus, muscle",16.06,0.16,74.53,4.19,5.05,0.0,0.0
Rh30,Alveolar rhabdomyosarcoma,Male,17Y,Bone marrow,41.87,0.36,2.64,1.57,49.28,0.14,4.15
Rh41,Alveolar rhabdomyosarcoma,Female,7Y,Lung,32.3,0.0,0.0,1.24,66.46,0.0,0.0
Ri-1,Diffuse large B-cell lymphoma activated B-cell type,Female,57Y,Peripheral blood,47.45,0.0,3.88,3.34,45.33,0.0,0.0
RKN,Ovarian leiomyosarcoma,Female,45Y,Ovary,0.14,0.0,0.0,77.67,0.0,22.19,0.0
RKO,Colon carcinoma,Sex unspecified,Age unspecified,Colon,6.93,2.85,81.43,1.14,7.64,0.0,0.0
RL,Diffuse large B-cell lymphoma,Male,52Y,Ascites,28.35,1.05,0.0,0.17,68.96,0.0,1.47
RL95-2,Endometrial adenosquamous carcinoma,Female,65Y,Endometrium,28.28,0.33,0.0,1.49,68.38,0.0,1.52
RMG-I,Ovarian clear cell adenocarcinoma,Female,34Y,Ascites,0.0,0.61,0.0,81.67,0.42,17.3,0.0
RMUG-S,Ovarian mucinous cystadenocarcinoma,Female,62Y,Ovary,3.86,0.79,0.94,40.77,0.0,53.64,0.0
ROS-50,Adult B acute lymphoblastic leukemia,Male,69Y,Peripheral blood,31.58,0.07,0.0,0.46,66.51,0.0,1.38
RPMI-2650,Head and neck squamous cell carcinoma,Male,52Y,Pleural effusion,28.23,0.9,0.38,1.71,68.78,0.0,0.0
RPMI-6666,Unknown,Male,29Y,Unknown,27.33,0.17,0.0,0.15,71.83,0.0,0.52
RPMI-7951,Melanoma,Female,18Y,Lymph node,33.24,1.85,0.0,0.16,64.75,0.0,0.0
RPMI-8226,Plasma cell myeloma,Male,61Y,Peripheral blood,13.24,0.0,73.94,1.06,11.76,0.0,0.0
RPMI-8402,Childhood T acute lymphoblastic leukemia,Female,16Y,Peripheral blood,35.77,0.0,0.88,2.78,60.56,0.0,0.0
RPMI-8866,"Chronic myelogenous leukemia, BCR-ABL1 positive",Female,51Y,Peripheral blood,29.33,0.14,0.0,0.0,67.29,0.0,3.24
RS4;11,Adult B acute lymphoblastic leukemia,Female,32Y,Bone marrow,31.4,0.02,0.0,0.0,65.49,1.26,1.83
RT-112,Bladder carcinoma,Female,Age unspecified,Urinary bladder,32.8,0.0,0.0,1.6,65.6,0.0,0.0
RT-4,Bladder carcinoma,Male,63Y,Urinary bladder,31.61,0.0,0.0,2.72,64.69,0.0,0.98
RT112/84,Bladder carcinoma,Female,Age unspecified,Urinary bladder,36.11,0.0,2.22,2.64,59.02,0.0,0.0
RVH-421,Melanoma,Male,28Y,Brain,28.29,0.0,0.31,2.07,67.75,0.0,1.58
RXF 393L,Renal cell carcinoma,Male,54Y,Unknown,37.15,0.1,0.51,0.0,57.95,0.68,3.61
S-117,Thyroid gland sarcoma,Female,47Y,Thyroid gland,41.93,0.0,3.26,3.68,51.13,0.0,0.0
SaOS-2,Osteosarcoma,Female,11Y,Bone,38.6,0.17,1.32,0.46,52.25,0.55,6.66
Sarc9371,Osteosarcoma,Unknown,Unknown,Unknown,57.68,0.0,0.55,3.77,14.57,0.0,23.42
SAS,Tongue squamous cell carcinoma,Female,69Y,"Oral cavity, tongue",1.46,0.0,1.4,79.62,0.0,16.48,1.04
SAT [Human HNSCC],Head and neck squamous cell carcinoma,Unknown,Unknown,Unknown,0.0,1.29,0.32,77.72,1.81,18.87,0.0
SBC-1,Lung small cell carcinoma,Male,46Y,Lung,0.0,0.47,0.0,73.66,0.0,25.87,0.0
SBC-3,Lung small cell carcinoma,Male,24Y,Bone marrow,0.0,0.39,0.0,77.93,0.0,21.68,0.0
SBC-5,Thoracic SMARCA4-deficient undifferentiated tumor,Male,65Y,Pleural effusion,0.54,0.0,0.28,78.17,0.14,20.72,0.15
Sc-1,Follicular lymphoma,Male,67Y,Ascites,29.81,0.0,1.02,1.9,67.26,0.0,0.0
SCaBER,Bladder squamous cell carcinoma,Male,58Y,Urinary bladder,3.66,1.69,86.54,2.11,6.0,0.0,0.0
SCC-15,Tongue squamous cell carcinoma,Male,55Y,"Oral cavity, tongue",30.64,0.0,0.0,2.32,67.04,0.0,0.0
SCC-25,Tongue squamous cell carcinoma,Male,70Y,"Oral cavity, tongue",35.91,0.24,2.72,4.71,56.41,0.0,0.0
SCC-3,B-cell non-Hodgkin lymphoma,Female,20Y,Pleural effusion,6.83,0.0,4.47,76.44,0.0,12.26,0.0
SCC-4,Tongue squamous cell carcinoma,Male,55Y,"Oral cavity, tongue",28.55,0.04,0.0,0.0,69.79,1.1,0.53
SCC-9,Tongue squamous cell carcinoma,Male,25Y,"Oral cavity, tongue, anterior part",61.6,0.1,0.25,1.78,30.07,0.03,6.17
SCH,Gastric choriocarcinoma,Male,46Y,Omentum,0.0,0.0,0.0,77.74,0.0,22.24,0.01
SCLC-21H,Lung small cell carcinoma,Male,46Y,Pleural effusion,34.82,1.19,0.58,1.82,61.58,0.0,0.0
SEM,Childhood B acute lymphoblastic leukemia,Female,5Y,Peripheral blood,32.35,0.05,0.88,2.53,64.12,0.0,0.07
SET-2,Adult acute megakaryoblastic leukemia,Female,71Y,Peripheral blood,4.67,0.0,7.24,78.39,0.0,9.7,0.0
SF126,Glioblastoma,Female,50Y,"Brain, left frontal lobe",44.04,0.0,0.24,1.63,51.32,0.0,2.77
SF172,Glioblastoma,Female,36Y,Brain,12.87,0.48,75.55,4.1,7.0,0.0,0.0
SF268,Astrocytoma,Female,24Y,"Brain, right parietal lobe",32.77,0.34,0.25,0.35,65.25,0.0,1.04
SF295,Glioblastoma,Female,67Y,"Brain, left temporal lobe",25.86,0.0,0.0,1.31,72.83,0.0,0.0
SF539,Gliosarcoma,Female,34Y,"Brain, right temporo-parietal junction",60.44,1.68,1.47,1.5,25.95,2.04,6.93
SF767,Human papillomavirus-related cervical squamous cell carcinoma,Female,66Y,Omentum,33.99,0.35,1.45,2.49,61.71,0.0,0.0
SH-10-TC,Gastric mucinous adenocarcinoma,Unknown,Unknown,Stomach,1.4,0.0,0.0,64.56,0.0,34.04,0.0
SH-4,Melanoma,Female,60Y,Pleural effusion,28.47,0.74,2.19,4.52,64.08,0.0,0.0
SH-SY5Y,Neuroblastoma,Female,4Y,Bone marrow,29.2,1.17,0.0,0.35,69.09,0.1,0.08
SHP-77,Lung small cell carcinoma,Male,54Y,"Lung, left upper lobe",43.74,0.63,3.14,3.39,49.1,0.0,0.0
SIG-M5,Adult acute myeloid leukemia,Male,63Y,Bone marrow,43.72,0.0,2.46,4.98,48.84,0.0,0.0
SiHa,Human papillomavirus-related cervical squamous cell carcinoma,Female,55Y,"Uterus, cervix",0.24,0.0,0.0,84.36,0.0,15.4,0.0
SiMa,Adrenal gland neuroblastoma,Male,1Y8M,Adrenal gland,32.14,0.0,0.65,2.52,63.44,0.0,1.24
SiSo,Human papillomavirus-related cervical adenocarcinoma,Female,67Y,"Uterus, cervix",7.19,0.11,3.91,79.2,0.0,9.59,0.0
SJNB-10,Neuroblastoma,Male,2Y,Unknown,31.2,0.0,0.93,0.0,66.44,0.0,1.43
SJNB-12,Neuroblastoma,Female,10M,Bone marrow,30.06,0.0,0.78,1.75,67.42,0.0,0.0
SJNB-13,Neuroblastoma,Male,1Y,Unknown,11.4,0.52,68.95,1.69,16.7,0.0,0.75
SJNB-14,Neuroblastoma,Female,1Y1M,Unknown,42.92,0.13,0.42,0.0,50.65,0.23,5.64
SJNB-17,Neuroblastoma,Female,1Y,Unknown,30.22,0.8,1.11,1.46,66.06,0.35,0.0
SJNB-5,Neuroblastoma,Female,2Y,Bone marrow,4.93,0.0,87.26,2.17,5.14,0.0,0.49
SJNB-6,Neuroblastoma,Male,Age unspecified,Unknown,41.73,0.0,0.42,0.32,52.61,0.64,4.28
SJNB-7,Neuroblastoma,Male,7M,Unknown,31.49,0.0,0.35,0.0,68.16,0.0,0.0
SJSA-1,Osteosarcoma,Male,19Y,"Bone, femur",6.03,0.0,90.72,1.2,2.05,0.0,0.0
SK-BR-3,Breast adenocarcinoma,Female,43Y,Pleural effusion,33.02,0.0,0.7,2.13,63.89,0.0,0.26
SK-CO-1,Colon adenocarcinoma,Male,65Y,Ascites,28.45,0.56,0.04,2.24,68.7,0.0,0.0
SK-ES-1,Ewing sarcoma,Male,18Y,Unknown,34.15,0.0,0.13,0.63,63.44,0.0,1.64
SK-GT-2,Gastric fundus carcinoma,Male,72Y,"Stomach, fundus",31.83,14.81,20.34,2.09,30.94,0.0,0.0
SK-GT-4,Esophageal adenocarcinoma,Male,89Y,"Esophagus, distal",59.48,1.08,2.11,1.62,27.72,0.0,7.99
SK-HEP-1,Liver and intrahepatic bile duct epithelial neoplasm,Male,52Y,Ascites,64.2,1.18,0.65,0.0,23.66,2.22,8.09
SK-LMS-1,Vulvar leiomyosarcoma,Female,43Y,Vulva,31.02,0.0,0.0,1.76,66.04,0.0,1.17
SK-LU-1,Lung adenocarcinoma,Female,60Y,Lung,31.5,0.0,0.44,1.91,66.14,0.0,0.0
SK-MEL-1,Melanoma,Male,29Y,Thoracic lymph duct,62.08,0.0,1.29,4.27,23.14,0.0,9.23
SK-MEL-2,Melanoma,Male,60Y,"Thigh, skin",58.89,0.0,1.43,2.36,28.23,1.87,7.21
SK-MEL-24,Melanoma,Male,67Y,Lymph node,35.21,0.82,1.73,1.82,60.41,0.0,0.0
SK-MEL-28,Cutaneous melanoma,Male,51Y,Skin,64.91,0.56,1.75,3.0,20.11,1.38,8.29
SK-MEL-3,Cutaneous melanoma,Female,42Y,Lymph node,62.57,0.0,1.51,2.94,24.17,0.0,8.82
SK-MEL-30,Cutaneous melanoma,Male,67Y,Unknown,35.99,0.0,0.0,1.6,62.41,0.0,0.0
SK-MEL-31,Cutaneous melanoma,Female,33Y,Unknown,60.44,0.03,3.89,4.7,26.77,0.0,4.17
SK-MEL-5,Cutaneous melanoma,Female,24Y,Axillary lymph node,35.06,0.0,1.41,3.5,60.03,0.0,0.0
SK-MES-1,Lung squamous cell carcinoma,Male,65Y,Pleural effusion,32.97,0.0,0.88,1.52,64.63,0.0,0.0
SK-MG-1,Astrocytoma,Female,59Y,Unknown,58.92,0.87,2.66,0.78,25.75,2.54,8.48
SK-MM-2,Plasma cell myeloma,Male,54Y,Peripheral blood,52.35,0.0,3.65,2.84,38.09,0.0,3.06
SK-N-AS,Neuroblastoma,Female,6Y,Bone marrow,40.39,0.0,1.49,2.41,53.12,0.0,2.58
SK-N-BE(2),Neuroblastoma,Male,2Y2M,Bone marrow,63.46,0.88,1.71,1.41,24.66,0.0,7.87
SK-N-BE(2)-M17,Neuroblastoma,Male,2Y2M,Bone marrow,64.0,1.22,3.92,3.24,21.38,0.0,6.24
SK-N-DZ,Neuroblastoma,Female,2Y,Bone marrow,27.16,20.53,1.63,2.39,47.7,0.0,0.6
SK-N-FI,Neuroblastoma,Male,11Y,Bone marrow,27.95,8.08,24.58,2.3,35.17,0.57,1.35
SK-N-MC,Askin tumor,Female,12Y,Orbital region,29.43,0.0,1.84,0.61,67.85,0.0,0.27
SK-N-MC-IXC,Askin tumor,Female,12Y,Orbital region,25.63,0.0,0.0,0.0,74.37,0.0,0.0
SK-N-SH,Neuroblastoma,Female,4Y,Bone marrow,31.16,0.07,0.37,1.63,66.77,0.0,0.0
SK-NEP-1,Ewing sarcoma,Female,25Y,Pleural effusion,31.37,0.0,0.0,0.75,66.07,0.0,1.81
SK-OV-3,Ovarian serous cystadenocarcinoma,Female,64Y,Ascites,36.53,0.0,1.52,1.76,59.05,0.0,1.14
SK-PN-DW,Primitive neuroectodermal tumor,Male,17Y,Retroperitoneal space,35.42,0.0,0.0,1.81,62.77,0.0,0.0
SK-RC-31,Renal cell carcinoma,Male,Age unspecified,Lung,66.52,0.01,3.19,7.38,19.72,0.0,3.18
SK-UT-1,Uterine corpus leiomyosarcoma,Female,75Y,Uterus,54.91,1.42,1.59,0.0,32.8,1.64,7.64
SKG-IIIa,Human papillomavirus-related cervical squamous cell carcinoma,Female,38Y,"Uterus, cervix",0.0,0.0,0.18,84.88,0.0,14.94,0.0
SKM-1,Adult acute myeloid leukemia,Male,76Y,Peripheral blood,0.5,0.67,0.0,75.52,0.33,22.98,0.0
SKN,Uterine corpus leiomyosarcoma,Female,52Y,Unknown,3.89,0.0,0.3,0.0,0.0,87.84,7.96
SKN-3,Oral cavity squamous cell carcinoma,Sex unspecified,Age unspecified,Unknown,0.0,0.03,0.0,76.9,0.55,21.66,0.86
SKNO-1,Adult acute myeloid leukemia with maturation,Male,22Y,Bone marrow,2.59,0.0,1.83,90.65,0.2,3.5,1.23
SLR20,Bladder carcinoma,Female,82Y,Urinary bladder,24.34,0.52,0.0,2.35,72.79,0.0,0.0
SLR21,Clear cell renal cell carcinoma,Sex unspecified,Age unspecified,Not specified,31.24,0.64,0.09,0.0,66.35,0.43,1.26
SLR23,Clear cell renal cell carcinoma,Sex unspecified,Age unspecified,Not specified,31.41,0.14,0.0,0.79,67.65,0.0,0.0
SLR24,Clear cell renal cell carcinoma,Sex unspecified,Age unspecified,Kidney,41.0,0.0,0.24,2.8,55.96,0.0,0.0
SLR25,Clear cell renal cell carcinoma,Sex unspecified,Age unspecified,Not specified,38.41,0.0,0.9,3.02,57.41,0.0,0.26
SLR26,Clear cell renal cell carcinoma,Male,Age unspecified,Unknown,30.63,0.0,1.17,1.33,65.36,1.5,0.0
SN12C,Renal cell carcinoma,Male,Unknown,Kidney,31.1,1.06,0.58,0.47,64.97,0.0,1.82
SNB-19,Astrocytoma,Male,75Y,"Brain, parietal lobe",18.39,0.0,0.48,2.88,78.25,0.0,0.0
SNB-75,Glioblastoma,Female,75Y,Brain,38.96,0.06,0.77,2.51,57.46,0.0,0.24
SNG-M,Endometrial adenocarcinoma,Female,52-54Y,Obturator lymph node,0.0,0.03,0.0,75.48,0.0,24.49,0.0
SNU-1,Gastric adenocarcinoma,Male,44Y,Stomach,0.0,0.88,0.0,57.18,0.0,41.93,0.0
SNU-1033,Rectal adenocarcinoma,Female,45Y,Rectum,24.53,0.0,18.67,56.8,0.0,0.0,0.0
SNU-1040,Colon adenocarcinoma,Male,34Y,Colon,0.0,1.04,0.0,58.5,0.0,40.46,0.0
SNU-1076,Laryngeal squamous cell carcinoma,Male,60Y,Larynx,1.99,0.0,2.88,66.81,0.0,28.32,0.0
SNU-1077,Uterine carcinosarcoma,Female,60Y,Endometrium,1.53,0.0,0.64,64.52,0.0,33.3,0.0
SNU-1079,Intrahepatic cholangiocarcinoma,Male,Age unspecified,"Liver, intrahepatic bile duct",0.66,0.0,0.24,64.18,0.0,34.91,0.0
SNU-1105,Glioblastoma,Male,61Y,Brain,0.0,1.43,0.33,63.75,0.0,34.48,0.0
SNU-119,High grade ovarian serous adenocarcinoma,Female,50Y,Ascites,3.15,0.0,2.1,63.25,0.0,31.5,0.0
SNU-1196,Hilar cholangiocarcinoma,Sex unspecified,Age unspecified,Common hepatic duct,0.51,0.0,0.3,61.64,0.0,37.54,0.0
SNU-1197,Colon adenocarcinoma,Male,70Y,Colon,1.55,0.35,1.84,62.22,0.0,34.04,0.0
SNU-1214,Laryngeal squamous cell carcinoma,Male,55Y,Larynx,0.0,0.0,1.38,61.21,0.0,37.41,0.0
SNU-1272,Clear cell renal cell carcinoma,Female,63Y,Kidney,0.37,0.63,1.64,63.53,0.0,33.83,0.0
SNU-16,Gastric adenocarcinoma,Female,33Y,Ascites,2.71,0.82,3.14,65.94,0.0,27.38,0.0
SNU-175,Colon adenocarcinoma,Female,56Y,Peritoneum,0.0,0.33,0.24,60.01,0.0,39.42,0.0
SNU-182,Adult hepatocellular carcinoma,Male,24Y,Liver,2.24,0.0,1.29,65.62,0.0,30.85,0.0
SNU-201,Glioblastoma,Male,58Y,Brain,0.0,2.29,2.24,64.8,0.0,30.66,0.0
SNU-213,Pancreatic adenocarcinoma,Male,65Y,Pancreas,0.41,0.0,1.77,68.61,0.0,29.21,0.0
SNU-216,Gastric tubular adenocarcinoma,Female,46Y,Lymph node,1.27,0.0,2.54,69.93,0.0,26.25,0.0
SNU-245,Cholangiocarcinoma,Sex unspecified,Age unspecified,Bile duct,0.05,0.55,0.84,65.45,0.0,33.11,0.0
SNU-283,Rectal adenocarcinoma,Female,62Y,Omentum,1.16,0.52,1.3,60.74,0.0,36.27,0.0
SNU-308,Gallbladder carcinoma,Sex unspecified,Age unspecified,Gallbladder,1.83,0.0,0.26,62.71,0.0,35.2,0.0
SNU-324,Pancreatic adenocarcinoma,Male,50Y,Pancreas,0.0,0.0,0.0,60.53,0.0,39.47,0.0
SNU-349,Clear cell renal cell carcinoma,Male,68Y,Kidney,0.0,0.68,0.29,61.84,0.16,37.03,0.0
SNU-387,Adult hepatocellular carcinoma,Female,41Y,Liver,0.87,0.32,0.32,64.77,0.0,33.73,0.0
SNU-398,Adult hepatocellular carcinoma,Male,42Y,Liver,2.61,0.85,1.33,66.35,0.0,28.86,0.0
SNU-407,Colon adenocarcinoma,Male,37Y,Buttock,2.05,0.4,1.29,66.65,0.0,29.61,0.0
SNU-410,Pancreatic adenocarcinoma,Male,53Y,Liver,0.89,0.0,0.52,66.58,0.0,32.02,0.0
SNU-423,Adult hepatocellular carcinoma,Male,40Y,Liver,0.26,0.82,0.0,62.68,0.0,36.24,0.0
SNU-449,Adult hepatocellular carcinoma,Male,52Y,Liver,1.66,0.29,0.37,60.93,0.0,36.75,0.0
SNU-46,Laryngeal squamous cell carcinoma,Male,65Y,Larynx,4.64,0.0,1.74,68.94,0.0,24.69,0.0
SNU-466,Glioblastoma,Male,61Y,Brain,0.36,0.0,0.92,61.85,0.0,36.86,0.0
SNU-475,Adult hepatocellular carcinoma,Male,43Y,Liver,1.15,0.0,0.39,63.9,0.0,34.56,0.0
SNU-478,Ampulla of Vater adenocarcinoma,Sex unspecified,Age unspecified,"Pancreas, ampulla of Vater",1.02,0.85,0.0,60.73,0.0,37.41,0.0
SNU-489,Glioblastoma,Male,54Y,Brain,0.0,0.3,0.11,61.65,0.0,37.93,0.0
SNU-5,Gastric adenocarcinoma,Female,33Y,Ascites,0.76,0.0,0.0,65.54,0.0,33.69,0.0
SNU-503,Rectal adenocarcinoma,Male,52Y,Abdominal wall,0.39,0.0,0.0,62.02,0.0,37.59,0.0
SNU-520,Gastric adenocarcinoma,Female,60Y,Stomach,0.0,0.0,0.0,57.76,0.0,42.23,0.0
SNU-601,Gastric signet ring cell adenocarcinoma,Male,34Y,Ascites,0.68,0.43,1.93,63.23,0.0,33.73,0.0
SNU-61,Rectal adenocarcinoma,Male,48Y,Liver,1.34,0.17,1.54,63.73,0.0,33.22,0.0
SNU-620,Gastric adenocarcinoma,Female,59Y,Ascites,0.67,1.1,0.37,58.94,0.05,38.87,0.0
SNU-626,Glioblastoma,Male,65Y,Brain,0.0,0.0,0.03,63.88,0.0,35.09,0.99
SNU-668,Gastric signet ring cell adenocarcinoma,Male,63Y,Ascites,1.82,0.0,1.18,71.14,0.0,25.86,0.0
SNU-685,Uterine carcinosarcoma,Female,70Y,Endometrium,0.02,0.59,1.15,63.21,0.0,35.03,0.0
SNU-719,Gastric tubular adenocarcinoma,Male,53Y,Stomach,0.0,1.31,0.0,60.01,0.0,38.67,0.0
SNU-738,Oligodendroglioma,Male,40Y,Brain,1.57,0.0,1.32,64.14,0.0,32.96,0.0
SNU-761,Adult hepatocellular carcinoma,Male,49Y,Liver,1.38,0.0,0.61,59.84,0.0,38.16,0.0
SNU-8,Ovarian serous cystadenocarcinoma,Female,55Y,Ascites,0.45,0.79,0.06,58.48,0.01,40.21,0.0
SNU-81,Colon adenocarcinoma,Male,53Y,Colon,0.0,1.37,0.0,56.62,0.0,42.0,0.0
SNU-840,Malignant ovarian Brenner tumor,Female,45Y,Ovary,3.57,0.0,3.49,68.16,0.0,24.79,0.0
SNU-869,Ampulla of Vater adenocarcinoma,Sex unspecified,Age unspecified,"Pancreas, ampulla of Vater",19.53,0.0,15.94,64.53,0.0,0.0,0.0
SNU-878,Adult hepatocellular carcinoma,Female,54Y,Liver,5.72,0.0,5.81,66.98,0.0,21.49,0.0
SNU-886,Adult hepatocellular carcinoma,Male,57Y,Liver,0.0,0.92,1.56,64.25,0.0,33.26,0.0
SNU-899,Laryngeal squamous cell carcinoma,Male,56Y,Larynx,0.63,0.85,0.0,62.64,0.0,35.88,0.0
SNU-C1,Colon adenocarcinoma,Male,71Y,Peritoneum,4.43,0.0,3.6,70.54,0.0,21.43,0.0
SNU-C2A,Cecum adenocarcinoma,Female,43Y,Cecum,0.14,0.0,0.61,62.55,0.97,35.74,0.0
SNU-C2B,Cecum adenocarcinoma,Female,43Y,Cecum,0.0,0.36,0.0,60.61,0.0,39.03,0.0
SNU-C4,Colon adenocarcinoma,Male,35Y,Unknown,0.0,0.62,0.0,57.31,0.0,42.07,0.0
SNU-C5,Cecum adenocarcinoma,Female,77Y,Cecum,0.0,0.84,0.0,58.4,0.0,40.75,0.0
Sq-1,Lung squamous cell carcinoma,Male,Unknown,Unknown,0.0,0.0,0.4,81.37,0.0,17.66,0.56
SR,"Anaplastic large cell lymphoma, ALK-positive",Male,11Y,Pleural effusion,34.1,0.0,0.0,3.12,62.78,0.0,0.0
ST486,Burkitt lymphoma,Female,Age unspecified,Ascites,39.3,2.43,0.3,1.27,54.96,0.0,1.74
STS-0421,Gastric adenocarcinoma,Unknown,Unknown,Unknown,29.19,0.12,0.99,0.8,67.02,0.0,1.87
SU-DHL-1,"Anaplastic large cell lymphoma, ALK-positive",Male,10Y,Pleural effusion,24.81,22.55,3.76,5.57,43.3,0.0,0.0
SU-DHL-10,Diffuse large B-cell lymphoma germinal center B-cell type,Male,25Y,Pleural effusion,31.62,0.0,2.75,4.02,61.61,0.0,0.0
SU-DHL-16,B-cell non-Hodgkin lymphoma,Male,Age unspecified,Pleural effusion,29.29,0.75,0.78,0.0,66.22,0.0,2.95
SU-DHL-4,Diffuse large B-cell lymphoma germinal center B-cell type,Male,38Y,Peritoneal effusion,37.92,1.07,0.0,0.0,60.53,0.49,0.0
SU-DHL-5,Diffuse large B-cell lymphoma germinal center B-cell type,Female,17Y,Lymph node,32.3,0.0,1.37,1.36,63.92,0.0,1.05
SU-DHL-6,Diffuse large B-cell lymphoma germinal center B-cell type,Male,43Y,Peritoneal effusion,36.02,0.0,2.74,1.8,59.44,0.0,0.0
SU-DHL-8,Diffuse large B-cell lymphoma germinal center B-cell type,Male,59Y,Pleural effusion,32.58,0.0,0.67,0.1,64.1,0.0,2.54
SU.86.86,Pancreatic adenocarcinoma,Female,57Y,Liver,43.16,1.63,0.25,1.94,53.02,0.0,0.0
SUIT-2,Pancreatic ductal adenocarcinoma,Male,73Y,Liver,0.0,1.31,0.0,81.51,0.0,17.16,0.02
SUP-B15,Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1,Male,9Y,Bone marrow,27.71,0.5,0.0,0.25,70.33,0.2,1.01
SUP-B8,Childhood B acute lymphoblastic leukemia,Female,15Y,Bone marrow,28.0,0.0,0.05,0.63,69.66,0.05,1.61
SUP-HD1,Hodgkin lymphoma,Male,37Y,Pleural effusion,40.59,0.0,5.43,4.61,49.35,0.0,0.02
SUP-M2,"Anaplastic large cell lymphoma, ALK-positive",Female,5Y,Cerebrospinal fluid,38.68,1.22,2.59,2.73,54.77,0.0,0.0
SUP-T1,Childhood T lymphoblastic lymphoma,Male,8Y,Pleural effusion,41.99,1.61,0.14,0.0,46.77,0.0,9.49
SUP-T11,Adult T acute lymphoblastic leukemia,Male,74Y,Bone marrow,31.87,0.0,2.38,3.57,62.17,0.0,0.0
SW1088,Astrocytoma,Male,72Y,Unknown,29.71,0.6,0.0,1.08,68.27,0.34,0.0
SW1116,Colon adenocarcinoma,Male,73Y,Colon,32.62,0.0,1.32,3.41,62.64,0.0,0.0
SW1271,Lung small cell carcinoma,Male,69Y,Lung,32.2,1.29,0.42,2.56,63.53,0.0,0.0
SW13,Adrenal cortex carcinoma,Female,55Y,Adrenal gland,24.66,0.0,2.01,0.0,72.28,0.61,0.44
SW1353,Primary central chondrosarcoma,Female,72Y,"Bone, right humerus",31.35,0.0,0.24,2.24,66.16,0.0,0.0
SW1417,Colon adenocarcinoma,Female,53Y,Colon,34.82,0.0,0.0,2.13,62.18,0.0,0.86
SW1463,Rectal adenocarcinoma,Female,66Y,Rectum,44.61,0.0,5.61,8.03,41.75,0.0,0.0
SW1573,Minimally invasive lung adenocarcinoma,Female,44Y,Lung,32.09,0.18,0.36,0.45,66.92,0.0,0.0
SW1710,Bladder carcinoma,Female,84Y,Unknown,31.96,0.0,0.06,1.26,65.29,0.0,1.43
SW1783,Anaplastic astrocytoma,Male,68Y,Unknown,30.84,0.24,0.0,1.93,65.97,1.02,0.0
SW1990,Pancreatic adenocarcinoma,Male,56Y,Pancreas,35.04,0.78,0.49,2.9,60.78,0.0,0.0
SW403,Colon adenocarcinoma,Female,51Y,Colon,32.9,0.4,0.6,0.5,62.34,0.0,3.26
SW48,Colon adenocarcinoma,Female,83Y,Colon,29.21,0.0,0.09,0.0,69.25,1.44,0.0
SW480,Colon adenocarcinoma,Male,51Y,Colon,39.69,0.55,0.0,1.14,58.36,0.1,0.15
SW579,Thyroid gland squamous cell carcinoma,Male,59Y,Thyroid gland,32.66,1.95,0.11,0.43,63.94,0.0,0.91
SW620,Colon adenocarcinoma,Male,51Y,Lymph node,43.67,0.0,2.02,4.3,50.01,0.0,0.0
SW626,Colon adenocarcinoma,Female,46Y,Ovary,31.17,0.08,0.06,0.77,65.38,0.0,2.55
SW684,Fibrosarcoma,Male,68Y,Unknown,28.98,0.15,0.49,1.06,67.56,1.15,0.61
SW756,Human papillomavirus-related cervical squamous cell carcinoma,Female,46Y,"Uterus, cervix",34.34,0.0,3.44,3.59,58.26,0.0,0.36
SW780,Bladder carcinoma,Female,80Y,Urinary bladder,26.09,0.16,0.52,0.43,68.95,0.73,3.11
SW837,Rectal adenocarcinoma,Male,53Y,Rectum,30.8,0.0,2.4,1.12,65.15,0.53,0.0
SW872,Liposarcoma,Male,36Y,Unknown,24.84,0.0,1.25,2.4,69.64,0.14,1.73
SW900,Lung squamous cell carcinoma,Male,53Y,Lung,30.63,0.0,0.45,1.4,65.68,0.0,1.83
SW948,Colon adenocarcinoma,Female,81Y,Colon,33.37,1.47,0.0,0.0,63.91,0.0,1.25
SW954,Vulvar squamous cell carcinoma,Female,86Y,Vulva,27.38,0.0,0.24,0.14,70.36,0.57,1.33
SW962,Vulvar carcinoma,Female,64Y,Lymph node,31.99,0.7,4.03,4.56,58.72,0.0,0.0
SW982,Biphasic synovial sarcoma,Female,25Y,Synovium,29.52,0.11,0.0,0.0,67.54,0.0,2.82
T-47D,Invasive breast carcinoma of no special type,Female,54Y,Pleural effusion,62.69,1.2,0.86,3.03,22.59,1.59,8.04
T.T,Esophageal squamous cell carcinoma,Male,67Y,"Bone, jaw, mandible",2.44,0.0,0.13,82.54,0.0,14.89,0.0
T1-73,Unknown,Sex unspecified,Age unspecified,Bone,41.34,0.25,0.88,0.51,53.75,0.0,3.27
T24,Bladder carcinoma,Female,82Y,Urinary bladder,27.92,0.28,1.35,4.67,65.79,0.0,0.0
T3M-10,Lung large cell carcinoma,Male,40Y,Lymph node,2.71,0.0,1.75,84.13,0.0,11.41,0.0
T3M-4,Pancreatic ductal adenocarcinoma,Male,64Y,Lymph node,0.16,0.38,0.38,79.41,0.0,19.66,0.0
T84,Colon adenocarcinoma,Male,72Y,Lung,37.09,0.0,2.33,3.37,57.21,0.0,0.0
T98G,Glioblastoma,Male,61Y,Brain,60.81,0.16,1.56,4.73,26.22,0.0,6.52
TALL-1 [Human adult T-ALL],Adult T acute lymphoblastic leukemia,Male,28Y,Bone marrow,1.62,0.7,0.0,75.83,0.0,19.85,1.99
TASK1,Askin tumor,Female,21Y,Chest wall,2.87,0.97,1.94,86.4,0.0,7.58,0.24
TC-32,Primitive neuroectodermal tumor,Female,17Y,"Bone, left ilium",30.65,0.3,0.13,1.12,67.6,0.0,0.2
TC-71,Ewing sarcoma,Male,22Y,"Bone, humerus",31.66,0.12,0.1,1.75,65.4,0.0,0.97
TC-YIK,Cervical small cell neuroendocrine carcinoma,Female,31Y,Unknown,0.0,0.0,0.0,74.47,0.0,25.52,0.0
TCC-Pan2,Pancreatic ductal adenocarcinoma,Female,47Y,Ascites,3.52,0.0,1.68,89.24,0.0,5.56,0.0
TCCSUP,Bladder carcinoma,Female,67Y,Urinary bladder,28.53,0.0,0.0,1.27,68.68,0.03,1.48
TE 125.T,Unknown,Female,1Y,Unknown,25.92,41.29,5.57,1.9,25.13,0.18,0.0
TE 159.T,Unknown,Male,6Y,Unknown,27.14,21.64,1.8,2.4,45.27,0.0,1.76
TE 441.T,Rhabdomyosarcoma,Female,14Y,Connective tissue,5.2,0.35,87.48,1.73,4.76,0.0,0.48
TE 617.T,Rhabdomyosarcoma,Female,1Y8M,Connective tissue,29.92,1.43,0.0,0.0,65.86,0.0,2.79
TE-1,Esophageal squamous cell carcinoma,Male,58Y,Esophagus,2.41,0.0,0.32,85.61,0.0,11.65,0.0
TE-10,Esophageal squamous cell carcinoma,Male,58Y,Esophagus,4.65,0.0,5.82,81.86,0.0,7.66,0.0
TE-11,Esophageal squamous cell carcinoma,Male,58Y,Esophagus,0.0,0.0,0.0,89.62,0.0,10.38,0.0
TE-12,Esophageal squamous cell carcinoma,Male,Unknown,Unknown,0.0,0.13,0.0,76.19,0.56,22.61,0.51
TE-14,Esophageal squamous cell carcinoma,Male,57Y,Esophagus,3.92,0.0,3.44,83.33,0.0,9.3,0.0
TE-15,Esophageal squamous cell carcinoma,Female,58Y,Esophagus,0.0,0.0,0.0,83.86,0.0,15.31,0.83
TE-4,Esophageal squamous cell carcinoma,Female,48Y,Esophagus,2.93,0.0,2.46,82.3,0.0,12.31,0.0
TE-5,Esophageal squamous cell carcinoma,Female,73Y,Esophagus,0.36,0.66,0.34,86.45,0.0,11.83,0.36
TE-6,Esophageal squamous cell carcinoma,Male,71Y,Esophagus,1.62,0.0,0.98,84.09,0.0,13.31,0.0
TE-8,Esophageal squamous cell carcinoma,Male,63Y,Esophagus,3.7,0.0,1.28,88.72,0.0,6.31,0.0
TE-9,Esophageal squamous cell carcinoma,Male,48Y,Pleural effusion,0.0,0.49,0.0,84.82,0.0,14.68,0.0
TEN,Endometrial carcinoma,Female,74Y,Endometrium,0.3,0.0,0.21,76.96,0.0,22.41,0.11
TF-1,Erythroleukemia,Male,35Y,Bone marrow,1.13,0.04,0.64,79.7,0.0,18.49,0.0
TGBC11TKB,Gastric carcinoma,Female,72Y,Lymph node,0.0,0.0,0.0,81.43,0.0,18.57,0.0
TGBC1TKB,Gallbladder undifferentiated carcinoma,Female,Unknown,Lymph node,0.0,0.16,0.0,75.35,0.0,24.48,0.0
TGBC24TKB,Gallbladder carcinoma,Female,Unknown,Ascites,0.0,0.0,0.0,75.8,0.26,23.94,0.0
TGW,Adrenal gland neuroblastoma,Male,1Y11M,Adrenal gland,0.0,0.0,0.0,71.87,0.42,26.74,0.97
THP-1,Childhood acute monocytic leukemia,Male,1Y,Peripheral blood,0.0,0.3,0.0,77.63,0.0,20.4,1.67
TIG-3 TD,Unknown,Male,12FW,Fetal lung,0.0,0.91,0.0,74.91,0.0,24.18,0.0
TK [Human B-cell lymphoma],B-cell non-Hodgkin lymphoma,Female,80Y,Ascites,0.0,0.0,0.67,79.08,0.39,19.03,0.83
TK-10,Clear cell renal cell carcinoma,Male,43Y,Kidney,73.4,2.2,1.52,0.11,9.0,1.52,12.26
TM-31,Astrocytoma,Female,42Y,Brain,3.26,0.0,1.8,80.56,0.0,14.37,0.0
TMK-1,Gastric adenocarcinoma,Male,21Y,Lymph node,0.0,0.49,0.05,70.76,0.73,27.97,0.0
TO 175.T,Unknown,Male,29Y,"Trunk, skin",28.11,0.27,0.0,0.13,71.49,0.0,0.0
Toledo,Diffuse large B-cell lymphoma germinal center B-cell type,Female,Adult,Peripheral blood,64.81,0.0,7.85,5.12,17.53,0.0,4.69
TOV-112D,Ovarian endometrioid adenocarcinoma,Female,42Y,Ovary,43.09,0.33,0.0,2.98,53.45,0.0,0.16
TOV-21G,Ovarian clear cell adenocarcinoma,Female,62Y,Ovary,37.42,1.11,0.0,0.06,59.77,0.0,1.64
TT,Hereditary thyroid gland medullary carcinoma,Female,77Y,Thyroid gland,57.09,0.0,2.11,2.03,32.67,0.0,6.11
TT2609-C02,Thyroid gland follicular carcinoma,Male,57Y,Thyroid gland,33.37,0.39,0.11,2.11,62.71,0.0,1.31
TUHR10TKB,Clear cell renal cell carcinoma,Male,69Y,Kidney,0.0,0.0,0.0,79.7,0.0,19.89,0.4
TUHR14TKB,Renal cell carcinoma,Male,Age unspecified,Unknown,4.0,0.46,0.62,87.1,0.0,7.82,0.0
TUHR4TKB,Renal cell carcinoma,Male,60Y,Kidney,5.48,0.0,3.62,85.09,0.0,5.8,0.0
TUR,Adult acute monocytic leukemia,Male,37Y,Pleural effusion,22.94,0.04,0.0,0.5,75.18,0.0,1.33
TYK-nu,High grade ovarian serous adenocarcinoma,Female,38Y,Unknown,0.0,0.15,0.42,83.85,0.0,15.58,0.0
U-118MG,Astrocytoma,Male,47Y,Brain,0.0,0.0,1.71,1.75,96.54,0.0,0.0
U-138MG,Astrocytoma,Male,47Y,Brain,0.67,0.0,1.64,1.56,96.13,0.0,0.0
U-178MG,Astrocytoma,Male,56Y,Unknown,23.49,0.0,2.94,4.06,69.5,0.0,0.0
U-251MG,Astrocytoma,Male,75Y,"Brain, parietal lobe",17.65,0.0,0.69,2.21,79.45,0.0,0.0
U-343MGa,Glioblastoma,Male,54Y,"Brain, temporal lobe",22.03,0.0,1.11,4.21,72.65,0.0,0.0
U-698-M,Lymphoblastic lymphoma,Male,7Y,Unknown,22.56,0.0,3.7,4.43,69.32,0.0,0.0
U-87MG ATCC,Glioblastoma,Male,Age unspecified,Unknown,23.21,0.0,0.69,3.92,72.18,0.0,0.0
U-937,Adult acute monocytic leukemia,Male,37Y,Pleural effusion,26.06,0.0,0.0,2.39,71.54,0.0,0.0
U-CH2,Sacral chordoma,Female,72Y,Unknown,29.44,0.92,0.0,0.0,67.93,0.34,1.36
U266B1,Plasma cell myeloma,Male,53Y,Peripheral blood,15.72,0.0,0.0,2.78,80.76,0.29,0.45
U2OS,Osteosarcoma,Female,15Y,"Bone, tibia",31.08,0.0,2.75,5.19,60.98,0.0,0.0
UACC-257,Melanoma,Sex unspecified,Age unspecified,Unknown,32.65,0.57,0.0,0.83,65.94,0.0,0.0
UACC-62,Melanoma,Sex unspecified,Age unspecified,Skin,29.88,0.0,0.45,0.45,67.39,0.0,1.83
UACC-812,Invasive breast carcinoma of no special type,Female,43Y,Breast,21.07,50.48,6.53,6.42,13.71,0.0,1.78
UACC-893,Invasive breast carcinoma of no special type,Female,57Y,Breast,35.5,0.0,1.96,4.64,57.9,0.0,0.0
UD-SCC-2,Hypopharyngeal squamous cell carcinoma,Male,58Y,Unknown,35.31,0.0,3.2,4.0,57.49,0.0,0.0
UM-RC-2,Clear cell renal cell carcinoma,Sex unspecified,Age unspecified,Kidney,34.02,0.53,5.05,4.92,55.48,0.0,0.0
UM-RC-6,Renal cell carcinoma,Male,Age unspecified,Kidney,11.91,0.05,81.78,2.02,4.24,0.0,0.0
UM-UC-1,Bladder carcinoma,Male,26Y,Lymph node,9.04,0.0,85.83,2.25,2.87,0.0,0.0
UM-UC-3,Bladder carcinoma,Male,Age unspecified,Urinary bladder,36.94,0.0,3.66,3.71,55.69,0.0,0.0
UMC-11,Lung carcinoid tumor,Male,Age unspecified,Unknown,26.54,0.0,0.55,1.07,69.48,0.34,2.02
UO-31,Renal cell carcinoma,Female,Age unspecified,Kidney,28.82,0.0,1.96,3.55,65.67,0.0,0.0
UOK101,Clear cell renal cell carcinoma,Unknown,Unknown,Kidney,34.1,0.0,1.6,2.72,60.33,0.0,1.25
UPCI-SCC-090,Tongue squamous cell carcinoma,Male,46Y,"Oral cavity, tongue",29.79,0.0,0.0,3.18,67.02,0.0,0.0
UT-7,Adult acute megakaryoblastic leukemia,Male,64Y,Bone marrow,3.36,0.0,2.07,82.57,0.0,12.0,0.0
UWB1.289,BRCA1-associated hereditary breast and ovarian cancer syndrome,Female,56Y,Unknown,26.96,0.0,0.18,0.95,70.57,0.0,1.35
VA-ES-BJ,Epithelioid sarcoma,Male,41Y,Bone marrow,28.41,0.0,0.49,0.0,67.75,0.0,3.35
VAL,Diffuse large B-cell lymphoma,Female,50Y,Bone marrow,32.11,0.0,0.0,0.0,64.59,0.47,2.83
VCaP,Prostate carcinoma,Male,59Y,"Bone, vertebra",27.77,0.05,0.0,1.4,69.8,0.0,0.98
VL51,Splenic marginal zone lymphoma,Female,70Y,Peripheral blood,0.1,0.13,0.61,76.13,0.0,22.43,0.59
VM-CUB-1,Bladder carcinoma,Male,Age unspecified,Urinary bladder,35.26,0.0,1.21,3.22,60.31,0.0,0.0
VMRC-LCD,Lung adenocarcinoma,Male,Age unspecified,Lung,39.12,0.0,0.98,3.69,56.21,0.0,0.0
VMRC-LCP,Lung squamous cell carcinoma,Sex unspecified,Age unspecified,Lung,34.15,0.0,0.95,1.52,62.75,0.0,0.62
VMRC-MELG,Melanoma,Male,Age unspecified,Unknown,28.76,0.0,4.63,0.15,63.56,2.24,0.66
VMRC-RCW,Renal cell carcinoma,Male,Age unspecified,Unknown,24.69,0.43,2.21,1.64,69.86,0.0,1.16
VMRC-RCZ,Renal cell carcinoma,Sex unspecified,Age unspecified,Unknown,34.32,0.0,0.43,2.06,61.8,0.0,1.38
WIL2 NS,Hereditary spherocytosis,Male,5Y,Spleen,28.06,0.61,0.0,0.0,69.86,0.0,1.47
WM115,Melanoma,Female,55Y,"Right anterior leg, skin",31.51,0.17,0.0,0.0,67.47,0.0,0.85
WM1552C,Cutaneous melanoma,Male,72Y,Hypodermis,23.98,0.24,0.0,0.0,72.29,1.1,2.39
WM1799,Melanoma,Male,Age unspecified,Not specified,45.7,0.0,0.37,4.29,47.56,0.0,2.08
WM266-4,Melanoma,Female,55Y,"Right thigh, skin",32.46,0.0,0.04,0.0,66.56,0.62,0.32
WM278,Cutaneous melanoma,Female,62Y,Skin,30.87,0.0,0.85,0.99,64.04,2.12,1.13
WM35,Cutaneous melanoma,Female,24Y,Skin,26.42,0.0,0.0,0.26,72.7,0.38,0.25
WM793,Cutaneous melanoma,Male,37Y,Skin,61.38,0.27,2.43,4.02,24.77,1.29,5.85
WM88,Melanoma,Male,Age unspecified,Not specified,37.01,0.0,3.54,3.99,55.46,0.0,0.0
WM983B,Melanoma,Male,54Y,Inguinal lymph node,64.28,0.0,2.75,5.11,22.68,0.0,5.18
WRO,Thyroid gland follicular carcinoma,Female,Age unspecified,Not specified,61.74,0.0,2.33,1.32,24.0,3.34,7.27
WSU-DLCL2,Diffuse large B-cell lymphoma germinal center B-cell type,Male,41Y,Pleural effusion,31.27,0.0,0.21,2.12,66.4,0.0,0.0
WSU-NHL,Diffuse large B-cell lymphoma germinal center B-cell type,Female,48Y,Pleural effusion,24.73,0.04,0.0,0.0,71.53,0.46,3.25
YAPC,Pancreatic carcinoma,Male,43Y,Ascites,0.0,0.82,0.0,85.11,0.0,13.9,0.15
YD-10B,Tongue squamous cell carcinoma,Male,67Y,"Oral cavity, tongue",0.96,0.0,0.0,62.45,0.0,36.59,0.0
YD-15,Tongue squamous cell carcinoma,Male,39Y,"Oral cavity, tongue",1.62,1.03,0.84,65.12,0.0,31.39,0.0
YD-38,Gingival squamous cell carcinoma,Male,67Y,"Oral cavity, gingiva",0.26,0.56,0.0,61.56,0.0,37.62,0.0
YD-8,Tongue squamous cell carcinoma,Female,46Y,"Oral cavity, tongue",1.01,0.59,0.0,62.69,0.0,35.7,0.0
YH-13,Glioblastoma,Male,49Y,"Brain, left fronto-parietal lobe",0.0,0.0,0.04,83.27,0.0,16.69,0.0
YKG-1,Glioblastoma,Female,53Y,"Brain, right temporo-occipital lobe",0.34,0.77,0.57,82.14,0.28,15.9,0.0
YMB-1,Invasive breast carcinoma of no special type,Female,63Y,Ascites,37.62,0.0,1.26,3.7,57.42,0.0,0.0
YMB-1-E,Invasive breast carcinoma of no special type,Female,63Y,Ascites,32.06,0.0,0.06,0.0,66.59,0.0,1.29
YT,Natural killer cell lymphoblastic leukemia/lymphoma,Male,15Y,Pericardial effusion,0.0,0.69,0.12,74.01,0.0,25.17,0.0
ZR-75-1,Invasive breast carcinoma of no special type,Female,63Y,Ascites,32.67,0.0,0.0,1.23,65.96,0.0,0.14
ZR-75-30,Invasive breast carcinoma of no special type,Female,47Y,Ascites,14.38,0.74,71.64,3.41,9.83,0.0,0.0
